Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,actin binding (GO:0003779),0.7230563381837946,2.131080631441671,0.0,0.0009785619655546189,0.001,42/170,6.29%,PDLIM3;SYNPO2;TPM2;CAP2;DMD;KCNMA1;TPM1;LDB3;MYOZ2;TNNI2;SMTN;TNNC2;ABRA;PDLIM1;NRAP;PDLIM5;CALD1;LMOD2;ACTN4;TNNT3;MYL2;VCL;MICAL2;SYNPO2L;LMOD3;SYNE1;FERMT2;MYH9;MYL3;MYO9B;LCP1;MRTFA;ITGB1;MAP1B;FHL3;SLC6A2;PDLIM7;UTRN;SYNE2;GC;MAPT;SORBS1
prerank,alpha-actinin binding (GO:0051393),0.9142261592371598,2.0930581810923394,0.0,0.0019571239311092377,0.004,14/24,4.42%,PDLIM3;SYNPO2;PALLD;MYOT;LDB3;TTN;CACNA1C;PDLIM1;NRAP;PDLIM5;MYPN;KCNA5;KCNN2;PDLIM7
prerank,muscle alpha-actinin binding (GO:0051371),0.9480820957412595,2.0214826256134604,0.0,0.010764181621100807,0.031,9/15,0.96%,PDLIM3;SYNPO2;PALLD;LDB3;TTN;PDLIM1;NRAP;PDLIM5;MYPN
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.8013972425342287,-1.9988657652500923,0.0,0.015661499256742407,0.015,4/13,2.30%,BMP6;BMP7;BMP4;CDH5
prerank,BMP receptor binding (GO:0070700),-0.8013986653787389,-1.9695794384488239,0.0,0.015139449281517663,0.029,4/12,2.30%,BMP6;BMP7;BMP4;CDH5
prerank,myosin binding (GO:0017022),0.7194076199956413,1.9229037760633971,0.0,0.07070110201132121,0.207,6/55,1.34%,MYBPC1;MYLK2;DMD;CALD1;ACTA1;MYL2
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.8732763832311465,1.909783732931512,0.0,0.07691497049259302,0.263,2/15,0.33%,JPH2;OBSCN
prerank,actinin binding (GO:0042805),0.8580484449725863,1.889221252180895,0.0015082956259426848,0.09867166486009073,0.367,9/21,4.09%,SYNPO2;MYOT;TTN;CACNA1C;PDLIM5;CSRP1;CSRP3;KCNA5;KCNN2
prerank,retinoid binding (GO:0005501),-0.6476536177045227,-1.8767423926474252,0.0,0.05916566385880465,0.146,6/22,4.18%,ALDH1A2;RBP1;PTGDS;CYP26B1;ABCA4;RBP4
prerank,titin binding (GO:0031432),0.8800185769531209,1.857638566204037,0.0,0.14384860893652895,0.542,5/13,3.16%,MYBPC1;OBSCN;TCAP;TRIM63;CAMK2D
prerank,tropomyosin binding (GO:0005523),0.8492368595484383,1.8530422039675034,0.001697792869269949,0.13430762977237143,0.558,5/16,1.60%,LMOD1;CALD1;LMOD2;TNNT3;LMOD3
prerank,cell adhesion mediator activity (GO:0098631),0.7677479432815447,1.8112915390770763,0.006144393241167435,0.21952406760608614,0.782,7/24,6.21%,NEXN;PALLD;MYPN;BCAM;ROBO3;JAM3;DSCAM
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.6652193380974465,1.802160794847277,0.00641025641025641,0.22183999759123207,0.814,17/55,12.49%,CACNB2;RYR1;ATP2A1;RYR2;ATP2B4;ATP2A2;ITPR1;SLC8A2;PKD1L3;TRPV2;ATP2B1;TRPC5;ATP2A3;ANXA9;PANX1;CHRNA7;TRPM2
prerank,cell-cell adhesion mediator activity (GO:0098632),0.7071804609187117,1.8014474097024737,0.008130081300813009,0.2034519286566739,0.816,11/42,7.36%,NEXN;PALLD;PDLIM1;PDLIM5;MYPN;ROBO3;ANXA1;JAM3;DSCAM;CD200;CNN3
prerank,voltage-gated calcium channel activity (GO:0005245),0.7215472993227994,1.7926949013543072,0.009971509971509971,0.20818905817174516,0.843,7/37,4.25%,CACNB2;RYR1;CACNA1S;CACNA1C;CACNA2D1;CACNA1H;CACNB4
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.7560653483427635,1.7858734923341297,0.00744047619047619,0.2085842466578345,0.869,2/24,0.33%,JPH2;OBSCN
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.876829025691124,1.7627427058448237,0.008865248226950355,0.25274857624610725,0.921,3/11,1.66%,RYR1;RYR2;ITPR1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.5749603585316373,-1.7569176177232102,0.0032679738562091504,0.21351843986692148,0.511,9/26,8.02%,SLC6A13;SLC16A12;ABCG2;SLC16A9;SLC6A1;SLC6A12;SLC6A6;SLC16A1;SLC16A11
prerank,ligand-gated calcium channel activity (GO:0099604),0.7773468101648389,1.7544662122758692,0.0203125,0.25997129551567705,0.945,4/19,2.87%,RYR1;RYR2;ITPR1;GRIN2C
prerank,high voltage-gated calcium channel activity (GO:0008331),0.8997039863130253,1.7441654978495609,0.011627906976744186,0.27136746507286524,0.953,4/10,4.25%,CACNB2;CACNA1S;CACNA1C;CACNB4
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.7100531824106499,1.739933241841051,0.015942028985507246,0.2670322916592869,0.961,4/34,3.92%,JPH2;OBSCN;FERMT2;MYO1B
prerank,mannosyltransferase activity (GO:0000030),-0.5933871983010088,-1.7288719230989655,0.005747126436781609,0.23596658880158564,0.629,9/21,21.59%,TMTC1;TMTC2;DPY19L4;TMTC4;DPY19L1;PIGV;ALG1;ALG12;POMT1
prerank,P-type ion transporter activity (GO:0015662),0.820591245420416,1.728183617248454,0.017094017094017096,0.28514208385188755,0.973,5/12,10.33%,ATP2A1;ATP2B4;ATP2A2;ATP2B1;ATP2A3
prerank,adenylate cyclase binding (GO:0008179),0.8797064969154496,1.7260355235146936,0.009708737864077669,0.2757999645023676,0.977,6/10,7.26%,CAP2;AKAP6;ADCY5;ADCY2;CALM1;CAP1
prerank,calcium activated cation channel activity (GO:0005227),0.7871800189765097,1.7182670144932157,0.016260162601626018,0.2824619113573407,0.981,7/17,8.74%,KCNMA1;ANO1;KCNMB1;ANO6;KCNN2;ANO10;TRPM4
prerank,calcium-activated potassium channel activity (GO:0015269),0.8310688129294448,1.7126976416463056,0.01565217391304348,0.28336358631131603,0.987,3/11,4.09%,KCNMA1;KCNMB1;KCNN2
prerank,voltage-gated cation channel activity (GO:0022843),0.6081555959501935,1.71076825806258,0.005820721769499418,0.27564311366099875,0.987,13/97,5.58%,CACNB2;KCNMA1;RYR1;CACNA1S;CACNA1C;CACNA2D1;GRIN2C;KCNQ5;KCNA5;KCNQ4;CACNB4;KCNB1;KCNH1
prerank,NADPH binding (GO:0070402),0.808017537359522,1.7103221069786265,0.015789473684210527,0.26467973859631666,0.987,2/13,3.45%,KCNAB1;CRYZ
prerank,phosphatidic acid binding (GO:0070300),0.7472171542628754,1.6793787473871449,0.022727272727272728,0.3369515034726404,0.998,5/19,7.68%,JPH2;PACSIN2;MARK1;RAPGEF6;OPA1
prerank,miRNA binding (GO:0035198),-0.5326464355889458,-1.6783442763357166,0.00625,0.3429868337226587,0.827,17/30,34.48%,AGO3;PUM1;MATR3;ZC3H7A;TUT4;PNPT1;ZC3H12A;FMR1;TUT7;ZC3H7B;YBX1;RBM10;AGO4;ZC3H10;HNRNPA2B1;ELAVL1;SPOUT1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.6752566953845307,1.6738837644140006,0.023776223776223775,0.33823015777429843,0.998,3/38,1.87%,JPH2;OBSCN;HIP1
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.8216466471303946,1.6730987840643659,0.015734265734265736,0.32759243646874625,0.998,6/12,11.99%,GABRE;GABRA4;GABRA5;GABRB2;GABRG1;GABRB3
prerank,anion transmembrane transporter activity (GO:0008509),-0.6766111495888846,-1.6712568894219093,0.014285714285714285,0.3178538563439816,0.848,5/12,8.17%,ABCG2;SLCO2B1;SLC39A8;SLC22A6;SLC4A2
prerank,potassium channel regulator activity (GO:0015459),0.6349242330517731,1.6692748165140843,0.017264276228419653,0.32640478006610735,0.998,8/49,8.13%,KCNAB1;FLNA;KCNMB1;SLC5A3;KCNE4;KCNIP3;ENSA;WNK2
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.6256612105262644,-1.6690730509651217,0.012165450121654502,0.2842562115098747,0.854,5/15,7.38%,PIK3CA;PI4KA;PIK3R3;PI4K2A;PIK3CB
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.7203629696206243,1.6582970595107205,0.02830188679245283,0.34424412002546406,1.0,4/23,6.55%,JPH2;HIP1;CLVS1;PHLDA3
prerank,vinculin binding (GO:0017166),0.7938871160309768,1.6471668351108868,0.029250457038391225,0.3639913076702646,1.0,5/11,7.37%,DMD;ACTN1;UTRN;TLN1;RTCB
prerank,diacylglycerol kinase activity (GO:0004143),0.8082325957849057,1.6423411628200242,0.015901060070671377,0.36523194427716893,1.0,2/11,0.44%,DGKB;DGKG
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.828104806569629,1.639810046260508,0.018115942028985508,0.36045803498929657,1.0,4/10,9.22%,GABRE;GABRA4;GABRA5;GABRG1
prerank,GABA-A receptor activity (GO:0004890),0.7558864398571531,1.639077285526829,0.03135313531353135,0.3510896852041431,1.0,6/18,11.99%,GABRE;GABRA4;GABRA5;GABRB2;GABRG1;GABRB3
prerank,cation channel activity (GO:0005261),0.5755184652895959,1.625231515614963,0.0166270783847981,0.37775457209697844,1.0,23/94,12.49%,CACNB2;RYR1;RYR2;TMEM38B;ASIC3;TRPC6;ANO1;ANO6;KCNQ4;PKD1L3;TRPV2;CALHM5;ANO10;TRPM4;TRPC5;ABCC8;TMEM38A;ANXA9;PANX1;KCNK3;KCNA2;CHRNA7;TRPM2
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.5914688233220073,1.6228722608368742,0.02063106796116505,0.37271698393918573,1.0,17/72,11.79%,JPH2;OBSCN;HIP1;CGAS;MYO1B;MARK1;SYTL2;TTPA;PHLDA3;PLCB1;AMER1;PLCD1;ACTN2;SNX18;ANXA9;GRAMD2A;OSBPL2
prerank,calcium channel activity (GO:0005262),0.5791278337172538,1.6208569908040193,0.01820388349514563,0.36835868274806005,1.0,18/84,12.49%,CACNB2;RYR1;RYR2;CACNA1S;CACNA1C;TRPC6;CACNA2D1;CACNB4;PKD1L3;TRPV2;NCS1;TRPM4;TRPC5;ANXA9;PANX1;CACNA1B;CHRNA7;TRPM2
prerank,gated channel activity (GO:0022836),-0.6155569535346157,-1.6161884222011809,0.018433179723502304,0.42112031334796257,0.953,9/14,25.66%,PIEZO1;PIEZO2;TMEM63A;TMC7;TMEM266;TMC4;TMC6;TMEM63B;PACC1
prerank,filamin binding (GO:0031005),0.7772048853598126,1.6107398411236675,0.037300177619893425,0.38710280420731463,1.0,2/11,2.54%,SYNPO2;DPYSL4
prerank,cation:chloride symporter activity (GO:0015377),-0.6828289665220024,-1.6097264395912128,0.016913319238900635,0.40239612090323496,0.962,5/10,18.19%,SLC12A2;SLC6A1;SLC12A7;SLC12A6;SLC12A8
prerank,mechanosensitive ion channel activity (GO:0008381),-0.6330555187001462,-1.6087624313638547,0.024774774774774775,0.36951646428180723,0.963,7/12,21.47%,PIEZO1;PIEZO2;TMEM63A;TMC7;TMC4;TMC6;TMEM63B
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.7974440172263251,1.6049917119050163,0.04007285974499089,0.39306453870466873,1.0,1/10,0.36%,NCF2
prerank,calcium ion binding (GO:0005509),0.5305003190446899,1.604684031295289,0.0,0.3835962904974106,1.0,40/323,5.70%,ASPN;SLIT1;SLIT3;RYR1;ATP2A1;TTN;CDH6;RYR2;AOC3;TNNC2;SPARCL1;MYL2;ESYT2;CASQ1;HRC;ATP2A2;ITPR1;FER1L5;PPP3CA;S100G;RASGRP2;DYSF;ASTN2;CDH13;SLC8A1;ANXA1;ASPH;LOXL2;ITSN1;LPL;LCP1;PADI2;STIM1;PITPNM3;CDH4;CAMKK2;SYT10;NUCB1;TESC;CDHR3
prerank,sialyltransferase activity (GO:0008373),-0.5569357219927403,-1.599910317843896,0.025380710659898477,0.36891531582548787,0.976,9/20,10.99%,ST3GAL4;ST3GAL6;ST8SIA4;ST3GAL1;ST3GAL5;ST6GALNAC3;ST8SIA1;ST3GAL3;ST8SIA2
prerank,alkali metal ion binding (GO:0031420),-0.6440620915253374,-1.5973793542526507,0.022332506203473945,0.348729383450131,0.977,3/13,7.62%,ATP1A2;HDAC4;PDXK
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.565709519274162,1.590295699958826,0.016548463356973995,0.4125767794772973,1.0,22/91,11.88%,JPH2;OBSCN;HIP1;CGAS;MYO1B;MARK1;TTPAL;KCNH1;SYTL2;TTPA;MAPT;CLVS1;PHLDA3;PLCB1;AMER1;PLCD1;ACTN2;SNX18;ANXA9;GRAMD2A;OSBPL2;WDR45
prerank,histone demethylase activity (GO:0032452),-0.514428173419098,-1.5817684563119647,0.01764705882352941,0.37035716813801334,0.986,12/27,26.45%,KDM7A;KDM5C;KDM5B;KDM2A;KDM3B;JMJD6;RIOX2;KDM4D;KDM1A;KDM6A;FBXL19;HR
prerank,R-SMAD binding (GO:0070412),-0.572681403640547,-1.5799656121160146,0.012165450121654502,0.35109601000448315,0.988,10/18,18.21%,LDLRAD4;SMAD3;DDX5;SMAD6;RANBP3;RGCC;TRIM33;SMAD2;SMAD4;PMEPA1
prerank,carbohydrate:cation symporter activity (GO:0005402),0.7772492621837183,1.5769542603435063,0.04954128440366973,0.4403284204504396,1.0,5/11,8.88%,SLC5A3;SLC2A10;SLC23A2;SLC23A1;SLC5A11
prerank,BMP binding (GO:0036122),0.7778826550460524,1.5767583742648745,0.050788091068301226,0.4301615196388023,1.0,3/11,3.01%,TCAP;HJV;GREM2
prerank,damaged DNA binding (GO:0003684),-0.4533087784584633,-1.5700996393524378,0.01079136690647482,0.3563643643377929,0.995,27/44,36.05%,HMGB1;ERCC5;XRCC1;DDB1;NBN;EP300;CRY2;XPA;DCLRE1A;ERCC2;ERCC1;RAD1;ERCC4;DCLRE1B;HMGB2;OGG1;RPA3;TDG;SDE2;APTX;FANCG;RAD18;NEIL3;RPA2;ERCC3;DCLRE1C;RPA1
prerank,MAP kinase kinase kinase activity (GO:0004709),0.7725884349986639,1.5554826836726408,0.047957371225577264,0.48543663219834476,1.0,2/11,1.23%,MAP3K20;MAP3K5
prerank,"DNA binding, bending (GO:0008301)",-0.6083338810149594,-1.553636431625053,0.04145077720207254,0.38588705815730406,0.999,8/14,26.96%,LEF1;FOXD1;HMGB1;FOXL1;HMGA2;SAP30L;HHEX;HMGB2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.6580086633192056,-1.549222493283257,0.024330900243309004,0.378370220932336,0.999,4/10,12.36%,ANKRD13A;PML;FAN1;DNAJB2
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.5728945113738868,1.5452197183981622,0.031476997578692496,0.505688963641609,1.0,8/73,5.49%,LHCGR;EDNRA;HCRTR1;CRHR2;EDNRB;VIPR2;TSHR;CYSLTR2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.5507828701980574,1.5325334192511666,0.03864168618266979,0.5367189980620367,1.0,14/75,10.97%,KCNAB1;HSD17B10;DHRS4;HIBADH;MDH1;ME3;HSD17B7;DHRS3;HSD17B4;LDHD;CBR1;HADHB;NSDHL;PTGR1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.664623666459674,1.5221962085277667,0.056962025316455694,0.5583674575454655,1.0,6/22,13.12%,ATP2A1;ATP2A2;ATP6V0A2;ATP6V1C1;ATP2A3;ATP6V0D2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.7457849757341493,1.5146112311866367,0.07473309608540925,0.5726289345391137,1.0,2/11,3.36%,PADI3;PADI2
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.586100199907932,-1.5083974271711271,0.03217821782178218,0.4901224977925808,1.0,5/15,7.74%,ALDH1A2;ALDH1A1;ALDH3A2;ALDH4A1;ALDH7A1
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.6489765253422962,-1.5065711860642452,0.040380047505938245,0.4719853826006938,1.0,4/10,12.36%,ANKRD13A;FAN1;DNAJC2;DNAJB2
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.42391871608397524,-1.5034395556389337,0.012345679012345678,0.4601497638766698,1.0,19/51,18.56%,SLC22A8;SLCO2B1;SLCO1C1;SLCO2A1;SLC7A5;SLC25A3;MCU;SLC35E2B;SLC35E2A;SLC22A6;CLCN4;SLCO3A1;SLC25A14;SLC22A4;SLC5A5;SLC25A30;SLC25A11;SLC35D2;SLC35D1
prerank,calcium-release channel activity (GO:0015278),0.7029460578031794,1.5025715487365154,0.06761006289308176,0.6036686304104387,1.0,3/17,1.66%,RYR1;RYR2;ITPR1
prerank,ion gated channel activity (GO:0022839),0.6372057396718247,1.4932176667084747,0.07737226277372262,0.6246079479304669,1.0,8/24,9.83%,ANO1;ANO6;TTYH1;KCNT2;ANO10;TRPM4;KCNT1;ANO3
prerank,protein heterodimerization activity (GO:0046982),0.5013307003336941,1.492895885475238,0.019027484143763214,0.6126796436989825,1.0,38/178,11.60%,TPM2;TPM1;AGTR1;AOC3;MEF2C;RALGAPA2;UBA2;HIP1;PDGFB;ITGA3;NR4A1;FZD4;ITGB1;EXT2;BCL2;KCNB1;MEF2A;ATP1B1;SAE1;TAF1;TP53;TUBB2B;BCL2L2;FZD9;ADD2;RALGAPA1;TPM4;GCA;NR4A2;RALGAPB;DGKD;HIF1A;SRI;TOP2B;PDGFA;ATF3;ABCG1;BOK
prerank,sodium channel regulator activity (GO:0017080),0.6009742751107806,1.4921018604215326,0.059322033898305086,0.602970311935445,1.0,7/37,7.26%,FGF13;ATP2B4;FGF14;SNTA1;CAMK2D;NEDD4;PRSS8
prerank,glucuronosyltransferase activity (GO:0015020),0.657179748039296,1.4852589253645143,0.07804878048780488,0.6148055392215901,1.0,3/19,3.74%,LARGE1;CSGALNACT1;EXT2
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.6324734937674237,1.4816202900032693,0.07250755287009064,0.6161364868119957,1.0,5/24,6.39%,MYLK2;CAMK2G;CAMK2D;PHKA2;MAPKAPK2
prerank,GABA receptor activity (GO:0016917),0.6606749061686155,1.4809357444090723,0.07931570762052877,0.6073546388097959,1.0,6/21,11.99%,GABRE;GABRA4;GABRA5;GABRB2;GABRG1;GABRB3
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.6895717962367021,1.4762639527253767,0.08914100486223663,0.6008014627790612,1.0,5/16,9.83%,ANO1;ANO6;TTYH1;ANO10;ANO3
prerank,intracellular chloride channel activity (GO:0061778),0.6895717962367021,1.4762639527253767,0.08914100486223663,0.6008014627790612,1.0,5/16,9.83%,ANO1;ANO6;TTYH1;ANO10;ANO3
prerank,Wnt-activated receptor activity (GO:0042813),0.7020621571104203,1.4729244419764125,0.07941653160453808,0.6009069441337899,1.0,7/15,11.55%,FZD5;ROR1;FZD4;FZD8;FZD9;LRP5;TSPAN12
prerank,lysine-acetylated histone binding (GO:0070577),-0.5325552752548465,-1.472658744868367,0.04909560723514212,0.5251368794260759,1.0,7/20,7.53%,MLLT3;CARM1;ATAD2B;BRD9;ZMYND8;TRIM24;BRDT
prerank,acetylation-dependent protein binding (GO:0140033),-0.5325552752548465,-1.472658744868367,0.04909560723514212,0.5251368794260759,1.0,7/20,7.53%,MLLT3;CARM1;ATAD2B;BRD9;ZMYND8;TRIM24;BRDT
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.5615524024980636,-1.4723043830860294,0.06521739130434782,0.5042132677379013,1.0,9/14,31.79%,SLC7A11;SLC1A3;SLC17A6;SLC38A7;SLC1A1;SLC25A22;SLC1A2;SLC25A18;SLC1A6
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5875989523689895,-1.4690175349432175,0.06862745098039216,0.4938175125645926,1.0,6/12,14.28%,IGF1;ARRB1;GNAS;SOCS2;IGF2;INSR
prerank,calcium channel regulator activity (GO:0005246),0.5975585214339114,1.4686313518553988,0.07344632768361582,0.6046654559438461,1.0,10/37,10.49%,PRKG1;ITPR1;INAFM2;PACSIN3;RRAD;STIM1;GEM;CALM1;SRI;REM1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.5927879427329209,-1.466940438058391,0.047619047619047616,0.4823340194172643,1.0,7/13,17.60%,ALDH1A2;ALDH1A1;ALDH3A2;ALDH4A1;ALDH7A1;ADH5;ALDH1L1
prerank,voltage-gated chloride channel activity (GO:0005247),0.7344557177148958,1.4635589652557675,0.11806797853309481,0.61158435671361,1.0,3/10,5.97%,ANO1;ANO6;CLCN6
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.5264995682251997,-1.4580474411631108,0.04591836734693878,0.49451667282770845,1.0,4/18,6.30%,ALDH1A2;ALDH1A1;FAR2;ALDH3A2
prerank,transaminase activity (GO:0008483),0.7016338298709272,1.454957981029001,0.12093862815884476,0.629464130792015,1.0,3/11,7.86%,BCAT2;GOT1;GOT2
prerank,metal ion binding (GO:0046872),0.4736991191826764,1.4519057513976075,0.0030120481927710845,0.6296883154683046,1.0,71/477,10.26%,ASPN;SLIT1;SLIT3;RYR1;ATP2A1;TTN;MAP3K20;CDH6;RYR2;AOC3;TNNC2;SPARCL1;STK38L;MAP3K5;MYL2;ESYT2;UBA2;CASQ1;HRC;DYRK2;ATP2A2;ITPR1;FER1L5;PPP3CA;S100G;ADCY2;RASGRP2;DYSF;ASTN2;CDH13;SLC8A1;ANXA1;ASPH;LOXL2;CSGALNACT1;ITSN1;LPL;LCP1;PADI2;STIM1;PITPNM3;GEM;CDH4;CAMKK2;SYT10;MARK1;NUCB1;TESC;CDHR3;TPPP;EML1;CALB1;CALM1;STK26;RASGRP1;OPA1;PAPOLA;PRKACB;DIS3L2;NCS1;TPM4;CDH2;TRPM4;GCA;BRSK1;AASDHPPT;TPD52;RAP2A;AGRN;SRI;AOAH
prerank,phospholipase C activity (GO:0004629),0.6237933879206338,1.4499924632390868,0.09341500765696784,0.6261673639589088,1.0,7/25,9.49%,EDNRA;PLCE1;PLCB4;PLCL1;CCL5;PLCB1;PLCD1
prerank,glucose transmembrane transporter activity (GO:0005355),0.6585358695405095,1.449309014922969,0.08798646362098139,0.6184195957155013,1.0,4/17,8.88%,SLC2A4;SLC5A3;SLC2A10;SLC5A11
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.6575633498657801,1.446127560347921,0.10097719869706841,0.6186530877154748,1.0,5/18,9.07%,PDLIM1;PDLIM5;ANXA1;CNN3;PPP1CA
prerank,NADP binding (GO:0050661),0.5956220945596834,1.4454333009613676,0.08088235294117647,0.6109743372124534,1.0,3/32,4.65%,KCNAB1;CRYZ;ME3
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.6764554180893992,1.4413368819454835,0.1103202846975089,0.6149132843550524,1.0,4/13,8.73%,RYR2;SOX9;PKIA;PRKAR1B
prerank,E-box binding (GO:0070888),-0.44234557019078935,-1.4396456327485312,0.05517241379310345,0.5386809958640495,1.0,14/34,26.20%,TCF4;ZEB1;MAX;AHR;HES1;BHLHE41;PER1;BHLHE40;PPARG;ATOH8;TAL1;TFAP4;SNAI1;TWIST1
prerank,phosphatidylglycerol binding (GO:1901611),-0.5696549843253513,-1.438394826087969,0.0671462829736211,0.5252182785226627,1.0,6/13,14.95%,PITPNA;PLTP;GSDME;PITPNC1;GSDMD;STOML2
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.5100530050430373,1.4346196725869704,0.06088992974238876,0.6276881941174968,1.0,19/100,12.03%,JPH2;OBSCN;HIP1;FERMT2;MYO1B;TTPAL;KCNH1;TTPA;MAPT;DAB2IP;CLVS1;PHLDA3;ANKFY1;FCHSD2;GAP43;DENND1A;MYO10;WDR45;SNX13
prerank,potassium channel activity (GO:0005267),0.5079334261035485,1.4345643699126354,0.061714285714285715,0.6185534000478159,1.0,18/89,11.35%,KCNMA1;TMEM38B;KCNMB1;KCNQ5;KCNA5;KCNQ4;KCNN2;KCNB1;CCDC51;KCNH1;KCNT2;GRIK5;KCNT1;ABCC8;TMEM38A;KCNH8;KCNK3;KCNA2
prerank,antiporter activity (GO:0015297),-0.5057765669272051,-1.4334687121406349,0.08860759493670886,0.5235813218187396,1.0,11/20,29.34%,SLC35E2B;SLC35E2A;CLCN4;SLC25A14;SLC25A30;SLC25A11;SLC35D2;SLC35D1;SLC35E3;SLC35E4;SLC35C2
prerank,motor activity (GO:0003774),0.5278835526839887,1.4323798234885512,0.07575757575757576,0.6172279597735758,1.0,20/60,14.54%,MYO1E;MYL6;KIF27;MYH9;KIF2A;DYNLRB1;KIF3B;DNAH17;KIF1A;PIN1;KIF5B;CENPE;KIF1C;DYNC1I2;KIF5C;KIF5A;APPBP2;KIF20B;KIF18A;KIF6
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.6150371814705272,1.4316644702959953,0.10223642172523961,0.6104808459313641,1.0,3/21,5.14%,PDE3A;PDE5A;PDE4A
prerank,hexose transmembrane transporter activity (GO:0015149),0.6826811627313569,1.4306733813933898,0.11921708185053381,0.604905068735913,1.0,2/12,2.86%,SLC2A4;SLC5A3
prerank,actin monomer binding (GO:0003785),0.6225023189152988,1.4211618448827945,0.11736334405144695,0.6264863963983831,1.0,5/22,3.40%,LMOD2;MYL2;LMOD3;MYL3;MRTFA
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.3840037707351385,-1.4184046937654404,0.031914893617021274,0.5552254091341905,1.0,26/53,30.26%,SLC7A11;SLC1A3;SLC47A1;SLC3A2;SLC7A5;CTNS;SLC6A9;SLC43A2;SLC17A6;SLC66A1;SLC38A5;SLC38A6;SLC25A38;SLC38A7;SLC7A7;SLC15A4;SLC1A4;SLC36A1;SLC43A1;SLC1A1;SLC25A22;SLC1A2;SLC25A15;SLC7A6;SLC25A18;SLC38A9
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5542497476007628,1.4156790103713506,0.08798882681564246,0.6354944497972621,1.0,3/38,3.37%,SERPINB8;SERPINI1;SERPINE2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.5893607706881966,1.4121115527377903,0.11485451761102604,0.6380089965831792,1.0,3/23,5.14%,PDE3A;PDE5A;PDE4A
prerank,growth factor activity (GO:0008083),0.5143102994464269,1.4113134312108124,0.08484848484848485,0.6318336582999958,1.0,9/74,7.15%,NTF3;FGF1;PDGFB;THPO;JAG1;IL2;VEGFA;GDNF;AREG
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.6785320610044412,1.4111586233019604,0.13345195729537365,0.6237875868160103,1.0,3/12,8.44%,TENT5B;PAPOLA;TENT4A
prerank,chemoattractant activity (GO:0042056),0.5939840592141119,1.4109834969224868,0.11045655375552282,0.6161592671006675,1.0,5/26,6.87%,NTF3;PDGFB;CCL5;VEGFA;GDNF
prerank,microtubule plus-end binding (GO:0051010),0.6181615794822125,1.4068440702741842,0.12519809825673534,0.6204082861616282,1.0,11/20,17.38%,CLASP2;STIM1;DST;MAPRE2;CLIP3;FBXW11;CLASP1;KIF18A;MAPRE3;KNSTRN;DCTN1
prerank,chemorepellent activity (GO:0045499),-0.4589350291875125,-1.403824843261552,0.07076923076923076,0.5886766033128052,1.0,9/25,13.74%,SEMA3D;EPHA7;SEMA3C;SEMA6A;SEMA7A;SEMA3A;SEMA4D;SEMA6D;DPP4
prerank,death receptor binding (GO:0005123),0.671541539815561,1.4037761543903018,0.13644214162348878,0.6212864827973825,1.0,3/15,6.25%,NTF3;MYD88;DAB2IP
prerank,androgen receptor binding (GO:0050681),-0.46823729409831416,-1.401616428045417,0.07575757575757576,0.5793172755372799,1.0,11/25,19.26%,NSD1;PRKCB;FOXP1;DDX5;RNF6;PRMT2;SNW1;EP300;CALR;KDM1A;PARK7
prerank,transforming growth factor beta binding (GO:0050431),0.602147684866509,1.3998500377581429,0.11641791044776119,0.6261186287707509,1.0,5/23,3.63%,LTBP1;VASN;CD36;LRRC32;TGFB3
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.6013834055238199,-1.3997867654260132,0.09957627118644068,0.5681132083328128,1.0,5/10,8.85%,SLCO2B1;SLCO1C1;SLCO2A1;SLC22A6;SLCO3A1
prerank,voltage-gated anion channel activity (GO:0008308),0.6529352385949087,1.398308256167828,0.13793103448275862,0.623282811935445,1.0,4/15,8.76%,ANO1;ANO6;CLCN6;VDAC1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.6681870355413915,1.3965666395644698,0.14695340501792115,0.620879445626525,1.0,2/12,5.14%,PDE3A;PDE4A
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.5555148865648284,-1.3936810334525003,0.10574712643678161,0.5708840214786276,1.0,5/12,18.11%,PIK3CA;PIK3R3;PIK3CB;PIK3R6;ATM
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.6605629093222392,1.38588063948311,0.12802768166089964,0.6464833824389069,1.0,2/14,6.79%,NCF2;KMO
prerank,glutamate receptor activity (GO:0008066),-0.47679223045545704,-1.3820601364230023,0.0945945945945946,0.595020960650606,1.0,7/19,19.55%,GRM3;GRM7;GRIK3;GRIN2D;GRM5;GRID2;GRIK1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.6066062126642386,1.380963327858936,0.12149532710280374,0.654422156892051,1.0,6/23,9.49%,EDNRA;PLCE1;PLCB4;CCL5;PLCB1;PLCD1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.5444261281792129,-1.3789151455057198,0.1394736842105263,0.5893803125699495,1.0,5/14,15.20%,ATXN3;MINDY3;OTUD7B;USP7;MINDY1
prerank,fatty acid synthase activity (GO:0004312),-0.5886188759187905,-1.3786221303556048,0.12831858407079647,0.574804499036932,1.0,7/10,34.38%,ELOVL7;ELOVL4;ELOVL6;ELOVL1;OXSM;ELOVL5;MCAT
prerank,protein homodimerization activity (GO:0042803),0.44687454745191646,1.3753474654842783,0.004008016032064128,0.663779550420674,1.0,119/590,15.03%,MYOM1;TPM2;SOX6;PLN;FLNA;TPM1;ATP2A1;RBPMS;ACTN1;RBPMS2;TRPC6;CAMK2G;ACTN4;MAP3K5;RBM44;MYOM3;ANO1;CHMP4C;HIP1;HSPB6;PDGFB;SYNE1;PDGFC;MYH9;PIP4K2A;MYO9B;CAMK2D;FZD4;LPL;PADI2;CCL5;ACP3;EXT2;NACC2;KCNN2;NR2F2;BCL2;BMPR1A;TBX18;LHPP;TYW5;ATG7;TESC;HSD17B4;ZDHHC2;CRPPA;TPPP;DAB2IP;TERT;VEGFA;GRHL1;ZBTB38;GDNF;SFPQ;STK26;PLEK;BCL2L2;FZD9;GLA;ADD2;TGFB2;RELA;MAP3K10;DAPK3;TRIM68;TPM4;MVD;GCA;MGLL;LRRFIP1;PTH1R;DGKD;HOOK1;TPD52;ST6GAL1;RAB11FIP3;RAB11FIP4;DNM1L;S100A6;PDGFA;GGCT;ATF3;TERF2;ABCG1;BOK;DUSP29;TSG101;GSTA4;AIMP1;GBP2;DROSHA;CHRNA7;KIF20B;SNX9;NR6A1;PDCD10;POU3F3;HPS4;ST3GAL2;CEP43;TMEM192;MKLN1;PDK2;MTCL1;DGCR8;STK10;MCL1;ZBTB4;EPRS1;HM13;SPPL2B;LRRK2;TNNC1;GLB1;KNSTRN;MLXIPL;KARS1;SNX1;EXD2
prerank,solute:sodium symporter activity (GO:0015370),0.5670586465993808,1.3744256295013177,0.1323529411764706,0.6589636276044802,1.0,5/27,8.88%,SLC5A3;SLC4A8;SLC20A2;SLC4A7;SLC5A11
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.5268459931423983,-1.3696635111181894,0.10152284263959391,0.5738634352658031,1.0,6/16,10.85%,PTPRB;PTPRG;PTPRN2;PTPRM;PTPRZ1;PTPRD
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.5268459931423983,-1.3696635111181894,0.10152284263959391,0.5738634352658031,1.0,6/16,10.85%,PTPRB;PTPRG;PTPRN2;PTPRM;PTPRZ1;PTPRD
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.6065375862782262,1.3693680859080388,0.15057283142389524,0.6665372420727729,1.0,2/21,0.93%,RYR2;AKAP6
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.5809415339122648,1.3690244334204158,0.14871016691957512,0.6599331912990873,1.0,6/25,9.77%,OBSCN;HIP1;TTPA;PHLDA3;PLEK;FCHSD2
prerank,cAMP response element binding (GO:0035497),-0.5968466515522416,-1.360956938922492,0.10208333333333333,0.5878028062506151,1.0,6/10,20.05%,CREB5;ATF2;CREB1;CREB3L1;ATF7;HMGA2
prerank,metal ion transmembrane transporter activity (GO:0046873),0.5759419968976939,1.3597876051948734,0.13670133729569092,0.680767767400611,1.0,9/27,10.33%,ATP2B4;CNNM2;ITPR1;SLC8A2;SLC4A8;ATP2B1;SLC23A1;MRS2;ATP2A3
prerank,solute:anion antiporter activity (GO:0140323),-0.525555268209461,-1.3542874042463218,0.12373737373737374,0.595982195525623,1.0,4/14,11.15%,SLC7A11;SLC26A7;SLC4A2;SLC26A2
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5560063444016115,-1.3512819766310848,0.14316702819956617,0.5922717672410246,1.0,2/11,0.83%,SRRM2;LEF1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.5657362150220222,-1.3464610658038132,0.1331877729257642,0.5941640604387473,1.0,3/10,7.38%,PIK3CA;PIK3R3;PIK3CB
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.6678051352499007,1.3461686740193908,0.18613138686131386,0.7167141766817733,1.0,3/10,7.01%,PRDM16;SUV39H2;ASH1L
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.4342849887785465,-1.3458677121587124,0.09841269841269841,0.5823989523607277,1.0,15/29,31.79%,SLC13A3;SLC26A7;SLC25A14;SLC26A2;SLC25A30;SLC25A11;SLC38A7;SLC1A4;SLC1A1;SLC25A22;SLC26A6;SLC25A21;SLC25A18;SLC13A5;SLC1A6
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.5813755120145238,-1.3446695687459784,0.12240184757505773,0.5727796141215865,1.0,7/10,36.36%,B4GALT1;B4GALT6;B4GALT7;B3GALT2;B3GALT1;A3GALT2;B3GALT6
prerank,bHLH transcription factor binding (GO:0043425),-0.4907233013946491,-1.341906824449343,0.11232876712328767,0.5685013155734681,1.0,9/19,26.20%,SMAD3;FHL2;PSMD9;BHLHE41;BHLHE40;KDM1A;LMO2;USF1;TWIST1
prerank,ankyrin binding (GO:0030506),0.604894564606151,1.334574705790393,0.17647058823529413,0.746751508825458,1.0,3/19,4.31%,OBSCN;SLC8A1;FLNC
prerank,metalloaminopeptidase activity (GO:0070006),0.6195363395108555,1.3299665280598538,0.173015873015873,0.753546480618021,1.0,4/16,7.41%,MMP17;LNPEP;RNPEP;ENPEP
prerank,FMN binding (GO:0010181),-0.5621150154021396,-1.3272883133652755,0.15151515151515152,0.6027066963969703,1.0,3/11,9.32%,POR;PPCDC;NOS3
prerank,Toll-like receptor binding (GO:0035325),0.6517476827679723,1.321501708997171,0.20863309352517986,0.7738297838916264,1.0,3/11,6.25%,CD36;MYD88;DAB2IP
prerank,cholesterol binding (GO:0015485),-0.37909890161881615,-1.3201273337917803,0.05454545454545454,0.6117147219898791,1.0,17/47,23.58%,OSBPL8;ABCA1;PTCH1;OSBPL10;GRAMD1C;ANXA6;APOD;SCARB2;SIDT1;PROM1;SOAT1;GRAMD1A;STARD4;SYP;STARD3NL;STARD5;NPC1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.480144268575066,-1.319797808602899,0.12652068126520682,0.600482763502513,1.0,11/16,31.79%,SLC13A3;SLC25A14;SLC25A30;SLC25A11;SLC38A7;SLC1A4;SLC1A1;SLC25A22;SLC25A18;SLC13A5;SLC1A6
prerank,voltage-gated potassium channel activity (GO:0005249),0.47301123939097967,1.316771065138007,0.12220916568742655,0.7816079561863246,1.0,12/80,9.72%,KCNMA1;KCNJ12;KCNQ5;KCNA5;KCNQ4;KCNN2;KCNE4;KCNB1;KCNH1;KCNT2;KCNT1;KCNH8
prerank,leak channel activity (GO:0022840),-0.4824904998623984,-1.311229110444327,0.13414634146341464,0.6149748708147519,1.0,3/18,6.55%,KCNK2;NALCN;KCNK5
prerank,mannose binding (GO:0005537),0.6418443232133983,1.3098603281050136,0.2003577817531306,0.7965390297277837,1.0,2/12,7.74%,CLN5;MBL2
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.5126630955373905,-1.3094781431271354,0.14496314496314497,0.6087705076476578,1.0,5/14,17.15%,SLC26A7;SLC25A14;SLC26A2;SLC25A30;SLC25A11
prerank,DNA-binding transcription factor binding (GO:0140297),0.4327916246517952,1.3043754138449608,0.08900523560209424,0.8069737000576835,1.0,26/189,9.19%,MYOCD;PRDM16;MEF2C;HEY2;CRTC1;GABPA;PRRX1;RUNX1T1;TEAD3;CRTC3;HDAC9;ANKRD2;BCL2;PIAS4;MEF2A;MTDH;TAF1;TP53;AR;YAP1;RELA;MAP3K10;DAPK3;PPARA;MTA3;SKI
prerank,sodium channel activity (GO:0005272),0.5218796245012596,1.3033785690792552,0.1721763085399449,0.8020742377253202,1.0,3/37,1.95%,SCN4A;ASIC3;CACNA1H
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.44435453167016253,-1.3006189360366815,0.1211340206185567,0.6241747703781465,1.0,7/20,15.27%,SLC39A10;SLC30A10;SLC39A11;SLC39A8;SLC30A1;SLC39A1;SLC39A6
prerank,amino acid:sodium symporter activity (GO:0005283),-0.5469424771649973,-1.2962967433590946,0.1650943396226415,0.6260539314000771,1.0,4/11,3.69%,SLC6A13;SLC1A3;SLC6A1;SLC6A12
prerank,ligand-gated anion channel activity (GO:0099095),0.597053214505361,1.294233409578166,0.2009966777408638,0.8247360598765071,1.0,6/17,11.99%,GABRE;GABRA4;GABRA5;GABRB2;GABRG1;GABRB3
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.6271988056920226,1.2937199576128935,0.22945205479452055,0.8181377151607361,1.0,7/13,10.75%,PDGFB;PDGFC;PDGFD;VEGFA;ITGB3;PDGFRB;PDGFA
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.3578189576443313,-1.293492007934823,0.09917355371900827,0.6231568176991834,1.0,19/54,19.79%,NGLY1;ASPA;ACER2;NAAA;HDAC4;PIGL;SIRT7;HINT1;ASAH2;SUDS3;UPB1;ASRGL1;NTAQ1;ASPG;HINT3;HDAC2;NADSYN1;AMDHD2;MIER1
prerank,GTPase inhibitor activity (GO:0005095),-0.5149835911436096,-1.2929075994115298,0.1780821917808219,0.613725679802607,1.0,3/13,3.93%,CPEB2;SLIT2;PDE6D
prerank,water transmembrane transporter activity (GO:0005372),-0.5341815278775002,-1.2894506758321724,0.1603563474387528,0.6134728322895439,1.0,1/11,1.63%,PDPN
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.5475679453441262,1.2870981352256097,0.20060331825037708,0.8329341530443541,1.0,6/27,8.17%,ASIC3;SLC8A2;SLC8A1;SLC4A8;SLC23A1;SLC9A8
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.2920073234264009,-1.2852569947398986,0.03225806451612903,0.615802950085798,1.0,27/134,9.92%,SLC6A13;SLC16A12;SLC1A3;SLC13A3;ABCG2;PDPN;GJA1;SLCO2B1;SLC6A1;SLC6A6;SLC26A7;SLC16A1;SLCO1C1;SLC25A17;SLCO2A1;SLC3A2;SLC25A32;SLC52A1;SLC7A5;SLC39A8;CTNS;SLC22A6;SLC16A11;SLC6A9;SLCO3A1;ABCC4;SFXN2
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.5789615630081351,1.2851907758266683,0.19592476489028213,0.8310731061062266,1.0,5/19,9.22%,GABRE;GABRA4;GABRA5;GRIK5;GABRG1
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.4796032851574856,-1.2848621713010018,0.14766839378238342,0.5962680800358652,1.0,8/17,22.00%,EPHA7;EPHA4;EPHA3;EPHA8;EPHA10;EPHB4;EFNB3;EPHB2
prerank,ephrin receptor activity (GO:0005003),-0.4796032851574856,-1.2848621713010018,0.14766839378238342,0.5962680800358652,1.0,8/17,22.00%,EPHA7;EPHA4;EPHA3;EPHA8;EPHA10;EPHB4;EFNB3;EPHB2
prerank,histone acetyltransferase binding (GO:0035035),0.5661696280617248,1.282614154057692,0.19278996865203762,0.8311866580491604,1.0,11/21,20.79%,MEF2A;TP53;TRIM68;HIF1A;SIRT2;ZBTB7A;CITED2;KANSL1;STAT1;EGR1;KANSL1L
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.6029921651963047,1.2798621800657517,0.21061946902654868,0.8327562326869806,1.0,6/12,21.19%,TAF1;RELA;STAT1;HDAC1;POU2F1;H3-3A
prerank,ATPase activator activity (GO:0001671),-0.4603458876918896,-1.2789464640589001,0.1778975741239892,0.6035753533229591,1.0,7/20,12.40%,ATP1B3;DNAJC10;TOR1AIP2;TOR1AIP1;ATP1B2;DNAJB2;DNAJC19
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.4685877119785129,1.273852959447849,0.18333333333333332,0.8439669425836258,1.0,7/74,4.76%,DGKB;DGKG;NMRK2;FAM20A;HK2;GNE;ADPGK
prerank,sterol transfer activity (GO:0120015),-0.4595505586908033,-1.2722710038156146,0.18276762402088773,0.6132571579930446,1.0,7/17,23.45%,PLTP;ABCA1;GRAMD1C;GRAMD1A;STARD4;OSBP;STARD5
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.5308076845658165,-1.2718012714894726,0.17420814479638008,0.6050642077930249,1.0,8/11,36.42%,SLC25A17;SLC35B3;LRRC8A;SLC25A24;SLC35B2;SLC17A9;SLC25A25;SLC19A1
prerank,kinase binding (GO:0019900),0.4142286395721766,1.2712854272417995,0.0634441087613293,0.8450164850054198,1.0,60/435,11.37%,MYOM1;ACTA2;FLNA;ARHGEF7;TTN;PPP1R12A;INKA2;MYOM2;PRKAB2;LIMS1;CCNA2;FERMT2;FZD5;CCND2;CSPG4;FAM83D;KCNA5;BCAR3;RHOBTB3;LAX1;PARN;TSKS;ACTB;UTRN;DOK7;LYST;CAV1;MAPT;DAB2IP;DUSP3;TP53;PPP2R5A;PARP1;PTPN1;CALM1;TPX2;BTG1;RAD9A;ADD2;RELA;TRIM68;CCND1;RHOF;VDAC1;PPP1CB;SKI;PAK2;TOM1L2;ADCY6;DGKD;HIF1A;CEP192;PDGFRB;GYS1;ANKRA2;RB1;PFKM;PRKCD;UNC5C;RHOH
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.4280786077314688,1.2711265686768785,0.10920770877944326,0.837565165774849,1.0,29/181,11.66%,MYOCD;HEY2;ACTN4;SMARCD3;NR1H4;PRRX1;TEAD3;ARID1A;ANKRD2;ACTB;PIAS4;SETD6;MEF2A;NCOA7;MTDH;TAF1;SMARCB1;TP53;AR;PPARGC1A;MED1;RELA;PPARA;MTA3;HIF1A;RB1;TACC2;PIAS2;BAZ2A
prerank,carboxy-lyase activity (GO:0016831),-0.43331955491676283,-1.2687119398691782,0.12797619047619047,0.6040607635202095,1.0,9/23,21.18%,PPCDC;UXS1;ECHDC1;AMD1;PCK2;AZIN1;DDC;ODC1;GAD1
prerank,I-SMAD binding (GO:0070411),-0.5021647109645658,-1.26779068732804,0.1738095238095238,0.5974500547233612,1.0,7/13,17.37%,SMAD3;SMAD6;SMAD9;CTNNB1;TGFBR1;SMAD2;SMAD4
prerank,hyaluronic acid binding (GO:0005540),-0.5618960014317823,-1.2677263925398652,0.1927437641723356,0.588540158432917,1.0,4/10,14.42%,CEMIP;CD44;LAYN;IMPG2
prerank,calcium channel inhibitor activity (GO:0019855),0.6321998559813214,1.2663354936264375,0.23007246376811594,0.8460129778052489,1.0,3/11,7.03%,ITPR1;PACSIN3;CALM1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.6019994246317619,1.2654770282752872,0.23170731707317074,0.8410602912357993,1.0,4/13,9.22%,GABRE;GABRA4;GABRA5;GABRG1
prerank,transferrin receptor binding (GO:1990459),0.6304695712295328,1.2646879392627335,0.23132969034608378,0.8359274983160929,1.0,1/10,0.59%,HJV
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5336356190744245,-1.2644495976148638,0.20833333333333334,0.587999691497915,1.0,7/11,38.50%,CASP8;CASP9;CASP4;CASP12;CASP6;PYCARD;CASP1
prerank,5'-3' exonuclease activity (GO:0008409),-0.4800529070844559,-1.261728166849304,0.171990171990172,0.5872140956616241,1.0,7/14,25.83%,MRE11;FAN1;TRIR;DCP2;DCLRE1A;DCLRE1B;EXOG
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.334725951923776,-1.261687774214092,0.09090909090909091,0.5788248015158556,1.0,12/71,5.83%,EYA2;PTPN13;EYA1;PTPRB;EYA4;PTPRG;PTPN14;CDC14B;PTPN11;PTPRN2;PTPRM;PTPRZ1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.5341337073492085,1.2612109144529937,0.19562043795620437,0.8399922046524579,1.0,8/28,16.83%,GABRE;GABRA4;GABRA5;GRIK5;GABRG1;CHRNA7;CHRNA4;GRIK4
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.5060953349074938,-1.260199929462979,0.19070904645476772,0.5743295513151109,1.0,9/12,44.76%,B3GALNT1;B3GNT2;B3GALT2;B3GALT1;B3GNT9;B3GNT3;B3GNT8;B3GNT6;B4GAT1
prerank,alanine transmembrane transporter activity (GO:0022858),-0.5113968658580528,-1.260037320287518,0.18276762402088773,0.5666374547988718,1.0,6/12,21.65%,SLC6A6;SLC3A2;SLC38A5;SLC38A7;SLC1A4;SLC36A1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.5100841780462119,-1.2589325148520343,0.17471264367816092,0.5617692775064297,1.0,8/12,36.42%,SLC25A17;SLC35B3;LRRC8A;SLC25A24;SLC35B2;SLC17A9;SLC25A25;SLC19A1
prerank,voltage-gated sodium channel activity (GO:0005248),0.5480557740657652,1.2588259013853427,0.21528861154446177,0.8406114164650236,1.0,2/22,1.95%,SCN4A;CACNA1H
prerank,receptor antagonist activity (GO:0048019),0.5740813029308954,1.2560949939319477,0.2271186440677966,0.8416250014919171,1.0,3/17,6.03%,FST;CCL5;PXDN
prerank,potassium ion leak channel activity (GO:0022841),-0.4731186797282555,-1.2509285938518089,0.19004524886877827,0.5749701096995843,1.0,2/15,6.55%,KCNK2;KCNK5
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.525744360306964,1.2498417406534865,0.2152671755725191,0.854092378400234,1.0,5/25,9.92%,ART1;SIRT3;PARP1;ART4;SIRT2
prerank,adenylyltransferase activity (GO:0070566),0.5427165569200425,1.249783536932121,0.21253822629969418,0.8467418749380488,1.0,7/21,14.97%,NMNAT2;PAPOLA;TENT4A;NMNAT1;COASY;OASL;KARS1
prerank,endopeptidase inhibitor activity (GO:0004866),0.4436960340660958,1.2495181520111156,0.15757575757575756,0.8404044669967101,1.0,7/82,6.82%,SERPINB8;SERPINI1;ROCK1;ITIH4;SERPINE2;LXN;TIMP4
prerank,protein kinase C activity (GO:0004697),-0.4883571181134837,-1.2494675921745293,0.20823798627002288,0.5710380161431341,1.0,4/14,7.70%,PRKCB;PRKCH;SMG1;PRKCE
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.5508696473276136,1.2483785889477157,0.2442622950819672,0.8366449528457499,1.0,2/18,4.70%,HSD17B10;HSD17B7
prerank,lipoprotein particle binding (GO:0071813),0.5469350732238493,1.2465546467587052,0.2016,0.8354557139712693,1.0,4/20,6.18%,CD36;CDH13;LPL;MAPT
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5063090039176612,1.2434167524536972,0.1997126436781609,0.8382846896034901,1.0,6/32,5.58%,KCNQ5;KCNA5;KCNQ4;KCNE4;KCNB1;KCNH1
prerank,SH2 domain binding (GO:0042169),0.5050118680182938,1.2430774235976587,0.2225392296718973,0.8322171943161242,1.0,7/31,11.25%,DLC1;LAX1;NUP62;IRS1;INPPL1;PAG1;ARHGAP5
prerank,WW domain binding (GO:0050699),0.5177148300451939,1.2417599960544443,0.21550387596899226,0.829154466796956,1.0,7/26,20.00%,ENAH;WBP1;KIF20B;TCEAL3;TCEAL6;TCEAL9;NDFIP2
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.5588412553247044,1.241545472451913,0.24247226624405704,0.8230358504958047,1.0,4/18,5.14%,HJV;LTBP1;ACVR2A;BMPR1A
prerank,CXCR chemokine receptor binding (GO:0045236),-0.5170119996931323,-1.237591074758086,0.23543123543123542,0.5952622637502655,1.0,2/11,8.88%,ITCH;YARS1
prerank,acid-thiol ligase activity (GO:0016878),0.5853672750228485,1.2375093988130617,0.25689655172413794,0.8283810093533852,1.0,1/13,0.89%,ACSS1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.3815917545590514,-1.2368621640170705,0.13768115942028986,0.5895730180728952,1.0,14/32,22.83%,SLC6A6;SLC3A2;SLC7A5;SLC6A9;SFXN2;SLC43A2;SLC38A5;SLC38A6;SLC25A38;SLC38A7;SLC1A4;SLC36A1;SLC43A1;SLC1A1
prerank,aminopeptidase activity (GO:0004177),0.525468325077058,1.2357262324057463,0.22889842632331903,0.8272778898798183,1.0,5/26,7.41%,MMP17;LNPEP;RNPEP;BLMH;ENPEP
prerank,glycine binding (GO:0016594),-0.5203657634077636,-1.2350177513876779,0.21460176991150443,0.586811291631848,1.0,5/11,20.83%,GLRB;GRIN3A;GLRA2;SRR;GLRA1
prerank,chloride channel inhibitor activity (GO:0019869),-0.5332092990294623,-1.2335525219440968,0.2149321266968326,0.5835180133332607,1.0,6/10,17.83%,WNK1;WNK4;WNK3;STX1A;VAMP8;STX8
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.5696485733852383,1.229683112483619,0.23865546218487396,0.8400755579577958,1.0,3/15,15.01%,PLA2G3;PLA2G4A;PLA2G4C
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.4948778906038028,-1.226113749643862,0.21052631578947367,0.5947008287389351,1.0,4/12,17.72%,KDM7A;KDM3B;KDM4D;KDM1A
prerank,sequence-specific mRNA binding (GO:1990825),0.6025650069289809,1.223605770020971,0.2585551330798479,0.852043373362912,1.0,1/10,0.82%,RBM24
prerank,receptor tyrosine kinase binding (GO:0030971),0.47199734075413674,1.223234917193761,0.22007722007722008,0.8463699867517764,1.0,10/56,6.83%,ANGPT2;ANGPT1;ANGPT4;SOCS5;PITPNM3;ARHGEF16;IRS1;DUSP3;TP53;PTPN1
prerank,regulatory RNA binding (GO:0061980),-0.36908541339369955,-1.2222541874138029,0.17454545454545456,0.5970946591633044,1.0,17/38,34.48%,AGO3;PUM1;MATR3;ZC3H7A;TUT4;PNPT1;ZC3H12A;FMR1;TUT7;ZC3H7B;YBX1;RBM10;AGO4;ZC3H10;HNRNPA2B1;ELAVL1;SPOUT1
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.4377828679217004,-1.2170166292778062,0.225,0.6039924861507646,1.0,7/18,11.76%,TGFBR3;SMAD3;SMAD6;ENG;FKBP1A;TGFB1;TGFBR1
prerank,ADP binding (GO:0043531),0.5239175155313058,1.2155585500070913,0.25263157894736843,0.8637517946276828,1.0,8/25,11.57%,ACTA1;MYH9;MYO9B;MYO18A;COQ8A;MIEF1;LONP1;ABCG1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.5863778207686103,1.2117178476421406,0.2762237762237762,0.869594852823332,1.0,2/11,1.66%,TRPC6;ITPR1
prerank,microtubule binding (GO:0008017),0.40248205195096476,1.2088908666831986,0.16132368148914167,0.8717228759559797,1.0,71/222,18.91%,FGF13;KIF27;CLASP2;FAM83D;HOOK2;KIF2A;STIM1;MAP1B;TOGARAM2;HAUS8;DST;KIF3B;MAP7D3;ARHGEF2;CEP290;MAPRE2;TUBGCP6;KIF1A;MAPT;NDRG1;TPPP;EML1;EML5;HDGFL3;TPX2;RMDN3;TOGARAM1;OPA1;KIF5B;SUN2;WHAMM;CCDC170;HOOK1;CENPE;CCDC181;KIF1C;DNM1L;FHDC1;KIF5C;CLIP3;FBXW11;KIF5A;KIF20B;CLASP1;MAST1;MTCL1;MAP4;KIF18A;HAUS7;LRRK2;KIF6;MAPRE3;UXT;KNSTRN;DNM2;CCDC66;ABRAXAS2;MAP9;GAS2L3;KIF7;S100A8;S100A9;STARD9;DCTN1;SGIP1;MAP1A;MAP1S;MAP6;CEP295;HAUS4;HDAC6
prerank,CoA-ligase activity (GO:0016405),0.56057696673344,1.2075282521224617,0.2943201376936317,0.8691147404459209,1.0,1/14,0.89%,ACSS1
prerank,Hsp70 protein binding (GO:0030544),-0.3830163090008622,-1.2045739575325938,0.2185430463576159,0.6285354372443703,1.0,8/31,14.14%,DNAJB12;DNAJC10;PRKN;DNAJC2;STUB1;ERN1;DNAJB2;SNCA
prerank,carbohydrate kinase activity (GO:0019200),0.5971946958495581,1.2041229117685253,0.2937062937062937,0.8729525472720704,1.0,3/11,7.55%,HK2;GNE;FGGY
prerank,MAP kinase activity (GO:0004707),-0.46294181381478605,-1.2034871802294564,0.24880382775119617,0.6238937487047361,1.0,7/14,26.72%,MAPK14;MAPK4;MAPK9;MAPK6;MAPK7;MAPK10;MAPK8
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.5194865595132385,-1.2028741113808548,0.2543478260869565,0.6182314682792491,1.0,3/10,12.76%,KDM7A;KDM2A;RIOX2
prerank,kinase activity (GO:0016301),0.415119458846503,1.201995591850906,0.2110609480812641,0.8729818524160771,1.0,21/109,14.40%,DGKB;DGKG;CKM;NMRK2;CKMT2;SEPHS2;ADPGK;SEPHS1;TAF1;COQ8A;PSTK;PKN2;DGKD;ITPKC;COASY;PRKD3;PIK3C3;DGKZ;CHKB;CKB;LRRK2
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.5264673206243844,-1.2011640511115604,0.2391304347826087,0.6157855837174538,1.0,6/10,38.50%,CASP8;CASP9;CASP4;CASP12;CASP6;CASP1
prerank,tau-protein kinase activity (GO:0050321),0.5293611326630001,1.2009561554262733,0.2779552715654952,0.869800733761802,1.0,5/20,10.88%,ROCK1;MARK1;DYRK1A;BRSK1;ROCK2
prerank,store-operated calcium channel activity (GO:0015279),0.5851607864821993,1.200017869259436,0.28598848368522073,0.8663878623452524,1.0,2/10,8.90%,TRPC6;TRPC5
prerank,cholesterol transfer activity (GO:0120020),-0.44334157971768384,-1.1997443696480108,0.22588832487309646,0.6121582290879579,1.0,5/16,17.16%,PLTP;ABCA1;GRAMD1C;GRAMD1A;STARD4
prerank,pentosyltransferase activity (GO:0016763),0.475775886683935,1.1990578160638974,0.25895316804407714,0.8630113239055835,1.0,8/36,13.72%,ART1;LARGE1;SIRT3;PARP1;ART4;SIRT2;PPAT;SIRT4
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.44687278598184366,1.195034095179785,0.23945409429280398,0.8689630254125015,1.0,10/60,10.19%,LRRC2;CAMK2G;PPM1L;PPM1J;PPP3CA;PPM1E;PPM1A;PPP1CB;PPP1CA;CTDSP2
prerank,nucleoside-diphosphatase activity (GO:0017110),0.5690822482871811,1.1939866892441318,0.28522920203735147,0.8659985582815567,1.0,2/12,7.17%,ENTPD1;ENTPD7
prerank,GDP binding (GO:0019003),0.4422724628651588,1.1926791786974187,0.2388451443569554,0.8637345045454506,1.0,8/63,9.86%,RASL12;RAP1A;RERG;GEM;RAP2C;RRAS;MIEF1;RAP2A
prerank,protein serine/threonine kinase activity (GO:0004674),0.3879776329717172,1.189534444772762,0.14068825910931174,0.8667789885618434,1.0,81/335,17.81%,MYLK2;MYLK;TTN;MAP3K20;MYLK4;CAMK2G;STK38L;MAP3K5;ROCK1;MAST4;KALRN;PRKAB2;DYRK2;CDK6;FAM20A;CAMK2D;ACVR2A;MARK1;BMPR1A;DYRK1A;PRKCQ;MAP4K3;MAP4K5;TAF1;RPS6KA2;MAPKAPK2;DYRK1B;CHEK1;NUAK1;MAP3K10;WNK2;DAPK3;MAP2K1;BRSK1;PKN2;PAK2;CDK7;STK33;STK24;EIF2AK2;ROCK2;PRKCD;ACVR1B;CDK12;DMPK;BMPR1B;TNIK;BCR;CDC42BPB;STK36;PRKD3;TAOK3;CDK15;MAST1;CPNE3;CSNK1E;SGK1;STK10;MAPK1;LRRK2;PRKAA2;PRKCA;PRKACA;SRPK2;MAPK12;CSNK1A1;RAF1;PLK4;HIPK2;MAST3;ATP23;MAP3K13;EIF2AK3;CDK14;MAP3K2;MARK2;BRD4;MASTL;EIF2AK4;STK35;DAPK2
prerank,protein phosphatase binding (GO:0019903),0.4099291890485553,1.1873942412994927,0.217440543601359,0.8673931022591296,1.0,13/117,7.71%,MYOZ2;ATP2B4;PPP1R3A;MAP3K5;ITGA1;STRN3;MFHAS1;AKAP11;MAPT;DAB2IP;TP53;TRAF3;ENSA
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.4001397341464583,-1.1868874587327627,0.23607427055702918,0.6379330685757849,1.0,13/22,32.95%,OTUD7B;PARP10;OPTN;IKBKG;TAB2;ATRIP;WDR81;PRPF8;ZBTB1;IKBKE;SQSTM1;TNFAIP3;MINDY2
prerank,microtubule motor activity (GO:0003777),0.4467589212648192,1.1837397779971766,0.22933333333333333,0.8721922798988317,1.0,18/51,17.28%,KIF27;KIF2A;DYNLRB1;KIF3B;DNAH17;KIF1A;KIF5B;CENPE;KIF1C;DYNC1I2;KIF5C;KIF5A;APPBP2;KIF20B;KIF18A;KIF6;KIF7;STARD9
prerank,histone deacetylase binding (GO:0042826),0.422312590589536,1.1825132768270226,0.24883720930232558,0.8695182378752274,1.0,21/88,14.13%,MEF2C;HEY2;GMNN;NACC2;PRDM1;HDAC9;MEF2A;TP53;SFPQ;RAD9A;RELA;CCND1;MTA3;PKN2;SIRT2;TOP2B;ANKRA2;KPNA2;CHD4;MEF2B;MTA1
prerank,exonuclease activity (GO:0004527),-0.3353972673074754,-1.177530110398125,0.1896551724137931,0.6553744200338488,1.0,22/46,27.19%,REXO5;MRE11;ENPP2;RAD50;FAN1;ENPP3;TRIR;EXOSC1;REXO1;ENPP1;ISG20L2;EXOSC9;ZC3H12A;EXOSC2;RAD1;AEN;DCLRE1B;EXOSC7;EXOSC3;EXOG;EXD1;EXOSC5
prerank,tubulin binding (GO:0015631),0.3862038523615636,1.1755884159730776,0.17426545086119555,0.8850472763111246,1.0,78/296,17.51%,ARHGEF7;FGF13;AGBL1;DLEC1;KIF27;CLASP2;FAM83D;HOOK2;KIF2A;TTLL7;MAP1B;TOGARAM2;HAUS8;DST;KIF3B;PRUNE1;MAP7D3;ARHGEF2;GABARAP;MAPRE2;TUBGCP6;KIF1A;MAPT;NDRG1;TPPP;RABGAP1;IFT81;EFHC1;EML1;EML5;HDGFL3;TPX2;RMDN3;TOGARAM1;OPA1;KIF5B;SUN2;WHAMM;CCDC170;WASHC1;BRSK1;HOOK1;CENPE;CCDC181;KIF1C;DNM1L;NCALD;ALDOA;FHDC1;TBCD;KIF5C;UNC5C;CLIP3;KIF5A;KIF20B;CLASP1;MAST1;MTCL1;MAP4;KIF18A;STMN2;LRRK2;KIF6;MAPRE3;UXT;DNM2;CCDC66;ABRAXAS2;MAP9;GAS2L3;INO80;KIF7;S100A8;S100A9;STARD9;DCTN1;SGIP1;MAP1A
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.5067070607129448,-1.1748880802863446,0.2698072805139186,0.6554132138394644,1.0,3/10,3.69%,SLC6A13;SLC6A1;SLC6A12
prerank,gamma-tubulin binding (GO:0043015),0.5090787327529287,1.1739312783958455,0.29595015576323985,0.8837920028905216,1.0,4/22,9.13%,ARHGEF7;TUBGCP6;NDRG1;BRSK1
prerank,beta-tubulin binding (GO:0048487),0.4824986672303739,1.1717603536388195,0.2762039660056657,0.8844025586468078,1.0,4/31,5.50%,FGF13;DLEC1;TTLL7;GABARAP
prerank,chloride channel activity (GO:0005254),0.4462163598164094,1.1674843448478143,0.27168367346938777,0.8913687200720971,1.0,11/59,11.99%,ANO1;GABRE;ANO6;CLCN6;GABRA4;TTYH1;GABRA5;GABRB2;GABRG1;ANO3;GABRB3
prerank,protein tyrosine kinase activity (GO:0004713),0.4078070842744749,1.166933151477985,0.25510204081632654,0.8869055622740747,1.0,11/108,5.45%,TTN;NTRK3;DYRK2;MERTK;MST1R;ROR1;FRK;MUSK;CAMKK2;PEAK1;DYRK1A
prerank,monocarboxylic acid binding (GO:0033293),0.5289245511693784,1.1644486036700121,0.3106796116504854,0.8882746462429365,1.0,2/18,4.32%,NR1H4;NR2F2
prerank,ribosomal large subunit binding (GO:0043023),-0.49316192246336255,-1.163493340505477,0.30585683297180044,0.678177721148628,1.0,4/11,13.61%,CPEB2;NMD3;LTN1;NEMF
prerank,N-acetyltransferase activity (GO:0008080),0.5197274247427478,1.1609235161098153,0.3122977346278317,0.8928253911806543,1.0,8/19,18.45%,NAT10;SAT2;NAT8L;NAT8;NAT14;NAT2;NAT1;ESCO1
prerank,MHC class I protein binding (GO:0042288),-0.461189781680688,-1.160022079605536,0.27684964200477324,0.6795599106068421,1.0,7/13,44.86%,DERL1;ABCB9;TAP1;TAPBP;ATP5F1B;TAP2;LILRB1
prerank,U6 snRNA binding (GO:0017070),0.5334528669473301,1.156411039187121,0.3182640144665461,0.9003755212598018,1.0,3/14,10.93%,LSM8;EIF5A;PRPF4
prerank,leucine zipper domain binding (GO:0043522),0.5763336689382433,1.1556448282615528,0.3240223463687151,0.8965454253482678,1.0,5/10,18.01%,MRTFA;DAPK3;PAWR;PMF1;DDIT3
prerank,telomeric DNA binding (GO:0042162),-0.3618301614113458,-1.155625094298946,0.24397590361445784,0.6837152338568452,1.0,12/32,17.91%,UPF2;XRCC5;STN1;SMG1;RAD50;BLM;XRCC6;HNRNPD;CTC1;TERF2IP;KDM1A;SMG6
prerank,MAP kinase phosphatase activity (GO:0033549),0.5608247929292061,1.155555946489201,0.32154882154882153,0.8908413379668882,1.0,4/12,12.82%,DUSP5;DUSP3;DUSP29;DUSP16
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.5265837968771634,1.1528429450261195,0.3022452504317789,0.8931373687063016,1.0,4/16,8.60%,ALOX5;ETHE1;HGD;ADI1
prerank,metalloexopeptidase activity (GO:0008235),0.44698654838115937,1.1526056344682671,0.29069767441860467,0.8879202650589322,1.0,7/51,7.41%,MMP17;AGBL1;LNPEP;RNPEP;CPA4;CPA3;ENPEP
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.5460864708204127,1.1525609030990298,0.32854578096947934,0.8822879893200861,1.0,3/12,8.50%,CRYZ;DHRS4;CBR1
prerank,frizzled binding (GO:0005109),-0.36303806135583294,-1.1519042005630078,0.26174496644295303,0.6865686921482618,1.0,13/34,33.20%,WNT4;WNT5A;WNT9A;SDCBP;RNF43;WNT6;MYOC;ZNRF3;WNT16;DVL2;WNT11;CCDC88C;BAMBI
prerank,potassium ion antiporter activity (GO:0022821),-0.4397608102177788,-1.1459760822430336,0.30641330166270786,0.6953372446605188,1.0,7/15,27.32%,SLC24A3;SLC9A2;SLC9A6;SLC9A9;SLC9A5;SLC24A2;SLC24A4
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.4451778862634588,1.1422371375549363,0.3131578947368421,0.9073100278562354,1.0,7/44,9.03%,PRDM16;SMYD1;SUV39H2;ASH1L;KMT2D;SETD3;NSD3
prerank,voltage-gated ion channel activity (GO:0005244),0.5469893695501785,1.1409652112619926,0.32945091514143093,0.9053705487976235,1.0,3/14,8.76%,CACNA1H;ANO6;VDAC1
prerank,protein phosphatase 1 binding (GO:0008157),0.49761813372768415,1.1372031957825417,0.3328100470957614,0.9106048884180457,1.0,2/21,5.82%,PPP1R3A;AKAP11
prerank,cation transmembrane transporter activity (GO:0008324),-0.31512205319290476,-1.1365198464196078,0.22448979591836735,0.7143182334685727,1.0,18/48,22.83%,SLC41A1;SLC6A6;SLC3A2;SLC7A5;SLC6A9;SFXN2;SLC39A1;SLC66A1;SLC38A5;SLC38A6;SLC25A38;SLC8B1;SLC38A7;MMGT1;SLC15A4;SLC1A4;SLC36A1;SLC1A1
prerank,cadherin binding (GO:0045296),0.3781913115739791,1.1355355539868852,0.23523421588594703,0.9098954053514287,1.0,48/315,10.24%,CTNNA3;FLNA;NOTCH3;CDH6;PDLIM1;PDLIM5;CALD1;VASN;VCL;ESYT2;PFKP;CNN2;MYH9;PHLDB2;COBLL1;CDH13;ANXA1;PACSIN2;BZW2;ITGB1;TAGLN2;MYO1B;CDH4;ARHGEF16;CDHR3;MPP7;EPN2;NDRG1;DAB2IP;CHMP5;KTN1;PTPN1;TLN1;CNN3;KIF5B;CDH2;PPP1CA;ANLN;PKN2;PAK2;ARHGAP1;LRRFIP1;EPHA2;BAG3;PARVA;IST1;STK24;EIF3E
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.3531929370602517,-1.135151627467137,0.25418060200668896,0.7103359996224723,1.0,9/32,12.76%,KDM7A;KDM2A;TET3;TET2;EGLN3;BBOX1;PHYH;EGLN2;RIOX2
prerank,growth factor receptor binding (GO:0070851),0.40368590229462903,1.1337601790646985,0.2926267281105991,0.9090163667447623,1.0,16/95,10.75%,FGF1;HIP1;PDGFB;PDGFC;IL2;PDGFD;ATXN2;VEGFA;IL12RB1;AREG;PIBF1;ITGB3;ADAM17;PDGFRB;HBEGF;PDGFA
prerank,ubiquitin protein ligase activity (GO:0061630),-0.24483867246504934,-1.1337397850126805,0.14705882352941177,0.7067264994501281,1.0,58/228,15.37%,RNF220;KCMF1;RNF145;NEDD4L;SH3RF1;TRIP12;AREL1;ITCH;RNF38;CUL3;RNF185;MYCBP2;PPIL2;UBE2D3;RNF135;RC3H2;RNF144B;SHPRH;RNF217;TRIM24;RNF6;UBR2;BIRC2;RNF25;RNF13;HERC2;LTN1;MDM2;PELI1;TOPORS;TRIM25;WWP1;SH3RF3;SMURF2;RNF144A;PRKN;UBE3A;MGRN1;MKRN2;RNF181;UBE4B;TRIM5;RNF34;STUB1;DTX1;VPS18;TRIM14;RNF125;DTX3L;RNF166;SH3RF2;SIAH1;RNF115;HECW1;BIRC3;RNF10;NHLRC3;RNF43
prerank,transmitter-gated ion channel activity (GO:0022824),0.48139896386781783,1.1325241434681266,0.34017595307917886,0.9069312296760207,1.0,7/29,11.99%,GABRE;GABRA4;GABRA5;GRIK5;GABRB2;GABRG1;GABRB3
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.3066536858345358,-1.1288165283447462,0.21844660194174756,0.7129391467778448,1.0,14/55,9.67%,SLC6A13;SLC16A12;SLC13A3;PDPN;SLC16A9;SLC6A12;SLC6A6;SLC16A1;SLC7A14;SLC25A32;SLC7A5;SLC16A11;SLC38A10;SLC22A4
prerank,syntaxin-1 binding (GO:0017075),0.4917969414924309,1.1287749821818718,0.3429003021148036,0.9117523188131506,1.0,2/22,1.34%,STXBP2;SYPL2
prerank,galactosyltransferase activity (GO:0008378),-0.47481196602628034,-1.1200809358909474,0.31756756756756754,0.7293512744776284,1.0,8/11,36.36%,B4GALT1;B4GALT6;B4GALT4;B4GALT7;B4GALT3;B4GALT2;A3GALT2;B3GALT6
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.42110425633288245,-1.1174088327008591,0.343980343980344,0.7288235294117648,1.0,9/15,31.79%,SLC1A3;SLC17A6;SLC38A7;SLC1A4;SLC1A1;SLC25A22;SLC1A2;SLC25A18;SLC1A6
prerank,peptide hormone receptor binding (GO:0051428),-0.46236791159817225,-1.1167079581372275,0.33182844243792325,0.723344175572792,1.0,5/11,37.66%,PSMC5;PTHLH;ADCYAP1;GNRH1;CCK
prerank,wide pore channel activity (GO:0022829),0.4866275271985715,1.1109674953643733,0.3568147013782542,0.9588095110647199,1.0,4/23,11.43%,GJD3;GJC1;PANX1;GJA4
prerank,nuclear localization sequence binding (GO:0008139),0.503750382612164,1.108772023584335,0.3656093489148581,0.9594109675784273,1.0,7/18,14.38%,CABP1;KPNA4;NUP153;RANBP6;KPNA2;KPNA3;IPO4
prerank,gap junction channel activity (GO:0005243),0.49023740360818713,1.1084579730006283,0.3712948517940718,0.9545633300335172,1.0,4/22,11.43%,GJD3;GJC1;PANX1;GJA4
prerank,ferrous iron binding (GO:0008198),-0.38433571788008847,-1.1081992781246985,0.29829545454545453,0.7385574071066807,1.0,11/21,26.19%,TET2;EGLN3;FTL;FTH1;PHYH;EGLN2;SNCA;CDO1;HIF1AN;ISCU;FECH
prerank,thyroid hormone receptor binding (GO:0046966),-0.3594519679486171,-1.1037915598715127,0.3081761006289308,0.7430747841529097,1.0,6/28,6.47%,NSD1;MED13;TRIP12;TACC1;MED17;PRMT2
prerank,low-density lipoprotein particle binding (GO:0030169),0.4987635752699453,1.101194520325019,0.3793706293706294,0.9707216084730236,1.0,2/16,2.68%,CD36;CDH13
prerank,protein tyrosine kinase activator activity (GO:0030296),0.4960887874031662,1.0998427524491097,0.3646496815286624,0.969242047075451,1.0,5/19,13.58%,ANGPT4;CCL5;ERCC6;PAK2;GAS6
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.24047572502341275,-1.099246444547366,0.18181818181818182,0.7481277327648639,1.0,98/346,19.45%,RNF220;TTC3;KCMF1;RNF145;NEDD4L;SH3RF1;TRIP12;FBXL5;RNF146;AREL1;ITCH;RNF38;FBXO10;CUL3;SEL1L;RNF185;MYCBP2;RNF20;PPIL2;UBE2D3;RNF135;BIRC6;RC3H2;RNF144B;SHPRH;RNF217;TRIM24;RNF6;PML;UBR2;BIRC2;RNF25;RNF13;FBXO9;HERC2;LTN1;RNF213;MDM2;PELI1;FBXO4;TOPORS;UBE2E2;CDC23;UBE2E3;FBXO7;RBCK1;TRIM25;WWP1;SH3RF3;SMURF2;RNF144A;RNF31;PRKN;UBE3A;MGRN1;FBXO25;MKRN2;RMND5B;RNF181;TRIM5;FBXO3;RNF34;STUB1;RMND5A;DZIP3;DTX1;VPS18;TRIM14;RNF125;DTX3L;RNF166;FBXW8;SH3RF2;SIAH1;UBE2H;RNF115;HECW1;BIRC3;RNF10;OBI1;NHLRC3;RNF43;TRIM56;DTX3;BCOR;CDC42;UBE2S;ANAPC4;UBA7;SIAH2;SYVN1;RNF130;CHFR;NEURL2;RNFT1;ARIH1;RNF41;BTRC
prerank,protein kinase binding (GO:0019901),0.3542900351198535,1.0975918313481612,0.26226226226226224,0.9702764169360905,1.0,62/480,10.14%,ACTA2;ARHGEF7;TTN;PPP1R12A;RYR2;INKA2;PDLIM5;PRKAB2;LIMS1;CCNA2;FERMT2;FZD5;CCND2;CSPG4;FAM83D;DUSP5;KCNA5;ITGB1;RHOBTB3;LAX1;HDAC9;PARN;ANKRD2;TSKS;ACTB;UTRN;DOK7;IRS1;LYST;CAV1;MAPT;DAB2IP;MAPKAPK2;DUSP3;TP53;PARP1;PIN1;PTPN1;CALM1;TPX2;PLEK;RAD9A;SOX9;ADD2;RELA;PKIA;TNIP1;TRIM68;CCND1;RHOF;PRKAR1B;VDAC1;GSTP1;PPP1CB;SKI;PAK2;TOM1L2;ADCY6;HIF1A;CEP192;PDGFRB;GYS1
prerank,double-stranded DNA binding (GO:0003690),-0.21788416713516556,-1.0962514037230846,0.0,0.7491367425429859,1.0,120/531,20.09%,TCF4;FLI1;NFAT5;ZBTB20;HLF;RBMS1;LEF1;NFATC3;HOXB6;FOXP1;ZIC1;ELF1;HMGB1;KDM5B;PKNOX2;CREM;ZIC4;KLF12;E2F3;GLI2;EGFR;ERG;CREB5;PKNOX1;RUNX2;JDP2;PRKDC;XRCC5;CUX1;HOXB4;MTF1;ARNT2;ELK3;PRRX2;TBX15;HOXA5;MRE11;WDR48;MEOX2;ELK4;MBD1;POLR3F;CRY1;KLF3;ZFP1;GLIS1;FOXC2;POU6F1;RAD50;FBH1;TFEB;MAU2;HSF2;TFCP2;CAMTA1;ERCC5;MAX;NR3C1;RFX2;AHR;MEIS2;OSR1;ESR1;MAFG;ATF2;ZNF740;SIX1;ZNF177;DDX60;HES1;TEAD2;ZIC5;IRF9;CREB1;TARDBP;XRCC6;SOX4;BHLHE41;ZNF76;KLF2;GMEB2;CEBPB;ELF2;ELK1;MAF;KLF10;ARNT;TEF;BHLHE40;CREB3L1;ATF7;GLIS2;KLF5;VSX1;KLF13;RARA;NFIB;TFE3;SMAD2;LHX6;PPARG;NPAS2;XPA;RORB;TFCP2L1;KLF11;E2F4;HOXB8;TGIF1;HSF1;CAMTA2;PARK7;MECP2;THRB;SATB1;HOXB9;HOXA9;MSH6;ONECUT2;NFATC2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.3698278868440804,1.0924101536181523,0.3273684210526316,0.9796511982186588,1.0,20/188,8.05%,SOX6;PRDM16;SOX5;MEF2C;GABPA;ARID5B;HINFP;MTERF3;TBX18;KLF15;SUV39H2;JUND;ARID5A;TP53;GRHL1;SFPQ;AR;YAP1;RELA;KMT2D
prerank,pyridoxal phosphate binding (GO:0030170),0.48603591403052754,1.0876914789588068,0.37205651491365777,0.9877222320014082,1.0,3/20,10.83%,PYGM;PYGB;ACCS
prerank,carboxylic acid binding (GO:0031406),-0.333205188895358,-1.0864083139171423,0.304,0.7698858134630461,1.0,14/38,25.66%,GRM7;UBR2;GLRB;NOS3;GRIN3A;GLRA2;PHYH;SRR;HIF1AN;EPDR1;GLRA1;PSAP;SESN2;GCLC
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.30136872633249545,-1.0856054775253767,0.2950191570881226,0.7650325253756147,1.0,20/49,24.54%,UBQLN1;OTUD7B;UBL7;UFD1;PARP10;OPTN;IKBKG;TAB2;BRCC3;EPS15;DZIP3;MINDY1;UBXN1;ATRIP;UBQLN2;WDR81;SHARPIN;PRPF8;ZBTB1;RAD23B
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.4468608049143428,1.084644605324482,0.3713850837138508,0.9912717586131164,1.0,6/31,11.35%,TMEM38B;KCNQ4;ABCC8;TMEM38A;KCNK3;KCNA2
prerank,magnesium ion binding (GO:0000287),0.36498674251994717,1.0836757867923794,0.35462555066079293,0.9883876433023222,1.0,18/135,9.86%,MAP3K20;STK38L;MAP3K5;UBA2;DYRK2;ADCY2;GEM;MARK1;TESC;TPPP;STK26;OPA1;PAPOLA;PRKACB;DIS3L2;BRSK1;AASDHPPT;RAP2A
prerank,G protein-coupled receptor activity (GO:0004930),0.3648306631916955,1.0836009007726468,0.3374485596707819,0.9828289508695371,1.0,18/239,10.07%,AGTR1;LHCGR;GPR20;HCRTR1;CRHR2;S1PR3;VIPR2;ADRA1D;TSHR;TAPT1;CYSLTR2;CXCR6;GPR17;NTSR2;XPR1;PTH1R;ADGRL2;PDGFRB
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.5104759092675409,1.0826562578711865,0.403747870528109,0.9799025388831532,1.0,6/12,19.83%,CDK6;CDK7;CDK12;MAPK1;BRD4;CDK13
prerank,solute:proton symporter activity (GO:0015295),-0.41320268437675806,-1.0797654426705998,0.3645833333333333,0.7733783679269274,1.0,4/16,7.66%,SLC2A13;SLC25A3;SLC39A8;CTNS
prerank,inward rectifier potassium channel activity (GO:0005242),0.45939680642055974,1.0790689792721424,0.3984615384615385,0.9849732336048043,1.0,3/24,9.37%,KCNJ12;KCNN2;ABCC8
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.4540191380649931,-1.0790598493466723,0.3977777777777778,0.7681127231802203,1.0,2/11,5.36%,SASH1;STK38
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.439330346148984,1.0783686441041667,0.3915574963609898,0.9813578568847748,1.0,5/29,8.73%,INKA2;PKIB;HEXIM1;PKIA;PRKAR1B
prerank,retinoid X receptor binding (GO:0046965),-0.4451695975185785,-1.0783302888371955,0.3744493392070485,0.7629807846998333,1.0,3/11,8.25%,NSD1;TACC1;MED25
prerank,iron ion binding (GO:0005506),-0.3028279621858421,-1.0782226344392194,0.3088235294117647,0.7563704605008491,1.0,13/48,15.09%,AGMO;KDM7A;FBXL5;AOX1;TET2;JMJD6;EGLN3;FTL;FTH1;PHYH;EGLN2;SNCA;CDO1
prerank,sterol binding (GO:0032934),-0.2993801022204081,-1.0778929830800765,0.3333333333333333,0.7506612527682552,1.0,19/56,23.58%,OSBPL8;ABCA1;PTCH1;OSBPL10;GRAMD1C;ANXA6;APOD;SCARB2;SIDT1;PROM1;SOAT1;GRAMD1A;INSIG1;STARD4;OSBP;SYP;STARD3NL;STARD5;NPC1
prerank,ATP binding (GO:0005524),0.36087049145304406,1.0775671103330515,0.32991803278688525,0.9780671245606736,1.0,44/266,13.66%,RYR1;MAP3K20;STK38L;MAP3K5;ACTA1;UBA2;DYRK2;PFKP;CDK6;MYH9;PDK4;MYO9B;RHOBTB3;MYO1B;KSR1;PEAK1;MARK1;BMPR1A;MYO18A;MAP4K3;MAP4K5;ABCE1;STK26;ERCC6;WNK2;DAPK3;PAPOLA;PRKACB;ABCD4;LONP1;BRSK1;HNRNPU;PFKM;DDX25;ABCG1;ACVR1B;DMPK;BMPR1B;CDC42BPB;SMARCA5;STK36;MAST1;ATP7B;PDK2
prerank,nuclear import signal receptor activity (GO:0061608),0.49712358046906086,1.0765626582380057,0.39322033898305087,0.9753000923361034,1.0,8/15,20.75%,KPNA4;RANBP6;KPNA2;TNPO3;KPNA3;IPO4;IPO9;HIKESHI
prerank,active ion transmembrane transporter activity (GO:0022853),-0.3283288388152821,-1.0757593574312654,0.34980988593155893,0.7495066874390406,1.0,11/37,12.29%,SLC22A8;SLCO2B1;SLCO1C1;SLCO2A1;CYB5A;SLC22A6;UQCRC1;SLCO3A1;SLC22A4;COX10;ATP13A3
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.49082988686714013,1.0751153416437522,0.38175675675675674,0.9740209982313148,1.0,3/15,9.35%,NDST3;HS2ST1;HS6ST1
prerank,TBP-class protein binding (GO:0017025),-0.37942625678852704,-1.071608539601916,0.36246786632390743,0.7538676405390201,1.0,11/21,26.87%,YEATS2;AHR;ESR1;DR1;PSMC5;PSMC2;TAF12;TAF13;GTF2A2;DRAP1;HHEX
prerank,ligand-gated cation channel activity (GO:0099094),0.38697620132239774,1.0712871843083525,0.3819277108433735,0.9794967929071877,1.0,9/75,12.49%,ASIC3;KCNJ12;GRIN2C;KCNN2;CCDC51;TRPM4;GRIK5;CHRNA7;TRPM2
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.3014322187236089,-1.0698919844150567,0.2956521739130435,0.7515340652035417,1.0,17/47,18.61%,SLC7A11;SLC6A13;SLC47A1;PDPN;SLC6A1;SLC6A6;SLC7A14;SLC3A2;SLC7A5;SLC38A10;SLC22A4;SLC43A2;SLC66A1;SLC38A5;SLC38A6;SLC38A7;SLC7A7
prerank,semaphorin receptor binding (GO:0030215),-0.35439142402391177,-1.0695242296854075,0.3202416918429003,0.746117424935865,1.0,7/23,11.10%,SEMA3D;SEMA3C;SEMA6A;SEMA7A;SEMA3A;SEMA4D;SEMA6D
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.43914803569887784,-1.0688849620628178,0.37995337995337997,0.7413377366127418,1.0,6/12,25.68%,SLC9B2;SLC9A2;LETM1;SLC9A6;SLC9A9;SLC9A5
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.35067687906876827,1.067992353949756,0.3273092369477912,0.9835798138557684,1.0,71/431,14.42%,RYR1;RASL12;MAP3K20;RAP1A;STK38L;MAP3K5;TUBA1C;ACTA1;UBA2;DYRK2;PFKP;CDK6;MYH9;PDK4;RRAD;MYO9B;RERG;GEM;RHOBTB3;MYO1B;MFHAS1;KSR1;PEAK1;MARK1;SEPHS1;BMPR1A;MYO18A;MAP4K3;MAP4K5;RAP2C;RRAS;RANBP17;TUBB2B;RHOJ;ABCE1;STK26;ERCC6;WNK2;DAPK3;PAPOLA;PRKACB;RHOF;ABCD4;LONP1;BRSK1;RRAGB;RAP2A;HNRNPU;REM1;PFKM;DDX25;RHOH;ABCG1;ACVR1B;DRG2;DMPK;BMPR1B;GBP2;CDC42BPB;SMARCA5;STK36;ADSS1;MAST1;LSG1;ATP7B;PDK2;TUBD1;SARS2;RAB14;LRRK2;DIRAS2
prerank,poly-purine tract binding (GO:0070717),0.4544401743560423,1.0656985534049124,0.3925373134328358,0.9850658884527526,1.0,7/27,11.07%,RBPMS;RBMS3;MCRS1;ATXN1;PPIE;HNRNPU;DDX1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.44381303105799047,-1.0655915514771788,0.4036885245901639,0.7435141926806824,1.0,9/11,50.51%,HMCES;HMGA2;NEIL1;NEIL3;NTHL1;NEIL2;APEX1;APEX2;APLF
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.4547834028425862,1.0635057891526076,0.391304347826087,0.9857882693002529,1.0,5/22,13.21%,RBM24;RBMS3;CPEB1;CPEB3;ZFP36L1
prerank,estrogen receptor binding (GO:0030331),-0.32865961158437174,-1.0634594952552059,0.35494880546075086,0.7427937622277622,1.0,8/32,10.49%,NSD1;LEF1;TACC1;NCOA1;PRMT2;CTNNB1;ESR1;TRIP4
prerank,amino acid binding (GO:0016597),-0.34005590937301283,-1.0622788836308603,0.35815602836879434,0.7397448148934664,1.0,11/31,21.39%,GRM7;GLRB;NOS3;DDAH1;GRIN3A;GLRA2;SRR;AARS1;DDAH2;GLRA1;ASS1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.49601120988659075,1.060227781777187,0.4100486223662885,0.9900426898171639,1.0,2/13,2.62%,PIP5K1B;PIP4K2A
prerank,cyclic nucleotide binding (GO:0030551),0.4582513631008826,1.0601596240485092,0.38958990536277605,0.9847683884557179,1.0,4/21,11.19%,PDE5A;PDE4A;KCNH1;PDE4D
prerank,copper ion binding (GO:0005507),0.42705800262370486,1.0574377496753973,0.41711229946524064,0.9869352822652835,1.0,11/42,18.03%,AOC3;LOXL2;RNF7;TP53;SUMF1;ATP7B;SNCG;MT3;SOD3;SNCB;P2RX4
prerank,protein tyrosine kinase binding (GO:1990782),0.3883512970356601,1.0568538233475349,0.36691542288557216,0.9834284699532104,1.0,10/71,6.83%,ANGPT2;ANGPT1;ANGPT4;SOCS5;ITGB1;PITPNM3;ARHGEF16;DUSP3;TP53;PTPN1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.4961428908902022,1.0519768345984573,0.41833333333333333,0.9919949525363232,1.0,2/14,4.10%,KCNA5;KCNE4
prerank,deubiquitinase activity (GO:0101005),-0.2645843800031637,-1.049735729980586,0.32857142857142857,0.76614501157446,1.0,24/88,19.24%,ATXN3;USP53;USP46;USP11;MINDY3;OTUD7B;USP45;UFD1;USP19;USP7;USP12;BRCC3;USP3;USP29;MINDY1;PAN2;VCPIP1;USP37;OTUD3;EIF3F;USP24;ZC3H12A;USP32;USP10
prerank,lipase activator activity (GO:0060229),0.5175091219309962,1.0483502693493496,0.4149908592321755,0.9969880791613388,1.0,2/10,4.86%,CCL5;ARHGAP6
prerank,translation elongation factor activity (GO:0003746),0.5045294149431128,1.0477150123636234,0.4293015332197615,0.9935044514413416,1.0,7/14,18.10%,EEFSEC;GFM2;EIF5AL1;EIF5A;TSFM;GTPBP2;EEF2
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.5018663518476936,1.0457382704058733,0.43275862068965515,0.9935854668889493,1.0,3/13,5.56%,WDR4;FTSJ1;TRMT10C
prerank,nucleotidyltransferase activity (GO:0016779),0.4690417342477483,1.0456412901994712,0.42487883683360256,0.9886703569579657,1.0,4/19,8.44%,CGAS;CRPPA;TERT;TENT4A
prerank,nucleoside-triphosphatase activity (GO:0017111),0.3450119765874961,1.044339288346429,0.3991769547325103,0.9871804461991649,1.0,56/248,16.95%,RASL12;RAP1A;MYO1E;MYL6;MYH9;KIF2A;RERG;GEM;RHOBTB3;GNAO1;GNAZ;MYO18A;NKIRAS2;KIF1A;RAP2C;TPPP;RRAS;ABCA3;PIN1;RHOJ;RAB3A;ENTPD7;OPA1;ATP2B1;RHOF;GNA12;GNG11;RRAGB;RAP2A;GFM2;ATAD1;KIF1C;DNM1L;GSPT1;MFN2;RHOH;RUVBL1;DRG2;KIF5A;GBP2;CLU;KIF20B;LSG1;GNAQ;RAB14;LRRK2;DIRAS2;RAB8B;RHOG;DNM2;VWA8;RHOT1;AGAP2;RAB8A;DHX9;RAB38
prerank,adenyl ribonucleotide binding (GO:0032559),0.3468280374670224,1.0420021398569537,0.4030612244897959,0.9880991420168377,1.0,46/291,13.02%,RYR1;MAP3K20;STK38L;MAP3K5;ACTA1;UBA2;DYRK2;PFKP;CDK6;MYH9;PDK4;MYO9B;RHOBTB3;MYO1B;KSR1;PEAK1;MARK1;BMPR1A;PDE4A;MYO18A;MAP4K3;MAP4K5;COQ8A;ABCE1;STK26;ERCC6;MIEF1;WNK2;DAPK3;PAPOLA;PRKACB;ABCD4;LONP1;BRSK1;HNRNPU;PDE4D;PFKM;DDX25;ABCG1;ACVR1B;DMPK;BMPR1B;CDC42BPB;SMARCA5;STK36;MAST1
prerank,chloride channel regulator activity (GO:0017081),-0.4054551229755883,-1.0401176200112454,0.4064039408866995,0.7849320914375101,1.0,6/14,17.83%,WNK1;WNK4;WNK3;STX1A;VAMP8;STX8
prerank,sulfotransferase activity (GO:0008146),-0.3158948671054318,-1.0397444634337845,0.42160278745644597,0.7795267207290887,1.0,5/33,8.17%,UST;CHST11;HS3ST3A1;CHST9;TPST1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.36959766846214764,-1.0385595999128479,0.3867403314917127,0.7763051534809802,1.0,4/20,7.72%,SENP1;SENP3;COPS2;USP7
prerank,semaphorin receptor activity (GO:0017154),-0.4325469359106783,-1.0344547022014987,0.4092920353982301,0.7806944149500955,1.0,4/11,8.23%,PLXNA2;NRP2;NRP1;PLXNA4
prerank,GTP binding (GO:0005525),0.34488522025510243,1.032359092407296,0.4087513340448239,1.0,1.0,34/172,16.95%,RASL12;RAP1A;TUBA1C;RRAD;RERG;GEM;RHOBTB3;MFHAS1;SEPHS1;RAP2C;RRAS;RANBP17;TUBB2B;RHOJ;RHOF;RRAGB;RAP2A;REM1;RHOH;DRG2;GBP2;ADSS1;LSG1;TUBD1;RAB14;LRRK2;DIRAS2;RHOG;DNM2;RHOT1;AGAP2;RAB8A;ARL4D;RAB38
prerank,platelet-derived growth factor binding (GO:0048407),0.5170653215261584,1.030096712794254,0.45750452079566006,1.0,1.0,5/11,12.43%,COL4A1;PDGFB;PDGFRB;PDGFA;COL3A1
prerank,metalloendopeptidase activity (GO:0004222),0.3690675196676386,1.0298727726097854,0.4253554502369668,1.0,1.0,15/76,15.10%,MMP17;ADAMTS14;ADAMTS5;ADAMTS19;AFG3L2;TRABD2B;ADAM17;MIPEP;THSD4;PHEX;ADAMTS20;ADAMTS16;PMPCB;ADAM19;ADAMTSL4
prerank,nuclear receptor binding (GO:0016922),0.35990879985236257,1.0296234287375363,0.43249427917620137,1.0,1.0,24/111,11.70%,ACTN4;SMARCD3;NR1H4;NR4A1;RERG;PADI2;ARID1A;TGFB1I1;NCOA7;ASXL1;TAF1;ARID5A;HMGN3;PPARGC1A;MED1;PPARGC1B;MED12;TRIM68;NR4A2;HIF1A;MED14;TACC2;BAZ2A;ZBTB7A
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.3314224382219306,-1.0287190320185744,0.39755351681957185,0.7887429339967034,1.0,6/25,9.32%,POR;CYP27A1;CYP26B1;FMO1;FMO2;NOS3
prerank,PDZ domain binding (GO:0030165),0.38455429497486726,1.0282037396956798,0.4221105527638191,1.0,1.0,14/61,14.25%,ATP2B4;SDC2;CRIM1;FZD4;ARHGEF16;FZD8;SYNJ2;ATP2B1;ADAM17;SLC22A5;TMEM88;NSF;TMEM88B;PLEKHA1
prerank,retinoic acid receptor binding (GO:0042974),0.47082705294635874,1.0279147042347854,0.4211409395973154,0.9968940208691294,1.0,5/17,9.10%,ACTN4;ASXL1;ARID5A;MED1;NR4A2
prerank,serine-type peptidase activity (GO:0008236),0.3646234734953769,1.0270637324833303,0.4201388888888889,0.994233635432976,1.0,7/96,10.51%,TMPRSS4;HTRA1;KLK2;APEH;PRSS8;MASP2;MBTPS1
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.2614112405139008,-1.0251478889636274,0.3790849673202614,0.7916250726675729,1.0,22/83,19.24%,ATXN3;USP53;USP46;USP11;MINDY3;OTUD7B;USP45;UFD1;USP19;USP7;USP12;BRCC3;USP3;USP29;PAN2;VCPIP1;USP37;OTUD3;USP24;ZC3H12A;USP32;USP10
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.42607812667272277,-1.0240689367036684,0.43779904306220097,0.7881649500955618,1.0,3/11,7.54%,CARM1;PRMT2;PRMT3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.514674860339056,1.0223987932072611,0.4386873920552677,1.0,1.0,1/10,3.53%,DCTD
prerank,anion channel activity (GO:0005253),0.3884516825765705,1.0223904292047532,0.45202020202020204,0.9967767823391999,1.0,10/61,11.99%,ANO1;GABRE;ANO6;GABRA4;GABRA5;VDAC1;GABRB2;GABRG1;ANO3;GABRB3
prerank,MAP-kinase scaffold activity (GO:0005078),-0.43928738844797705,-1.0195654871718403,0.46206896551724136,0.7933217111880434,1.0,4/11,11.07%,AKAP13;SH3RF1;MAPK8IP3;MAP2K2
prerank,telomerase RNA binding (GO:0070034),0.4390872399876907,1.0177821429859057,0.4414976599063963,1.0,1.0,8/22,18.90%,PARN;TERT;NAF1;HNRNPU;HNRNPC;TEP1;SNRPD3;EXOSC10
prerank,double-stranded RNA binding (GO:0003725),0.36798448714647675,1.0174946470550388,0.4466501240694789,0.9997929227092499,1.0,21/70,19.71%,ACTN1;VIM;MTDH;DICER1;EIF4A1;LRRFIP1;MBNL1;HNRNPU;EIF2AK2;DROSHA;OASL;DHX30;DGCR8;STAU2;RFTN1;DHX9;CLTC;PRKRA;ILF3;AGO1;ADARB1
prerank,metal ion:proton antiporter activity (GO:0051139),-0.40773701810760143,-1.0163613853893398,0.43896713615023475,0.7953551845620226,1.0,6/13,25.68%,SLC9B2;SLC9A2;LETM1;SLC9A6;SLC9A9;SLC9A5
prerank,snRNA binding (GO:0017069),0.3905443846117516,1.015257820691902,0.4363143631436314,1.0,1.0,10/42,15.96%,LSM8;HEXIM1;SF3B3;CCNT1;HNRNPU;EIF5A;PRPF4;SNRPB2;RBM41;LSM10
prerank,tRNA binding (GO:0000049),0.3967401654341547,1.0132718074313298,0.4410994764397906,1.0,1.0,15/43,17.63%,HSD17B10;NAT10;TYW5;TRMT10C;TERT;PSTK;SEPSECS;AIMP1;NSUN2;RPUSD4;SARS2;KARS1;SARS1;FARS2;EIF2AK4
prerank,cytokine receptor binding (GO:0005126),0.3623813736666498,1.0129551574019229,0.476303317535545,0.9974619208120458,1.0,12/83,10.35%,LIFR;CRLF1;IL2;CCL5;PXDN;VEGFA;IL12RB1;PIBF1;IL22;TGFB2;ADAM17;IL13RA1
prerank,endonuclease activity (GO:0004519),-0.283739794476431,-1.012845193115406,0.43253968253968256,0.7977401835151897,1.0,18/49,27.54%,AGO3;ZC3H12B;MRE11;N4BP2;TSNAX;ERCC5;DIS3;ERN1;ZC3H12C;SMG6;ZC3H12A;RNASEL;INTS11;KHNYN;ERCC4;EXOG;SND1;OGG1
prerank,endoribonuclease activity (GO:0004521),-0.31687664865856835,-1.0109575951791765,0.4517241379310345,0.7963239584204759,1.0,12/32,25.87%,AGO3;ZC3H12B;TSNAX;ERN1;ZC3H12C;SMG6;ZC3H12A;RNASEL;INTS11;KHNYN;EXOG;SND1
prerank,omega peptidase activity (GO:0008242),-0.2525518402331007,-1.010380555708754,0.4189189189189189,0.7919694383548592,1.0,29/89,24.97%,ATXN3;USP53;USP46;USP11;MINDY3;OTUD7B;USP45;UFD1;USP19;USP7;USP12;BRCC3;USP3;ASRGL1;USP29;PAN2;VCPIP1;USP37;OTUD3;USP24;ZC3H12A;USP32;USP10;MPND;USP25;CYLD;GGT7;OTUD1;UCHL1
prerank,fibroblast growth factor receptor binding (GO:0005104),0.4402912705579807,1.0094578009804065,0.46938775510204084,1.0,1.0,1/21,1.46%,FGF1
prerank,insulin-like growth factor I binding (GO:0031994),-0.3954419046780707,-1.0062863557420425,0.48333333333333334,0.7958612913347891,1.0,6/13,14.28%,IGFBP2;ITGA6;IGFBP3;ITGAV;IGFBP6;INSR
prerank,metallopeptidase activity (GO:0008237),0.34913007350006736,1.0048260235038364,0.46170921198668147,1.0,1.0,17/113,11.91%,MMP17;PAPPA2;ADAMTS14;ADAMTS5;ADAMTS19;LNPEP;RNPEP;AFG3L2;TRABD2B;ADAM17;MIPEP;THSD4;ADAM18;PHEX;ADAMTS20;ADAMTS16;EIF3H
prerank,5'-nucleotidase activity (GO:0008253),0.482547088265763,1.0031882857320027,0.4686411149825784,1.0,1.0,5/13,19.80%,ACP3;NT5C2;NT5M;NT5C3A;NT5C
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.4196887228540659,-1.0018425026892235,0.451685393258427,0.80155939899693,1.0,4/11,16.77%,STN1;RAD50;CTC1;TERF2IP
prerank,exoribonuclease activity (GO:0004532),-0.40704015595036036,-1.0011064220384078,0.43640897755610975,0.797538818033053,1.0,7/12,27.19%,EXOSC1;EXOSC9;ZC3H12A;EXOSC2;EXOSC7;EXOSC3;EXOSC5
prerank,SUMO binding (GO:0032183),0.4707332155440874,0.9965103605832787,0.4627949183303085,1.0,1.0,3/13,11.10%,UBA2;CBX4;CASP8AP2
prerank,microtubule minus-end binding (GO:0051011),0.4763178268012836,0.9963505978122515,0.4857142857142857,1.0,1.0,5/13,19.61%,CEP290;TUBGCP6;HAUS7;HAUS4;CAMSAP1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.49975191525310103,0.9941475823266219,0.47810858143607704,1.0,1.0,2/10,11.28%,DPYSL4;OPLAH
prerank,ribonuclease activity (GO:0004540),-0.2772129277670736,-0.9933225379207236,0.46524064171123,0.8113647366770366,1.0,22/56,27.89%,AGO3;ZC3H12B;TSNAX;SAMHD1;EXOSC1;RNASE4;ERN1;ZC3H12C;EXOSC9;SMG6;ZC3H12A;EXOSC2;RNASEL;INTS11;PPP1R8;KHNYN;EXOSC7;EXOSC3;EXOG;SND1;EXOSC5;ELAC2
prerank,nuclear receptor coactivator activity (GO:0030374),0.3825988619406779,0.9930567152287518,0.4783748361730013,1.0,1.0,9/52,10.59%,ACTN1;ACTN4;NCOA7;PPARGC1A;MED1;PPARGC1B;MED12;SFR1;MED14
prerank,phosphatidylcholine transporter activity (GO:0008525),0.44582306143995926,0.9914604421387954,0.4855769230769231,1.0,1.0,8/17,15.17%,ATP8B1;ABCB4;PITPNB;ABCA3;ATP10A;ABCG1;MTTP;PITPNM2
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.4183404540231271,0.9910397476699165,0.48,1.0,1.0,7/28,15.39%,MYD88;DAB2IP;TRAF3;TRAF5;CASP8AP2;FEM1B;STAT1
prerank,CARD domain binding (GO:0050700),-0.38269272934728493,-0.9904006838334077,0.45169082125603865,0.812733454183222,1.0,5/14,18.81%,NOD1;CARD10;IRGM;CARD14;CASP4
prerank,protein phosphatase 2A binding (GO:0051721),0.42698930074399555,0.988982916930345,0.4967532467532468,1.0,1.0,6/23,7.71%,STRN3;MFHAS1;MAPT;DAB2IP;TP53;ENSA
prerank,DNA secondary structure binding (GO:0000217),0.4016464382577102,0.9885646463506793,0.4846715328467153,1.0,1.0,3/31,6.18%,MEF2C;RAD51AP1;MAPT
prerank,small GTPase binding (GO:0031267),0.3343213640742183,0.9884162741757954,0.5192719486081371,1.0,1.0,40/170,14.69%,FLNA;RNF152;PLCE1;MYO9B;RHOBTB3;STRN3;UNC13D;TBC1D20;TNFAIP1;BICD2;ARHGEF16;KIF3B;ARHGEF2;MTSS2;RUSC2;CAV1;NDRG1;RABGAP1;CYFIP1;RAPGEF6;PEX5L;EVI5;DAPK3;WHAMM;DENND10;PAK2;ARHGAP1;ANKFY1;RAB11FIP3;RAB11FIP4;DNM1L;SH3BP4;RHOH;XPO5;HPS4;MYO5B;TNPO3;LRRK2;ANKRD27;RAB34
prerank,hexosaminidase activity (GO:0015929),-0.39647838405058755,-0.9868760652181648,0.49887133182844245,0.8158176368227992,1.0,4/12,20.44%,CEMIP;HEXA;CEMIP2;NAGA
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.41573155457595184,-0.9864531057107158,0.5177304964539007,0.8110866729363226,1.0,4/10,12.80%,DSE;RENBP;DSEL;GLCE
prerank,ATPase regulator activity (GO:0060590),0.3953346209118486,0.9859494522623321,0.4839609483960948,1.0,1.0,11/38,19.23%,PLN;ATP1B1;BAG3;DNAJC1;FNIP2;BAG2;HSPBP1;DNAJA2;DNAJB6;BRSK2;SIL1
prerank,poly(A) binding (GO:0008143),0.4405077693264164,0.9844633889367601,0.47875816993464054,1.0,1.0,5/21,11.07%,RBPMS;RBMS3;PPIE;HNRNPU;DDX1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.3358726917834739,0.9843411833727057,0.5047821466524973,1.0,1.0,24/173,11.72%,PRDM16;HEY2;ZFHX3;TBX2;ZEB2;ETS2;HEYL;ZNF436;NACC2;PRDM1;OSR2;TBX18;KCNIP3;SNAI2;RELA;PPARA;SKI;NR1D1;LRRFIP1;ZBTB33;ZNF3;SREBF2;ATF3;NFX1
prerank,cardiolipin binding (GO:1901612),-0.41933853775217794,-0.983475300054519,0.49336283185840707,0.812902158584713,1.0,5/10,25.64%,GSDME;GSDMD;STOML2;PLEKHN1;MME
prerank,lysophospholipase activity (GO:0004622),-0.3517549769834585,-0.982672836309447,0.49710982658959535,0.8090156996342037,1.0,9/20,25.77%,LYPLA1;ENPP2;PLA2G6;GDPD1;ABHD12;ASPG;GDE1;PNPLA6;LYPLA2
prerank,guanyl ribonucleotide binding (GO:0032561),0.32517855047553984,0.9817551945340639,0.507399577167019,1.0,1.0,37/196,16.95%,RASL12;RAP1A;TUBA1C;PDE5A;RRAD;RERG;GEM;RHOBTB3;MFHAS1;SEPHS1;RAP2C;RRAS;RANBP17;TUBB2B;RHOJ;MIEF1;RHOF;RRAGB;RAP2A;REM1;RHOH;DRG2;GBP2;ADSS1;LSG1;TUBD1;RAB14;LRRK2;DIRAS2;RAB8B;RHOG;DNM2;RHOT1;AGAP2;RAB8A;ARL4D;RAB38
prerank,ion channel inhibitor activity (GO:0008200),0.38868227898819097,0.978170272451133,0.4959677419354839,1.0,1.0,7/35,8.13%,ITPR1;PACSIN3;CAMK2D;CALM1;NEDD4;ENSA;WNK2
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.2088309659035768,-0.9737453770819948,0.5588235294117647,0.8249192762359039,1.0,85/269,24.01%,SNCAIP;SMAD3;ARRB1;UBXN7;FZD6;ATXN3;ITCH;SMAD6;POLR2A;CUL3;EGFR;XRCC5;RNF20;FOXO1;NFKBIA;NAE1;SHPRH;PML;DERL1;HSPA5;CASP8;PRR5L;HSP90AB1;SLF2;PCBP2;USP7;HERC2;BAG4;PRKAR2B;UQCRC1;PTPN22;MDM2;FBXO7;IKBKG;RNF31;PRKN;BAG1;TRIP4;AMBRA1;SLF1;UBC;BLZF1;RNF34;STUB1;STAT2;RTN4;DTX1;DTX3L;DBT;SLC22A18;PER1;CALR;SYT11;UBXN1;HGS;SMAD2;NEK6;GABARAPL2;HSPA9;WRAP53;CHEK2;RALB;PRKAR2A;SPOPL;ARRDC1;TRIB1;RPL11;ARIH1;SCAMP3;SUMO3;SUMO2;ABI2;HSPD1;UBB;AXIN1;DET1;UBE2B;TXNIP;PTPRN;YWHAZ;MAGEC2;USP25;TMBIM6;MAP1LC3A;CDKN1A
prerank,serine-type endopeptidase activity (GO:0004252),0.3528491220468901,0.9713422043511647,0.4988179669030733,1.0,1.0,5/80,10.51%,TMPRSS4;KLK2;APEH;MASP2;MBTPS1
prerank,peptidoglycan binding (GO:0042834),-0.4180234763871376,-0.9708206017141259,0.504424778761062,0.8266951385447882,1.0,8/10,52.53%,NOD1;PGLYRP1;NOD2;RNASE7;JCHAIN;NLRP3;TLR2;HK1
prerank,hormone receptor binding (GO:0051427),-0.3780919867512062,-0.9703761090971752,0.4895287958115183,0.8221891071877525,1.0,6/14,37.66%,SOCS2;PTHLH;ADCYAP1;NCOA6;NPPC;CCK
prerank,Notch binding (GO:0005112),-0.3351994715716826,-0.9667806179717631,0.5085714285714286,0.8252179834398523,1.0,9/22,19.80%,SNED1;AAK1;CUL3;CCN3;SNW1;DTX1;JAG2;NOTCH4;HIF1AN
prerank,Tat protein binding (GO:0030957),0.4773416594866191,0.9659374913017079,0.49911504424778763,1.0,1.0,2/10,6.19%,ACTB;SMARCB1
prerank,death domain binding (GO:0070513),-0.40396411084881445,-0.9646551338236418,0.5179372197309418,0.8245477493042945,1.0,6/11,17.38%,DAP;BCL2L1;IRGM;DAPL1;BAX;CRADD
prerank,ephrin receptor binding (GO:0046875),-0.3323295091630183,-0.9628619749169144,0.5014577259475219,0.8229553481066542,1.0,5/21,13.86%,EFNB2;GRB2;ANKS1A;LYN;EFNB1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.40468704569085084,0.9598082721222992,0.5212464589235127,1.0,1.0,7/27,14.45%,POLR2L;POLR2I;POLR2G;TERT;POLR1H;POLR2J;POLR3K
prerank,ATPase binding (GO:0051117),0.35138277810155916,0.9594811811973946,0.5294117647058824,1.0,1.0,8/71,7.14%,PLN;HRC;PPP3CA;SNTA1;ATP1B1;CAV1;ATP6V0A2;AR
prerank,AMP binding (GO:0016208),-0.394263095559064,-0.9579036908448828,0.5238095238095238,0.8287911244259292,1.0,2/11,0.66%,MPPED2;PRKAG2
prerank,phospholipid transfer activity (GO:0120014),-0.3313832153256953,-0.957221395560122,0.5281501340482574,0.8249364101838088,1.0,10/21,23.99%,PITPNA;PLTP;PITPNC1;CERT1;PLEKHA3;TNFAIP8L3;PRELID3B;C2CD2L;PRELID2;PRELID3A
prerank,UDP-glycosyltransferase activity (GO:0008194),0.34949714512465574,0.9559023608044308,0.5363196125907991,1.0,1.0,7/70,6.61%,LARGE1;CHSY3;CSGALNACT1;EXT2;GCNT2;HAS2;RFNG
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.36574786323389324,-0.9553544439429915,0.5318066157760815,0.8237464589201928,1.0,8/15,30.14%,AGPAT4;ABHD5;LPCAT2;AGPAT5;AGPAT1;ABHD8;LCLAT1;AGPAT2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.35701686142141975,0.9552298442585095,0.5232704402515723,1.0,1.0,10/60,10.07%,NTRK3;MERTK;CRIM1;MST1R;ROR1;MUSK;IGF2R;EPHA2;AXL;PDGFRB
prerank,cytokine activity (GO:0005125),-0.2250292662357104,-0.9540221189175941,0.6082474226804123,0.8214937195664891,1.0,10/131,6.82%,BMP6;WNT4;BMP7;HMGB1;IL15;BMP4;IL18;WNT5A;CXCL16;WNT9A
prerank,glycerophospholipid flippase activity (GO:0140333),0.46388371722753124,0.9533042998966441,0.5383275261324042,1.0,1.0,4/11,11.17%,ATP8B1;ABCB4;ABCA3;ATP10A
prerank,kinase activator activity (GO:0019209),0.3930114007308525,0.9504993797543552,0.5252525252525253,1.0,1.0,3/30,7.13%,FGF13;IL2;TPX2
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.2981739268887552,-0.9486342999318594,0.5420560747663551,0.8292951521468878,1.0,8/30,15.27%,SLC39A10;SLC30A10;SLC39A11;SLC39A8;SLC30A1;SLC25A28;SLC39A1;SLC39A6
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.32155277460380116,0.9483408685034855,0.5553121577217963,1.0,1.0,27/147,12.75%,ARHGEF7;RAP1A;KALRN;ABR;PLCE1;ARHGEF17;RASGRP2;DOCK8;ITSN1;DOCK10;ARHGEF16;ARHGEF2;NUCB1;RCC1L;RAPGEF6;RASGRP1;DNMBP;RIN2;DENND10;ARHGEF4;DOCK1;VAV1;DENND1A;FRMD7;BCR;SBF1;HPS4
prerank,neuropeptide receptor activity (GO:0008188),0.3925326355165702,0.946637148874554,0.5104790419161677,1.0,1.0,2/29,4.13%,NPY1R;TACR3
prerank,LRR domain binding (GO:0030275),0.44309787402544154,0.9464288508858398,0.5219683655536028,1.0,1.0,8/14,18.01%,MRTFA;DAPK3;ZXDC;PAWR;POLR2J;LRRFIP2;PMF1;DDIT3
prerank,protein phosphatase regulator activity (GO:0019888),0.35052842190359973,0.9450394409402479,0.5354919053549191,1.0,1.0,12/53,12.79%,RCAN2;PPP2R1B;SET;SAG;PPP2R5A;CALM1;RCAN3;ENSA;EIF2AK2;DMPK;CABIN1;ARPP19
prerank,tau protein binding (GO:0048156),0.37881177731137067,0.9445307688482488,0.5343618513323983,1.0,1.0,15/40,19.40%,ROCK1;ACTB;MARK1;DYRK1A;PIN1;BRSK1;ROCK2;CLU;BAG2;MARK2;DCTN1;MAP1A;BRSK2;HDAC6;MARK3
prerank,phospholipase activator activity (GO:0016004),0.46193079031826045,0.9444810266888225,0.4982078853046595,1.0,1.0,2/10,4.86%,CCL5;ARHGAP6
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.364012235858099,0.9423382229813747,0.5303430079155673,1.0,1.0,6/48,8.74%,ASIC3;TRPC6;PKD1L3;TRPV2;CALHM5;TRPM4
prerank,hexosyltransferase activity (GO:0016758),-0.22860730628837636,-0.9416056249419412,0.6101694915254238,0.8406089380287723,1.0,30/101,25.34%,TMTC1;TMTC2;MGAT4C;B4GALT1;CHSY1;DPY19L4;B4GALT6;GBE1;TMTC4;DPY19L1;MGAT4B;OGT;HEXA;B3GALNT1;PIGV;B4GALT4;CHPF2;B4GALT7;ALG1;GBA2;ALG12;B3GNT2;POMT1;GYG1;B3GALT2;LFNG;B4GALT3;GCNT1;MFNG;MGAT4A
prerank,hydro-lyase activity (GO:0016836),0.37269127977026284,0.9414068058537138,0.5285524568393094,1.0,1.0,8/41,9.78%,CA3;ENO3;TBXAS1;HSD17B4;HACD1;CDYL;ACO2;HADHB
prerank,protease binding (GO:0002020),0.3314274311450675,0.9407580459014491,0.5469293163383546,1.0,1.0,16/99,12.43%,TTN;ITGA3;ADRM1;STIM1;ITGB1;BCL2;TP53;TIMP4;ITGB3;AMFR;SRI;ANXA9;LONP2;NFRKB;POLG;COL3A1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.4142323046596905,0.9397604439342512,0.5230769230769231,1.0,1.0,8/22,18.74%,DUSP5;DUSP3;DUSP29;SBF1;DUSP16;DUSP23;MTMR3;DUSP12
prerank,transcription cis-regulatory region binding (GO:0000976),0.30740441620485615,0.9374676702812301,0.6548582995951417,1.0,1.0,49/406,11.81%,SOX6;PRDM16;SOX5;MEF2C;ACTN4;NR1H4;ALX4;RORA;SIM2;GABPA;ARID5B;HINFP;ZNF436;FOSL2;RBAK;VEZF1;MTERF3;OSR2;TBX18;MEF2A;GBX1;DBP;KLF15;SUV39H2;JUND;ARID5A;TP53;GRHL1;SFPQ;AR;YAP1;SOX9;SNAI2;RELA;KMT2D;CUX2;BBX;LONP1;NR1D1;HIF1A;ZNF3;NR2C2;TEAD1;RUNX1;RB1;ATF3;HOXC8;NFX1;PSPC1
prerank,G protein-coupled receptor binding (GO:0001664),0.3207630670968473,0.9369894854309743,0.5683530678148547,1.0,1.0,6/132,5.21%,FLNA;AGTR1;CCL5;GNAO1;SAG;GNAZ
prerank,hormone activity (GO:0005179),-0.2603274373080044,-0.9353407144769029,0.5753424657534246,0.8499579848243011,1.0,21/54,40.72%,IGF1;CHGB;METRNL;PPY;PTHLH;EDN3;ADCYAP1;SST;PENK;VGF;INHBB;INHA;GNRH1;EDN1;NPPC;C1QTNF12;CCK;SPX;GRP;NPFF;PNOC
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.23784266325455855,-0.9319260977698933,0.5961538461538461,0.8523001281416018,1.0,28/85,26.90%,PAFAH1B2;DDHD2;LYPLA1;ABHD5;ENPP2;CA2;PLA2G6;PLAAT3;NOTUM;GDPD1;ABHD12;ASPG;PLA2G7;ABHD3;LIPE;AARS1;GDE1;TARS2;PLA2G12A;APMAP;PNPLA6;ABHD6;LIPA;DAGLB;ABHD8;LYPLA2;PGLS;PNPLA2
prerank,ATP hydrolysis activity (GO:0140603),0.3687201081524359,0.93140428264139,0.5393258426966292,1.0,1.0,9/41,12.58%,MYO1E;RHOBTB3;MYO18A;ABCA3;ATP2B1;ATAD1;RUVBL1;CLU;KIF20B
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.34773127074475874,0.9311980783805068,0.5374064837905237,1.0,1.0,11/60,12.20%,NTRK3;MERTK;MST1R;ROR1;ACVR2A;MUSK;EPHA2;AXL;PDGFRB;ACVR1B;BMPR1B
prerank,neuropeptide binding (GO:0042923),-0.3359345725637933,-0.9304250125043682,0.5397590361445783,0.8503961335275678,1.0,11/18,54.63%,GPR149;GPR37;NMUR2;OPRL1;SSTR2;SORL1;MC4R;SSTR1;OPRD1;NMUR1;OPRM1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.3590934398578981,-0.929892894450531,0.532150776053215,0.8463024838871251,1.0,3/14,5.34%,SPOCK2;COL4A3;RECK
prerank,sodium:proton antiporter activity (GO:0015385),-0.38859365192530326,-0.9291225430933573,0.5558086560364465,0.8428250600015227,1.0,5/11,25.68%,SLC9B2;SLC9A2;SLC9A6;SLC9A9;SLC9A5
prerank,phosphatase binding (GO:0019902),-0.22761369558089806,-0.9288567211777256,0.6643835616438356,0.8382164914702344,1.0,30/105,20.80%,SMAD3;DLG1;MAPK14;CDH5;PXN;WNK1;EGFR;PTK2;MAGI2;CRY1;CTNNB1;MTMR4;PPME1;DZIP3;SIRPA;HSP90B1;SH3RF2;PDLIM4;SH3YL1;CRY2;PPP6R3;SMAD2;TERF2IP;SNX3;ANAPC4;STAT6;NFATC2;CEACAM1;CARHSP1;MVP
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3604460552183479,0.9274889900003888,0.5642023346303502,1.0,1.0,5/49,4.63%,ESYT2;FER1L5;DYSF;ANXA1;SYT10
prerank,ubiquitin binding (GO:0043130),-0.23959217010700457,-0.9273206678453327,0.5960591133004927,0.8366158894887417,1.0,35/73,31.87%,SMAD3;UBXN7;RNF185;WDR48;ILRUN;BIRC2;UBAP1;MDM2;FBXO7;IKBKG;RBCK1;RNF31;PRKN;DNAJB2;BUB3;TOLLIP;UBXN1;MVB12B;RNFT1;UBAP1L;SHARPIN;USP25;MVB12A;RAD23B;UCHL1;TRIM32;RNF19B;SQSTM1;USPL1;MARK4;TNFAIP3;GGA3;VPS28;OTULINL;PLAA
prerank,phospholipase binding (GO:0043274),-0.3693423690995447,-0.9264647490043744,0.5799086757990868,0.833385112301372,1.0,5/13,18.34%,PDPK1;PAFAH1B1;PRKN;DGKQ;BLNK
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.4237769213970951,0.9239800488790875,0.5536912751677853,1.0,1.0,3/15,5.03%,SOCS5;SOCS6;SOCS4
prerank,pyrophosphatase activity (GO:0016462),0.3584871890250212,0.9225249128118108,0.5579617834394904,1.0,1.0,8/50,8.91%,ENTPD1;NUDT7;NUDT4;PRUNE1;LHPP;BNIPL;ENTPD7;ATCAY
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.3648931024764622,-0.9217028827113721,0.5714285714285714,0.8386941031423533,1.0,7/13,30.14%,AGPAT4;ABHD5;LPCAT2;AGPAT5;AGPAT1;LCLAT1;AGPAT2
prerank,carboxypeptidase activity (GO:0004180),0.36950976204977987,0.9203926109474747,0.5538881309686221,1.0,1.0,4/35,7.33%,AGBL1;BLMH;CPA4;CPA3
prerank,GTPase binding (GO:0051020),0.30923077646716696,0.9169385804442004,0.6394485683987274,1.0,1.0,45/195,14.69%,FLNA;RNF152;PLCE1;MYO9B;LCP1;RHOBTB3;STRN3;UNC13D;TBC1D20;TNFAIP1;BICD2;ARHGEF16;KIF3B;ARHGEF2;MTSS2;RUSC2;CAV1;NDRG1;RABGAP1;CYFIP1;RAPGEF6;PEX5L;EVI5;DAPK3;WHAMM;DENND10;PAK2;ARHGAP1;RRAGB;ANKFY1;RAB11FIP3;RAB11FIP4;DNM1L;SH3BP4;RHOH;AIMP1;XPO5;HPS4;MYO5B;TNPO3;IARS1;EPRS1;LRRK2;ANKRD27;RAB34
prerank,single-stranded DNA helicase activity (GO:0017116),0.40124756557598795,0.915138865792222,0.5273865414710485,1.0,1.0,3/19,8.61%,WRNIP1;CHTF18;HELQ
prerank,metallocarboxypeptidase activity (GO:0004181),0.3892769145579998,0.9146760805083263,0.5562218890554723,1.0,1.0,3/26,7.33%,AGBL1;CPA4;CPA3
prerank,phosphoric diester hydrolase activity (GO:0008081),0.3688684655142699,0.9130103978594919,0.5738880918220947,1.0,1.0,4/35,3.59%,PLCE1;PLCB4;PLCL1;PLCXD1
prerank,phosphatidylinositol binding (GO:0035091),0.32888891370614903,0.9126885921191628,0.5744186046511628,1.0,1.0,24/91,18.15%,MYO1E;ESYT2;ITPR1;HIP1;PITPNB;MAPT;MREG;ANKFY1;GAP43;DENND1A;GRAMD2A;WDR45;SNX13;SNX9;SNX17;PARD3B;SNX1;PITPNM2;SNAP91;PHF12;SNX4;ESYT1;ZFYVE16;RPH3A
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.4537419265457484,0.9120819162521323,0.5736842105263158,1.0,1.0,2/11,11.92%,SLC25A29;SLC22A5
prerank,alpha-tubulin binding (GO:0043014),0.36738721318080725,0.9096226784479449,0.5888252148997135,1.0,1.0,4/31,8.93%,DLEC1;TTLL7;EFHC1;WASHC1
prerank,acetylcholine receptor activity (GO:0015464),0.40066839562662315,0.9086711816127075,0.5643410852713179,1.0,1.0,5/22,15.31%,HRH3;ANXA9;CHRNA7;CHRFAM7A;CHRNA4
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.3833385375621119,-0.908450483337908,0.5565217391304348,0.862401093218832,1.0,4/11,12.18%,SGMS1;SGMS2;PTDSS2;GNPTAB
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.4348892233630683,0.9077488265484225,0.5381882770870338,1.0,1.0,4/11,19.43%,AKR1B1;AKR1B10;RDH11;RDH13
prerank,GTPase activity (GO:0003924),0.3028192622214269,0.9059414809094309,0.6509926854754441,1.0,1.0,39/192,16.95%,RASL12;RAP1A;RERG;GEM;RHOBTB3;GNAO1;GNAZ;NKIRAS2;RAP2C;TPPP;RRAS;RHOJ;RAB3A;ENTPD7;OPA1;RHOF;GNA12;GNG11;RRAGB;RAP2A;GFM2;DNM1L;GSPT1;MFN2;RHOH;DRG2;GBP2;LSG1;GNAQ;RAB14;LRRK2;DIRAS2;RAB8B;RHOG;DNM2;RHOT1;AGAP2;RAB8A;RAB38
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.3681938333809529,0.9035846653451607,0.5846372688477952,1.0,1.0,9/34,14.67%,NDUFS1;NDUFA2;NDUFC1;NDUFB6;NDUFS3;NDUFV2;NDUFB8;NDUFS2;NDUFA1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.3681938333809529,0.9035846653451607,0.5846372688477952,1.0,1.0,9/34,14.67%,NDUFS1;NDUFA2;NDUFC1;NDUFB6;NDUFS3;NDUFV2;NDUFB8;NDUFS2;NDUFA1
prerank,tumor necrosis factor receptor binding (GO:0005164),0.4365733669710838,0.9007485748355715,0.5670840787119857,1.0,1.0,3/12,15.39%,TRAF3;TRAF5;STAT1
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.3452531691235228,0.8998648819230295,0.5858064516129032,1.0,1.0,5/46,6.61%,LARGE1;EXT2;GCNT2;PIGA;RFNG
prerank,pseudouridine synthase activity (GO:0009982),0.43884236594662085,0.8997198477701136,0.6052202283849919,1.0,1.0,5/13,18.22%,RPUSD3;PUS7L;RPUSD4;TRUB1;TRUB2
prerank,3'-5' DNA helicase activity (GO:0043138),-0.3324896506038749,-0.8988934135121067,0.6206896551724138,0.8784803867942538,1.0,3/16,11.82%,NAV2;FBH1;BLM
prerank,symporter activity (GO:0015293),-0.3819212410414737,-0.8981556202748194,0.5952890792291221,0.8747544861970712,1.0,3/10,28.36%,SLC5A5;MFSD2A;SLC5A6
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.29467332304603366,-0.8951504235711385,0.6282051282051282,0.8759811021405904,1.0,11/27,19.31%,DCUN1D3;ZMYM2;RNF144B;RNF217;RNF144A;PRKN;RNF125;SIAH1;TOLLIP;SIAH2;ARIH1
prerank,calcium:sodium antiporter activity (GO:0005432),0.4404978172975805,0.893785955051255,0.5851851851851851,1.0,1.0,2/10,2.70%,SLC8A2;SLC8A1
prerank,transcription coactivator binding (GO:0001223),-0.31959744313104826,-0.8935333390322877,0.5895316804407713,0.8741726835138387,1.0,10/20,19.37%,SMAD3;MED25;AHR;ESR1;TEAD2;CCNT2;CIT;SMAD4;ZBTB17;THRB
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.3706227238441616,-0.8919167048680855,0.6094117647058823,0.872540118946346,1.0,6/12,32.35%,SULF1;ARSI;GALNS;SULF2;SGSH;ARSB
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.29627191788441576,0.8915642285526282,0.7159090909090909,1.0,1.0,28/254,9.58%,PRDM16;MEF2C;SMARCD3;NR1H4;ALX4;NR4A1;GABPA;PRRX1;HINFP;FOSL2;VEZF1;OSR2;SP7;KLF7;MEF2A;DBP;FOXJ3;KLF15;TP53;GRHL1;HOXC4;AR;SOX9;RELA;ZFP62;PPARA;NR4A2;HIF1A
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.4417615911280856,0.8910137113112819,0.5729166666666666,1.0,1.0,2/11,4.45%,NUDT7;NUDT4
prerank,GTPase activator activity (GO:0005096),0.2920513108735681,0.8907609123491734,0.7040816326530612,1.0,1.0,52/313,11.69%,ARHGEF7;RAP1A;RALGAPA2;DLC1;TBC1D1;RGS6;KALRN;ABR;PLCE1;ARHGEF17;RASGRP2;DOCK8;MYO9B;ITSN1;ELMOD1;DOCK10;TBC1D20;ARHGAP10;ELMOD2;ARHGEF16;CHN1;ARHGEF2;LARS1;MTSS2;NUCB1;RABGAP1;RCC1L;RAPGEF6;RASGRP1;ARHGAP17;RALGAPA1;PLCB1;DNMBP;EVI5;RIN2;DENND10;ARHGAP39;ARHGAP30;ARHGEF4;RALGAPB;ARHGAP1;ASAP2;NPRL2;DOCK1;DNM1L;VAV1;DENND1A;TBCD;ARHGAP15;FRMD7;ARHGAP35;HTR2B
prerank,neurexin family protein binding (GO:0042043),-0.3862763036824487,-0.8891679891737001,0.6349892008639308,0.8731930720897406,1.0,4/10,17.12%,NLGN1;NLGN2;NLGN3;SYTL4
prerank,ion channel activity (GO:0005216),0.3237921602583474,0.8886341256942298,0.6213592233009708,1.0,1.0,11/80,12.49%,ASIC3;TRPC6;GRIN2C;PKD1L3;TRPV2;CALHM5;TRPM4;GRIK5;KCNK3;CHRNA7;TRPM2
prerank,histone methyltransferase binding (GO:1990226),-0.3715842815432302,-0.8881829105833818,0.6217391304347826,0.8703519493384366,1.0,2/11,7.19%,CTNNB1;HSP90AB1
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.34739806114835037,-0.8853676747211804,0.6391509433962265,0.871125368542178,1.0,6/14,35.51%,POP1;TSEN34;ELAC2;POP4;RPP38;RPP21
prerank,lipoprotein particle receptor binding (GO:0070325),-0.28675756543866615,-0.8847776666960558,0.6791277258566978,0.8672789079739489,1.0,4/27,12.90%,LRP1;APOE;SYT1;HSP90B1
prerank,single-stranded DNA binding (GO:0003697),-0.21750344953422315,-0.8812477893649452,0.7480916030534351,0.8692072081747757,1.0,31/93,27.80%,RBMS1;HMGB1;STN1;TDP2;WDR48;FUBP1;FBH1;PCBP2;ERCC5;SAMHD1;PURB;BLM;RTF1;HMCES;CTC1;SSBP2;CRY2;PARK7;PMS2;HSPD1;POLR2H;POLR3C;NUCKS1;IGHMBP2;ERCC1;RAD23B;ERCC4;TOP1;HMGB2;RPA3;WBP11
prerank,cGMP binding (GO:0030553),0.4247514107515399,0.8806895074051848,0.5867620751341681,1.0,1.0,1/11,2.77%,PDE5A
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.35276781483638897,-0.8803299961190552,0.6100478468899522,0.8661017908968641,1.0,2/12,6.70%,GAB2;FRS2
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.35497010342331803,0.8787070323440679,0.5988779803646563,1.0,1.0,9/34,15.17%,SMYD1;SETD6;SETD3;NSD3;ATPSCKMT;VCPKMT;N6AMT1;KMT5B;EEF1AKMT2
prerank,protein phosphatase inhibitor activity (GO:0004864),0.3675484257527341,0.8781492439519356,0.5920471281296024,1.0,1.0,8/26,12.79%,PABIR1;SET;SAG;PPP1R14C;ENSA;PPP1R14A;CABIN1;ARPP19
prerank,thioesterase binding (GO:0031996),0.4299000057523704,0.878059435680766,0.5927927927927928,1.0,1.0,4/11,17.44%,TRAF3;TRAF5;HAUS7;ADRA2A
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.44097989826938844,0.8768900567252893,0.6070796460176991,1.0,1.0,2/10,12.82%,DUSP5;DUSP16
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.44097989826938844,0.8768900567252893,0.6070796460176991,1.0,1.0,2/10,12.82%,DUSP5;DUSP16
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.35940813091892987,-0.876697912395933,0.6322869955156951,0.8684657281028592,1.0,3/12,3.30%,CISD2;AOX1;XDH
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.4109742244612164,0.8756836187476084,0.5886287625418061,1.0,1.0,7/14,21.33%,NDUFS1;ACO2;RSAD1;ISCA2;IREB2;NFU1;RSAD2
prerank,SUMO transferase activity (GO:0019789),0.38874518638014866,0.8751872091435762,0.5846905537459284,1.0,1.0,7/16,19.31%,PIAS4;CBX4;PIAS2;MUL1;TRIM28;PIAS1;UBE2I
prerank,death receptor activity (GO:0005035),0.4246512030895688,0.8740224073955608,0.5821167883211679,1.0,1.0,3/11,13.74%,TNFRSF11A;TNFRSF25;TNFRSF10B
prerank,mRNA 5'-UTR binding (GO:0048027),-0.29708256255430576,-0.872912277960275,0.688622754491018,0.8713633467827564,1.0,6/24,18.71%,DDX3X;RPS13;RSL1D1;GNL3;FMR1;RPS7
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.35061836901249294,-0.8726333487496916,0.6164705882352941,0.8670252914373068,1.0,12/12,64.97%,ELOVL4;OPN3;GPR88;RRH;OPN1MW3;OPN1MW;RHO;OPN5;OPN1SW;GNAT2;OPN4;GPR52
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.38567997258476044,0.8719661809292621,0.616504854368932,1.0,1.0,4/21,15.31%,ANXA9;CHRNA7;CHRFAM7A;CHRNA4
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.3067567551711945,-0.8718248003937376,0.648876404494382,0.8639022981073922,1.0,9/20,31.74%,AGPAT4;LPGAT1;ABHD5;LPCAT2;AGPAT5;AGPAT1;LCLAT1;AGPAT2;DGAT2
prerank,SH3 domain binding (GO:0017124),0.3153854085789165,0.8705581631049947,0.6245353159851301,1.0,1.0,6/62,7.62%,ENAH;MYPN;SYNJ2;MAPT;DAB2IP;RAD9A
prerank,palmitoyltransferase activity (GO:0016409),0.3611229374318609,0.8658835099959922,0.6389301634472511,1.0,1.0,11/28,18.77%,GOLGA7B;ZDHHC2;HHAT;ZDHHC1;ZDHHC14;ZDHHC17;ZDHHC13;ZDHHC4;ZDHHC5;ZDHHC8;ZDHHC3
prerank,phosphoric ester hydrolase activity (GO:0042578),0.3311264632202886,0.8653525587448571,0.6352941176470588,1.0,1.0,11/49,12.82%,DUSP5;PLCXD1;ACP3;PRUNE1;LHPP;DUSP3;SACM1L;PPP1CB;PPP1CA;SBF1;DUSP16
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.22598573387508458,-0.8638377864120507,0.7757575757575758,0.8741958857349599,1.0,19/78,23.52%,USP46;USP11;CAPNS1;CTSL;CTSH;CASP8;USP7;USP12;CTSB;USP29;CASP9;USP37;CAPN10;USP24;CASP4;USP10;CTSS;CASP12;USP25
prerank,acylglycerol lipase activity (GO:0047372),-0.35575910816963685,-0.8605798265999212,0.6578313253012048,0.8756133683902187,1.0,4/11,23.16%,ABHD12;ABHD3;LIPE;ABHD6
prerank,poly(U) RNA binding (GO:0008266),-0.31180630439990925,-0.8582947424097018,0.6560693641618497,0.8752368623094892,1.0,6/20,10.43%,RBMS1;RBMS2;KHDRBS1;SSB;PABPC1;DAZAP1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.32257456487079744,0.8566910341455892,0.6588669950738916,1.0,1.0,19/57,20.68%,NDUFS1;COX7A2L;NDUFA2;COX8A;NDUFC1;NDUFB6;NDUFS3;NDUFV2;NDUFB8;NDUFS2;NDUFA1;CYB561A3;UQCRFS1;UQCRH;COX5B;NDUFV3;UQCRQ;NDUFS4;COX6A1
prerank,peptidase inhibitor activity (GO:0030414),-0.2722290084791913,-0.8538312877998874,0.7041800643086816,0.8797255265563249,1.0,6/33,10.65%,TFPI;PROS1;RECK;ITIH2;RENBP;SERPIND1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.3588486874018344,0.8532123997608926,0.6233183856502242,1.0,1.0,2/26,3.27%,CHSY3;CSGALNACT1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.27878814747632924,-0.8532076943249645,0.7033639143730887,0.876124696464679,1.0,9/27,17.15%,SLC22A8;SLC26A7;SLC39A8;SLC22A6;SLC25A14;SLC5A5;SLC26A2;SLC25A30;SLC25A11
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.41343377275580667,0.8512878591683614,0.6166077738515902,1.0,1.0,11/11,58.69%,HCN2;CNGA1;KCNA10;CNGA3;CNGA4;CNGA2;HCN1;AQP1;CNGB3;HCN4;CNGB1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.4176480013347551,0.850323128258025,0.6075731497418244,1.0,1.0,3/11,10.34%,PABIR1;PPP1R14C;PPP1R14A
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.34673987686342295,0.8468697714621295,0.6560332871012483,1.0,1.0,14/37,20.58%,NARS2;HARS2;LARS1;IARS2;IARS1;SARS2;EPRS1;KARS1;LARS2;SARS1;FARS2;GARS1;AARS2;CARS2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.3547003926362065,0.8450571933951712,0.6434659090909091,1.0,1.0,6/27,14.45%,POLR2L;POLR2I;POLR2G;POLR1H;POLR2J;POLR3K
prerank,CCR chemokine receptor binding (GO:0048020),0.34590976577454025,0.8434273313037427,0.6349206349206349,1.0,1.0,3/28,10.44%,CCL5;CNIH4;CCL14
prerank,poly-pyrimidine tract binding (GO:0008187),0.3628106607577333,0.8434126497078841,0.6553755522827688,1.0,1.0,7/23,11.71%,RBMS3;MCRS1;ATXN1;U2AF2;DIS3L2;HNRNPU;HNRNPC
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.3308488023316482,0.8433250940953717,0.6338028169014085,1.0,1.0,6/42,8.94%,CCNA2;CCND2;CCNQ;HEXIM1;CCND1;CCNT1
prerank,cysteine-type peptidase activity (GO:0008234),0.3057846431503632,0.8395574723345884,0.6845310596833131,1.0,1.0,13/73,14.90%,TINAGL1;USP2;BLMH;CAPN2;USP1;ATG4D;USP13;USP50;ATG4A;USP35;USP20;USP30;USP42
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.3818470778455328,0.8374414633895885,0.6372712146422629,1.0,1.0,5/16,17.86%,MTMR7;SACM1L;MTMR14;PTEN;MTMR3
prerank,outward rectifier potassium channel activity (GO:0015271),-0.34092293025367104,-0.8351906446474828,0.6753554502369669,0.9054942710814445,1.0,3/11,9.85%,KCNK2;PKD2;KCND3
prerank,phospholipase activity (GO:0004620),0.3082985904212771,0.8351002266282622,0.6798029556650246,1.0,1.0,5/67,3.65%,PLCE1;PLCB4;LPL;PLCL1;PITPNM3
prerank,fibroblast growth factor binding (GO:0017134),-0.29240428277367225,-0.8345304477581234,0.6918767507002801,0.9018272985992658,1.0,10/21,30.39%,RPS19;ITGAV;FGFR2;FIBP;FGFR4;KL;GPC1;CEP57;FGFRL1;FGFBP3
prerank,vitamin D receptor binding (GO:0042809),-0.32968815090300585,-0.833673039184646,0.7013888888888888,0.8985959680499548,1.0,9/14,29.76%,MED13;MED17;SNW1;MED24;MED16;MED30;TAF7;RXRA;THRAP3
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.35540651387384703,-0.8336697531894375,0.6880165289256198,0.8938217559855957,1.0,2/10,5.95%,GNAS;SHANK3
prerank,rRNA binding (GO:0019843),0.33028078805023375,0.8313908131215992,0.6971350613915416,1.0,1.0,6/42,10.53%,CAVIN1;FASTKD5;RCC1L;CIRBP;RPL5;MRPL16
prerank,transition metal ion binding (GO:0046914),0.27137175339202496,0.8313755693186808,0.8219315895372233,1.0,1.0,33/397,7.41%,AOC3;CRIP1;PAPPA2;TRIM54;MSRB3;CSRP1;DYRK2;POLR2L;LIMS1;TRIM2;ADCY2;LARGE1;LOXL2;RBAK;ITGB1BP2;SIRT3;ALOX5;ATAD3A;PIAS4;ARHGEF2;RNF7;ETHE1;KLF7;LNPEP;TYW5;RNPEP;SUV39H2;TP53;CALB1;PTPN1;ABCE1;RASGRP1;ENPEP
prerank,cytokine receptor activity (GO:0004896),0.3002503381983985,0.830677450682358,0.7125890736342043,1.0,1.0,9/83,10.76%,LIFR;CRLF1;FZD4;IL12RB2;IL10RA;IL12RB1;GPR17;IL13RA1;GFRA1
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.34536444206439754,0.830209730250196,0.6680672268907563,1.0,1.0,8/28,15.50%,RPS6KA2;MAP2K1;MAP2K3;SGK1;LRRK2;PRKAA2;PRKACA;MAP2K4
prerank,receptor ligand activity (GO:0048018),0.2741256409551201,0.8295193948593284,0.7836438923395446,1.0,1.0,17/245,7.87%,NTF3;FGF1;PDGFB;SEMA5A;CRLF1;THPO;GREM2;JAG1;IL2;TNFSF13B;TGFB3;CCL5;SEMA6C;VEGFA;GDNF;AREG;TGFB2
prerank,methyltransferase activity (GO:0008168),-0.23512919264009632,-0.8285891761401617,0.7649572649572649,0.8980751145223432,1.0,23/46,38.02%,COQ5;PRMT3;AS3MT;METTL3;EEF1AKMT1;TRMT11;BUD23;ARMT1;NSUN3;RRP8;SUV39H1;FTSJ3;COQ3;AMT;NDUFAF7;METTL27;GCSH;MRM2;BCDIN3D;NTMT1;GAMT;DNMT3B;PRMT8
prerank,phospholipase A2 activity (GO:0004623),0.3512120537039205,0.8275892759517448,0.6467153284671533,1.0,1.0,6/26,17.32%,PLA2G3;PLB1;PNPLA3;PLA2G4A;PLA2G4C;PRDX6
prerank,protein phosphorylated amino acid binding (GO:0045309),0.32053685971763773,0.8275308568703386,0.6730506155950753,1.0,1.0,10/42,13.45%,BCAR3;SHD;IRS1;FBXW7;PIN1;NEDD4;SAMSN1;VAV1;LDLRAP1;NCK2
prerank,myosin II binding (GO:0045159),0.40359785778182444,0.8273073806530798,0.6347197106690777,1.0,1.0,1/10,2.58%,MYL3
prerank,four-way junction DNA binding (GO:0000400),-0.2966628087609502,-0.8248256807165576,0.7359413202933985,0.900294415695216,1.0,6/17,28.15%,HMGB1;BLM;MSH6;RAD51C;HMGB2;XRCC2
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.39082198841083193,0.8240169479360968,0.6429809358752167,1.0,1.0,2/14,15.74%,DHRS3;RDH11
prerank,protein kinase C binding (GO:0005080),0.31851120926068194,0.8219606296935935,0.678996036988111,1.0,1.0,7/43,12.75%,PDLIM5;HDAC9;IRS1;PLEK;ADCY6;TOP2B;CAVIN3
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.30538696243921026,-0.819275945797159,0.7321867321867321,0.905967166952592,1.0,4/17,12.97%,PPT1;ACOT8;ACOT9;PLA2G6
prerank,nucleosomal DNA binding (GO:0031492),0.35285263142456147,0.8190240684865466,0.67601246105919,1.0,1.0,7/21,18.89%,H1-0;ACTB;SMARCB1;HNRNPC;CHD4;HDAC1;ACTL6A
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.35001249207418794,-0.8184017918121543,0.7207792207792207,0.9027386055956678,1.0,4/10,13.96%,ATF2;NAA50;EP300;NAA60
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.39664144640772037,0.8169661426117362,0.6526845637583892,1.0,1.0,2/12,5.14%,LTBP1;BMPR1A
prerank,nuclease activity (GO:0004518),-0.2235423969953443,-0.8156962635814836,0.8589211618257261,0.9026595711515559,1.0,19/52,29.26%,REXO5;MRE11;N4BP2;ERCC5;SAMHD1;DIS3;RNASE4;REXO1;ENPP1;ISG20L2;ZC3H12A;NME1;RNASEL;AEN;EXOG;SND1;OGG1;DNA2;PDE12
prerank,glutamate receptor binding (GO:0035254),0.36630530025892005,0.8150652850344373,0.6565656565656566,1.0,1.0,5/17,14.85%,HIP1;NSF;HOMER1;SHANK2;SHISA6
prerank,nucleotidase activity (GO:0008252),0.3797119129548024,0.8150154324504405,0.6615646258503401,1.0,1.0,5/15,19.80%,ACP3;NT5C2;NT5M;NT5C3A;NT5C
prerank,lipase activity (GO:0016298),-0.2382552281706107,-0.8148639166349276,0.7520325203252033,0.899572836689851,1.0,14/43,27.11%,DDHD2;PLA1A;LYPLA1;SEC23IP;ABHD5;DDHD1;ABHD12;ABHD3;LIPE;ABHD6;LIPA;DAGLB;PNPLA2;PNPLA8
prerank,nuclear export signal receptor activity (GO:0005049),0.3923015955297021,0.8098644339128855,0.6612612612612613,1.0,1.0,3/11,16.84%,RANBP17;XPO5;XPO1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.378572540741845,0.8079212255764181,0.654485049833887,1.0,1.0,2/15,5.55%,SLC4A8;SLC4A3
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.3289936617728262,0.8073450524957428,0.7067039106145251,1.0,1.0,6/33,8.61%,UBA2;DCUN1D2;AUP1;DCUN1D1;RNF180;PPARA
prerank,serotonin receptor activity (GO:0099589),0.35298797413821337,0.8051959766094036,0.7075038284839203,1.0,1.0,3/22,11.69%,HTR1B;HRH3;HTR2B
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.35298797413821337,0.8051959766094036,0.7075038284839203,1.0,1.0,3/22,11.69%,HTR1B;HRH3;HTR2B
prerank,G protein-coupled amine receptor activity (GO:0008227),0.35298797413821337,0.8051959766094036,0.7075038284839203,1.0,1.0,3/22,11.69%,HTR1B;HRH3;HTR2B
prerank,phosphotyrosine residue binding (GO:0001784),-0.24222456162745212,-0.803837805928122,0.8012820512820513,0.9134107628055387,1.0,6/37,6.43%,GRB2;PTPN11;RASA1;PIK3R3;VAV2;PLCG2
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.3570911787111617,0.8013664822977266,0.6810897435897436,1.0,1.0,3/18,5.03%,SOCS5;SOCS6;SOCS4
prerank,protein kinase regulator activity (GO:0019887),0.2822407105903873,0.8010507104804142,0.755608028335301,1.0,1.0,21/95,17.26%,FGF13;CCNA2;CCND2;CCNQ;HEXIM1;TPX2;ANKRD54;CCND1;PRKAR1B;CCNT1;PARVA;TAOK3;DNAJC3;CCNJL;ELP3;AGAP2;MT3;KIDINS220;CCNF;MARK2;FAF1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.3920533211748781,0.8004090463920104,0.6660929432013769,1.0,1.0,2/10,8.21%,NAA25;NAA20
prerank,epidermal growth factor receptor binding (GO:0005154),0.33797223264561255,0.7981345686516035,0.670995670995671,1.0,1.0,6/25,16.94%,HIP1;ATXN2;AREG;HBEGF;SNX1;SNX4
prerank,heme binding (GO:0020037),0.298999514662115,0.7980945105789564,0.7261462205700124,1.0,1.0,15/65,16.61%,GUCY1B1;PTGIS;HMOX2;TBXAS1;SDHC;PXDN;HEBP2;NR1D1;THAP4;RSAD1;SLC48A1;DGCR8;NOS1;JAK2;PGRMC1
prerank,organic cation transmembrane transporter activity (GO:0015101),0.3668728689882243,0.7973549164945696,0.6693944353518821,1.0,1.0,4/16,11.92%,SLC44A1;SLC7A8;SLC25A26;SLC22A5
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.3901795378841715,0.7966030070137926,0.6690017513134852,1.0,1.0,4/13,17.15%,IDI1;SREBF2;ECI1;MIF
prerank,general transcription initiation factor binding (GO:0140296),-0.2700033820122989,-0.7925456665086353,0.7688022284122563,0.9272033723236587,1.0,8/25,15.22%,YEATS2;AHR;ESR1;DR1;PSMC5;PSMC2;TAF12;TAF13
prerank,syntaxin binding (GO:0019905),0.28936725784788037,0.7922075222988741,0.7490729295426453,1.0,1.0,3/61,4.63%,STXBP2;SYPL2;SYT10
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.3163484181803753,0.7895048361436765,0.7213578500707214,1.0,1.0,12/34,19.36%,TAF1;UBE2W;UBE2F;UBE2E1;UBE2D1;AKTIP;UBE2J1;UBE2K;UBE2L6;UBE2A;UBE2I;UBE2Q1
prerank,chloride transmembrane transporter activity (GO:0015108),0.36207504068703605,0.7888671098123823,0.6776859504132231,1.0,1.0,2/16,5.97%,SLC4A8;CLCN6
prerank,protein kinase inhibitor activity (GO:0004860),0.30687240392983134,0.7886758771296057,0.7250341997264022,1.0,1.0,6/42,13.59%,INKA2;HEXIM1;PARVA;TAOK3;CEP43;DNAJC3
prerank,acetyltransferase activity (GO:0016407),0.32510702644314265,0.7886138544250827,0.720863309352518,1.0,1.0,5/31,10.39%,NAT10;SAT2;NAT8L;NAT8;NAT14
prerank,zinc ion binding (GO:0008270),0.2597290651850428,0.7885646231003318,0.863265306122449,1.0,1.0,23/293,7.41%,CRIP1;PAPPA2;TRIM54;MSRB3;CSRP1;POLR2L;LIMS1;TRIM2;RBAK;ITGB1BP2;SIRT3;ATAD3A;PIAS4;ARHGEF2;KLF7;LNPEP;RNPEP;SUV39H2;TP53;CALB1;PTPN1;RASGRP1;ENPEP
prerank,NAD+ binding (GO:0070403),0.37504187025101887,0.7848532220334559,0.6790352504638218,1.0,1.0,4/12,16.52%,SIRT3;SIRT2;HADH;SIRT6
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.2542057678582156,0.7843838016534264,0.968,1.0,1.0,121/830,16.14%,SOX6;PRDM16;SOX5;MEF2C;HEY2;ACTN4;ZFHX3;TBX2;NR1H4;EBF1;ZEB2;ALX4;RORA;NR4A1;EBF2;SIM2;GABPA;PRRX1;ETS2;HEYL;TEAD3;IRX5;HINFP;ZNF436;FOSL2;RBAK;NACC2;PRDM1;NR2F2;NR2C1;VEZF1;OSR2;SP7;KLF7;TBX18;KCNIP3;MEF2A;GBX1;KLF16;DBP;FOXJ3;KLF15;JUND;TAF1;CHD2;TP53;RXRG;GRHL1;ZNF418;ZBTB38;HOXC4;AR;ZFP28;ZNF431;SOX9;SNAI2;HSF4;RELA;ZFP62;CUX2;ZKSCAN4;PPARA;BBX;CARF;NR4A2;SKI;NR1D1;LRRFIP1;ZBTB33;HIF1A;ZBTB41;HNRNPU;ZNF3;NR2C2;TEAD1;SREBF2;RUNX1;RB1;ATF3;HOXC8;NKX6-1;ZKSCAN1;ZBTB7A;NFX1;ESRRA;NR6A1;POU3F3;MED8;ZBTB10;ZNF83;ZFP69;MXD4;BCL6;IKZF1;CASZ1;MEF2B;FOXJ1;ZBTB5;RFX7;ZKSCAN7;CLOCK;MTA1;ZBTB4;SP4;RFX1;EBF3;MLXIPL;KLF6;HOXB2;ZSCAN22;STAT1;HOXC5;NR5A1;RFX3;SARS1;ZSCAN18;SP1;STAT3;IKZF4;ZBTB9;CALCOCO1
prerank,RNA stem-loop binding (GO:0035613),-0.3161216262056354,-0.7818961945268741,0.7551963048498845,0.9392553554251696,1.0,5/12,20.19%,DDX3X;RC3H2;ZC3H12A;FMR1;METTL16
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.34322995194633055,0.7809387039882506,0.7269890795631825,1.0,1.0,7/21,19.83%,CDK6;CDK7;CDK12;CDK15;CDK14;CDKL2;CDK13
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.34322995194633055,0.7809387039882506,0.7269890795631825,1.0,1.0,7/21,19.83%,CDK6;CDK7;CDK12;CDK15;CDK14;CDKL2;CDK13
prerank,ubiquitin-specific protease binding (GO:1990381),-0.2842146041281216,-0.780928523914577,0.7855297157622739,0.936083064666628,1.0,5/19,19.26%,DERL1;PRKN;SART3;SYVN1;PARK7
prerank,RNA binding (GO:0003723),0.2531643618564151,0.7798962679893586,0.989,1.0,1.0,328/1321,20.45%,FLNA;SORBS2;MAP3K20;RBPMS;ACTN1;NOL6;RBPMS2;XIRP1;LSM8;ACTN4;RPL3L;CSRP1;CAVIN1;TNS1;SYNE1;KHDRBS3;MYH9;HNRNPR;VIM;HSD17B10;NUDT7;RAVER2;FASTKD5;RBM38;SAMD4A;DENR;MRPS31;H1-0;MRPL13;NAT10;PRPF38B;RBMS3;PARN;MCRS1;UTP14A;HARS2;RPUSD3;DDX23;NUDT4;SRP68;WDR33;RAD51AP1;UPF1;PCF11;CSDE1;ZNF638;CNOT4;MYO18A;TYW5;SF3B5;MTDH;POLR2G;TRMT10C;APEH;ATXN2;U2AF2;FAM32A;MYBBP1A;EIF1;MAPT;CHD2;WDR46;TERT;PARP1;RCC1L;HEXIM1;KTN1;RPS27L;PTPN1;CIRBP;ZCCHC7;RPL8;SFPQ;YTHDF2;FKBP3;RPF1;RCAN3;PA2G4;PPARGC1A;RTCB;CLNS1A;WDR36;PPARGC1B;CELF1;REXO4;DICER1;GOT2;RPS19BP1;DUSP14;MRPL43;SRSF4;FASTKD1;NAF1;PYM1;SRRM3;API5;PSTK;GPKOW;MBNL2;MRM1;PWP2;EIF4A1;MRPS35;MRPS28;FUS;LONP1;TDRD3;PPIE;ZC3H11A;PKN2;SEPSECS;LRRFIP1;MRPL45;RBM19;SECISBP2L;RPL5;SAMSN1;HADHB;SRP72;MRPL21;DDX59;MRPL23;PTBP2;RBM8A;KIF1C;MBNL1;U2AF1;EIF3E;DHX8;HNRNPU;PPP1R10;RPS23;MRPL16;EIF2AK2;EIF5A;TFB2M;ROCK2;CCT3;OTUD4;SRSF10;ALDOA;DDX1;FNDC3B;GSPT1;DDX25;RBM3;DCP1A;SF3A3;BAZ2A;NOP58;HNRNPC;NFX1;PSPC1;RBM6;EIF3H;MRPL9;KPNA2;YTHDC2;MAK16;DRG2;ALG13;SRRM1;AIMP1;TSFM;XPO5;DROSHA;RBM27;CPEB3;COL14A1;SF3B1;SF3B2;DCP1B;ZCRB1;OASL;NUFIP2;PCBP3;ZC3H4;MRPL42;NSUN2;ZFP36L1;CPNE3;RBM25;DXO;RPUSD4;TRIM28;CSNK1E;DHX30;SON;MTCL1;DGCR8;SYNCRIP;RPL15;TMSB4X;MAP4;GIGYF2;NUP98;SARS2;G3BP1;DDX55;CCDC9B;SRP19;CWC22;GDI2;EPRS1;IMP4;DDX56;EDF1;BZW1;EIF4E;STAU2;UBA1;KARS1;GLRX3;FASTKD2;SRPK2;RBM15;TEP1;NOL4;SF1;NANOS1;LAS1L;DDX18;PELP1;RFTN1;IREB2;NELFCD;RPL22;SARS1;DHX32;LSM10;SF3A1;PUF60;STAT3;SEC61B;ANXA11;FARS2;FIP1L1;PRRC2C;WBP4;ETF1;RPL31;IMMT;RBM45;MRPL14;DHX9;WDR6;DDX49;ACIN1;MRPL4;RPS6;MARK2;EIF4G2;USP36;BOP1;FKBP4;LUC7L;EIF2AK4;PDCD11;RPS17;RBM33;FAM98B;CEBPZ;EEF2;DHX29;FAM120C;MRPS21;NAP1L4;TRUB2;NDUFV3;AKAP1;HNRNPUL2;RBM14;MDH2;HDLBP;SNRPD3;TEFM;FRG1;MRPL40;MRPL22;LGALS1;EXOSC10;CMSS1;RTCA;N4BP1;TRMT6;HABP4;NIFK;UCHL5;RPS27A;SUMO1;CLTC;UBE2I;NTPCR;RPS14;PKM;KIN;SNIP1;PRKRA;ILF3;AARS2;QKI;RPGR;AGO1;SLC4A1AP;ADARB1;ZRANB2;PRMT1;TIAL1;PPRC1;SPATS2L;CDK13;PNN;JUN;SRP14;SERBP1;NSUN5;MRPS14;DDX10;ERI1;YTHDC1;WDR43;DHX37;NSRP1;CS;C1QBP;PRR3;EIF2S1;EIF2A
prerank,RNA polymerase II complex binding (GO:0000993),0.3127508431952314,0.7789958416102712,0.7268847795163584,1.0,1.0,11/32,22.33%,SCAF1;PCF11;HNRNPU;URI1;ELOF1;DHX9;BRD4;AGO1;WDR43;RPRD1A;CCAR2
prerank,Hsp90 protein binding (GO:0051879),-0.23643420065127563,-0.778288700493684,0.8073394495412844,0.9358126194076491,1.0,12/33,25.48%,SLC12A2;USP19;NR3C1;AHR;STUB1;ERN1;KDR;NPAS2;HSF1;TELO2;AHSA1;CSNK2A1
prerank,dynactin binding (GO:0034452),0.3890595066792836,0.778046375551249,0.723292469352014,1.0,1.0,2/12,6.18%,BICD2;MAPT
prerank,DNA binding (GO:0003677),0.2505985673038052,0.7762219691600108,0.951,1.0,1.0,97/694,13.69%,SOX6;PRDM16;HEY2;TBX2;NR1H4;ZEB2;ALX4;TRNP1;RORA;MLF1;NR4A1;SIM2;ETS2;ARID5B;CGAS;HINFP;BRIP1;H1-0;CHRAC1;RAD51AP2;SIRT3;GTF2H4;ARID1A;NR2F2;NR2C1;BCL2;GTF3C4;RAD51AP1;OSR2;CBFB;SP7;ZNF638;MEF2A;POLR2G;FOXJ3;MYBBP1A;MBD5;TAF1;MAPT;SMARCB1;CHD2;ARID5A;TERT;TIPIN;TP53;GRHL1;HDGFL3;SFPQ;PPARGC1A;MBD4;TDP1;CHTF18;REXO4;ERCC6;SOX9;SNAI2;RELA;KMT2D;CUX2;PPARA;MSL3;CARF;CCNT1;LONP1;NR4A2;LRRFIP1;ZBTB33;HIF1A;CRLF3;DEDD2;ZDHHC1;SYCP2;HNRNPU;ZNF3;MCMDC2;NR2C2;TEAD1;POLD1;ZBTB7A;ESRRA;POLG;RBM6;TSG101;LIN9;CSRNP3;HDGFL2;DEDD;NR6A1;POU3F3;SMARCA5;OASL;BCL6;CHD4;IKZF1;FOXJ1;TRIM28;DNASE1L1
prerank,lysine N-methyltransferase activity (GO:0016278),0.3422362568738181,0.7761302823128974,0.7268445839874411,1.0,1.0,5/20,15.17%,SETD6;SETD3;ATPSCKMT;VCPKMT;EEF1AKMT2
prerank,ribosomal small subunit binding (GO:0043024),-0.2858266542421934,-0.7750441498061751,0.7698019801980198,0.9359729595809443,1.0,2/17,2.55%,CPEB2;DDX3X
prerank,neuropeptide hormone activity (GO:0005184),-0.269952187512426,-0.7749481666663847,0.7865168539325843,0.9314306572890485,1.0,19/22,64.21%,PPY;ADCYAP1;PENK;CCK;SPX;GRP;NPFF;PNOC;NMB;AGRP;VIP;CRH;GAL;CALCB;UCN;NPPA;GHRH;HCRT;QRFP
prerank,anion:anion antiporter activity (GO:0015301),-0.28767073140408517,-0.7738126059369697,0.7718832891246684,0.9286442049386506,1.0,4/17,17.15%,SLC26A7;SLC4A2;SLC26A2;SLC25A11
prerank,endodeoxyribonuclease activity (GO:0004520),-0.2728275821784571,-0.7707040932063304,0.7686375321336761,0.9287911977936948,1.0,9/20,35.55%,MRE11;RAD50;ERCC5;ERCC1;ERCC4;EXOG;DNA2;ENDOV;DCLRE1C
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.2525468478094467,0.7665148790033998,0.8617463617463618,1.0,1.0,31/232,11.72%,TRIM54;RNF152;TRIM55;TRIM63;TRIM2;FBXL22;RNF150;PDZRN3;RNF114;ASB2;UBR5;ASB1;PIAS4;RNF7;CBLL1;NEURL4;NEDD4;RNF180;TRIM68;CBX4;NEURL1B;UHRF2;AMFR;TRIM7;NHLRC1;FBXO6;PELI2;UBE2D1;PIAS2;TRIM35;NFX1
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.2660340223536359,-0.7630114573909279,0.7922077922077922,0.9354930830546985,1.0,5/20,16.40%,TJP2;DLG1;MAGI3;CASK;DTYMK
prerank,amyloid-beta binding (GO:0001540),0.2761629307772518,0.7624839549031118,0.7951807228915663,1.0,1.0,14/79,16.82%,CD36;APBA1;FZD5;FZD4;ITM2C;TGFB2;CACNA1B;CHRNA7;CLU;LDLRAP1;ATP1A3;HSPG2;PGRMC1;CLSTN1
prerank,single-stranded RNA binding (GO:0003727),-0.21836813123158116,-0.7607894874289022,0.8408163265306122,0.9340518156721171,1.0,6/43,11.35%,AGO3;DDX3X;AQR;STRBP;JMJD6;DDX60
prerank,retinoic acid binding (GO:0001972),0.37251539441904313,0.7601595659186606,0.7258347978910369,1.0,1.0,1/12,4.32%,NR2F2
prerank,N-acyltransferase activity (GO:0016410),0.31219519933049567,0.7568221425951659,0.7619047619047619,1.0,1.0,6/32,10.39%,NAT10;SAT2;NAT8L;NAT8;CERS1;NAT14
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.3620200537311044,0.7559437932662558,0.7332155477031802,1.0,1.0,3/13,13.69%,DICER1;SLX4;DNASE1L1
prerank,DNA polymerase binding (GO:0070182),-0.27337229742700386,-0.7554889565198009,0.8131313131313131,0.9370138157257225,1.0,5/18,17.91%,HMGB1;HSP90AB1;FANCI;CDK2AP1;SMG6
prerank,chemokine binding (GO:0019956),0.30920955220997703,0.7544890169674007,0.751453488372093,1.0,1.0,4/30,8.27%,ITGB1;CXCR6;ITGB3;ITGA4
prerank,endopeptidase activity (GO:0004175),0.25105909202435034,0.7544051325422569,0.8987603305785123,1.0,1.0,32/257,15.10%,TMPRSS4;MMP17;ADAMTS14;ADAMTS5;KLK2;ADAMTS19;USP2;APEH;AFG3L2;TRABD2B;ADAM17;USP1;MASP2;MIPEP;PSMB1;MBTPS1;THSD4;PHEX;ADAMTS20;USP13;ADAMTS16;PSMB2;DDI2;PMPCB;USP35;USP20;USP30;ADAM19;PSMB7;USP42;PCSK4;ADAMTSL4
prerank,GTPase regulator activity (GO:0030695),0.2508640087900573,0.7537063055938443,0.8683937823834197,1.0,1.0,49/212,16.78%,RALGAPA2;DLC1;TBC1D1;RGS6;ABR;MYO9B;ELMOD1;TBC1D20;ARHGAP10;ELMOD2;CHN1;LARS1;MTSS2;RABGAP1;ARHGAP17;RALGAPA1;PLCB1;EVI5;RIN2;ARHGAP39;ARHGAP30;RALGAPB;ARHGAP1;ASAP2;NPRL2;DOCK1;DNM1L;SH3BP4;TBCD;ARHGAP15;RHOH;ARHGAP35;HTR2B;BCR;ARHGAP32;GNAQ;RGS5;LRRK2;ARHGAP24;IPO7;RUNDC1;TBC1D22B;ARHGAP26;AGAP2;RASGRP3;RGS10;VAV3;PREB;TBC1D12
prerank,pre-mRNA binding (GO:0036002),0.3161927692197281,0.7533660493568586,0.759825327510917,1.0,1.0,5/28,10.29%,RBM24;U2AF2;CELF1;U2AF1;HNRNPU
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.3206210915642316,-0.75270874429932,0.7888349514563107,0.9364265125642507,1.0,2/12,4.81%,CYFIP2;DCPS
prerank,protein kinase activator activity (GO:0030295),0.2808197446624109,0.7508951217673618,0.7982565379825654,1.0,1.0,7/60,9.23%,FGF13;FAM20A;CALM1;TPX2;ERCC6;MAP2K1;PAK2
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.24350533142841782,-0.7499066621855595,0.8580246913580247,0.935734422899957,1.0,11/28,35.51%,AGO3;POP1;EDC3;DBR1;ELAC2;POP4;ENDOV;RPP38;NUDT16;MRPL44;RPP21
prerank,insulin-like growth factor binding (GO:0005520),0.3486084510906049,0.7466962885808344,0.7603993344425957,1.0,1.0,4/15,7.49%,IGFBP5;IGFBP4;IGF2R;ITGB3
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.32042269492418657,0.7454810209806136,0.7662538699690402,1.0,1.0,8/24,18.77%,GOLGA7B;ZDHHC2;ZDHHC1;ZDHHC14;ZDHHC17;ZDHHC4;ZDHHC8;ZDHHC3
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.24151939732294286,0.7446489419235565,0.981,1.0,1.0,102/731,16.14%,SOX6;PRDM16;SOX5;MEF2C;HEY2;ZFHX3;TBX2;NR1H4;EBF1;ZEB2;RORA;NR4A1;EBF2;GABPA;PRRX1;ETS2;HEYL;TEAD3;IRX5;HINFP;FOSL2;NACC2;PRDM1;NR2F2;NR2C1;SP7;KLF7;TBX18;KCNIP3;MEF2A;KLF16;DBP;FOXJ3;KLF15;JUND;CHD2;TP53;RXRG;GRHL1;ZNF418;ZBTB38;HOXC4;AR;ZFP28;ZNF431;SOX9;SNAI2;HSF4;RELA;ZFP62;ZKSCAN4;PPARA;CARF;NR4A2;SKI;NR1D1;LRRFIP1;ZBTB33;HIF1A;ZBTB41;HNRNPU;NR2C2;TEAD1;SREBF2;RUNX1;ATF3;NKX6-1;ZKSCAN1;ZBTB7A;ESRRA;NR6A1;POU3F3;MED8;ZNF83;MXD4;BCL6;IKZF1;MEF2B;FOXJ1;ZBTB5;RFX7;ZKSCAN7;CLOCK;MTA1;ZBTB4;SP4;RFX1;EBF3;MLXIPL;KLF6;HOXB2;ZSCAN22;STAT1;HOXC5;NR5A1;RFX3;SARS1;ZSCAN18;SP1;STAT3;IKZF4;CALCOCO1
prerank,RNA polymerase binding (GO:0070063),0.33696217367750614,0.7442399897637435,0.7475409836065574,1.0,1.0,5/18,12.07%,NEDD4;STOM;CCNT1;PKN2;YTHDC2
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.3594764638937163,0.743164467545446,0.7693693693693694,1.0,1.0,3/12,7.49%,DAB2IP;VEGFA;ITGB3
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.34536478575618834,0.742922546936042,0.7360406091370558,1.0,1.0,4/14,17.86%,MTMR7;MTMR14;PTEN;MTMR3
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.2710806525451631,-0.7413984543777131,0.8349753694581281,0.9428622208042355,1.0,6/17,20.93%,LBR;BLVRB;BDH2;DPYD;DECR2;PECR
prerank,chemokine receptor activity (GO:0004950),0.3178594874549211,0.7407242869418416,0.7586206896551724,1.0,1.0,2/24,7.60%,CXCR6;GPR17
prerank,peptidase activator activity (GO:0016504),0.3154643751789956,0.7393281754196284,0.7885532591414944,1.0,1.0,4/22,11.10%,ADRM1;CAV1;PSME4;CASP8AP2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.23934358831151883,0.7385941766133585,0.984,1.0,1.0,102/730,16.14%,SOX6;PRDM16;SOX5;MEF2C;HEY2;ZFHX3;TBX2;NR1H4;EBF1;ZEB2;RORA;NR4A1;EBF2;GABPA;PRRX1;ETS2;HEYL;TEAD3;IRX5;HINFP;FOSL2;NACC2;PRDM1;NR2F2;NR2C1;SP7;KLF7;TBX18;KCNIP3;MEF2A;KLF16;DBP;FOXJ3;KLF15;JUND;CHD2;TP53;RXRG;GRHL1;ZNF418;ZBTB38;HOXC4;AR;ZFP28;ZNF431;SOX9;SNAI2;HSF4;RELA;ZFP62;ZKSCAN4;PPARA;CARF;NR4A2;SKI;NR1D1;LRRFIP1;ZBTB33;HIF1A;ZBTB41;HNRNPU;NR2C2;TEAD1;SREBF2;RUNX1;ATF3;NKX6-1;ZKSCAN1;ZBTB7A;ESRRA;NR6A1;POU3F3;MED8;ZNF83;MXD4;BCL6;IKZF1;MEF2B;FOXJ1;ZBTB5;RFX7;ZKSCAN7;CLOCK;MTA1;ZBTB4;SP4;RFX1;EBF3;MLXIPL;KLF6;HOXB2;ZSCAN22;STAT1;HOXC5;NR5A1;RFX3;SARS1;ZSCAN18;SP1;STAT3;IKZF4;CALCOCO1
prerank,signal sequence binding (GO:0005048),0.30268843019476344,0.7363425369667788,0.8014492753623188,1.0,1.0,8/35,14.38%,CABP1;KPNA4;PEX5L;NUP153;RANBP6;KPNA2;KPNA3;IPO4
prerank,FAD binding (GO:0071949),0.3200304308039793,0.7359234243196596,0.7571884984025559,1.0,1.0,4/24,14.48%,MICAL2;KMO;MICAL3;CYB5R3
prerank,transcription corepressor binding (GO:0001222),0.3039616258518101,0.7341915070279315,0.7868098159509203,1.0,1.0,3/27,11.70%,RORA;NR1D1;ZBTB7A
prerank,histone deacetylase activity (GO:0004407),0.327350615675251,0.7337135410289699,0.770096463022508,0.9993074792243768,1.0,6/19,18.91%,HDAC9;SIRT3;SIRT2;SIRT6;HDAC1;HDAC6
prerank,ribonuclease P RNA binding (GO:0033204),-0.3195888783115543,-0.7328993036468452,0.8140043763676149,0.9494299163708805,1.0,5/10,43.54%,POP1;POP4;RPP38;RPP21;POP7
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.3074012583970408,-0.7323614915861562,0.8187772925764192,0.9456131195784215,1.0,4/10,30.83%,ATXN3;CYLD;TNFAIP3;YOD1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.3632515480475241,0.732357096235905,0.7630161579892281,0.998420538850057,1.0,5/11,18.82%,UBR5;UBE4A;AMFR;UBE2K;ANAPC11
prerank,phosphatase inhibitor activity (GO:0019212),0.3275673973530202,0.7322690592613177,0.7520128824476651,0.9957760058768614,1.0,7/20,15.30%,SET;SAG;TESC;ENSA;CABIN1;ARPP19;URI1
prerank,manganese ion binding (GO:0030145),0.2798054526696592,0.732098948398686,0.7951807228915663,0.9932970060607388,1.0,3/48,2.30%,DYRK2;ADCY2;LARGE1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",-0.24176906516496122,-0.7306610512968407,0.8802228412256268,0.9434329552269105,1.0,13/24,36.77%,IP6K1;IP6K2;PPIP5K2;DTYMK;ITPKB;NME1;PMVK;AK4;AK1;PPIP5K1;NME2;AK5;AK3
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3488392648748923,0.7286256749997027,0.7470288624787776,0.9952485977529636,1.0,2/11,8.21%,NAA25;NAA20
prerank,potassium:proton antiporter activity (GO:0015386),-0.31254024901791133,-0.7255895005518451,0.8194130925507901,0.9453026053729232,1.0,4/10,25.68%,SLC9A2;SLC9A6;SLC9A9;SLC9A5
prerank,kinase inhibitor activity (GO:0019210),-0.23348659754306308,-0.7240201768384072,0.8733766233766234,0.942890560860128,1.0,16/33,33.83%,MBIP;NCK1;SNCA;SH3BP5L;TRIB1;QARS1;MAPK8IP1;SMCR8;CDKN1A;CDKN1C;SPRY4;SH3BP5;DUSP19;GMFB;SOCS3;WARS1
prerank,mRNA binding (GO:0003729),0.2386714471106187,0.7202638702182433,0.9243353783231084,1.0,1.0,40/249,14.17%,RBPMS;RBPMS2;RBM24;KHDRBS3;HNRNPR;CRYZ;SAMD4A;DENR;MRPL13;RBMS3;PARN;PCF11;TP53;CPEB1;CIRBP;YTHDF2;CELF1;SRSF4;SRRM3;EIF4A1;PPIE;ZC3H11A;SECISBP2L;RPL5;PTBP2;RBM8A;HNRNPU;DCP1A;HNRNPC;XPO5;CPEB3;SF3B1;DCP1B;PCBP3;ZFP36L1;RBM25;DXO;SYNCRIP;NUP98;G3BP1
prerank,RNA cap binding (GO:0000339),-0.2723256645700121,-0.7177279550639021,0.837037037037037,0.9459399862707235,1.0,5/16,20.59%,CYFIP2;DCPS;LSM1;NCBP2;EIF3D
prerank,O-acyltransferase activity (GO:0008374),0.2952642697272027,0.7175846111791319,0.8102710413694721,1.0,1.0,9/30,20.65%,LPCAT3;DGAT1;PLA2G4A;PLA2G4C;PRDX6;MBOAT7;GPAT3;LPCAT1;PLA2G15
prerank,DNA polymerase activity (GO:0034061),0.3106019949391449,0.7172353569648416,0.7837423312883436,1.0,1.0,4/22,11.83%,CHRAC1;TERT;POLD1;POLG
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.3490804148429604,0.7159777534129059,0.772020725388601,1.0,1.0,1/11,4.10%,KCNE4
prerank,cAMP binding (GO:0030552),0.33920655157370194,0.712874078367093,0.7673611111111112,1.0,1.0,2/11,11.19%,PDE4A;PDE4D
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.25913250751842815,-0.7126261618550782,0.861878453038674,0.9470856633868951,1.0,4/18,14.60%,RPS6KA3;BIRC2;SNCA;BIRC3
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.28455105608236286,-0.7116953301065878,0.8452380952380952,0.9438230515217616,1.0,5/13,19.44%,SLC66A1;SLC38A5;SLC38A7;SLC7A7;SLC15A4
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.23208473484065412,0.7114122427872421,0.97997997997998,1.0,1.0,57/597,11.81%,SOX6;PRDM16;SOX5;MEF2C;HEY2;TBX2;ALX4;NR4A1;GABPA;ETS2;ARID5B;IRX5;HINFP;PRDM1;NR2C1;MTERF3;OSR2;TBX18;KLF16;DBP;FOXJ3;KLF15;SUV39H2;JUND;MLH3;ARID5A;TP53;RXRG;GRHL1;SFPQ;HOXC4;AR;MBD4;YAP1;SOX9;SNAI2;HSF4;RELA;KMT2D;CUX2;MBNL2;BBX;NR4A2;NR1D1;KAT7;ZBTB33;HNRNPU;MCMDC2;NR2C2;TEAD1;SREBF2;RUNX1;ATF3;HOXC8;ZBTB7A;ESRRA;PSPC1
prerank,clathrin adaptor activity (GO:0035615),-0.2809502809403735,-0.710376195342384,0.8546365914786967,0.9410022645165773,1.0,4/15,13.13%,DAB2;AP1M1;STON2;AP2S1
prerank,transcription coregulator binding (GO:0001221),0.2708121171876,0.7070771551562697,0.8183041722745625,1.0,1.0,7/50,11.70%,RORA;CHD6;TERT;AR;RELA;NR1D1;ZBTB7A
prerank,RNA methyltransferase activity (GO:0008173),0.30771298967542826,0.7050553494104352,0.8076923076923077,1.0,1.0,3/19,12.14%,TRDMT1;FTSJ1;TGS1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.28425566686154957,0.7032515228970908,0.8220338983050848,1.0,1.0,4/35,9.30%,FRK;PEAK1;DYRK1A;SLA
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.350367851590184,0.701915847099872,0.8003629764065335,1.0,1.0,3/10,9.03%,ASH1L;SETD3;NSD3
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.21773394673168198,-0.7001985561845333,0.8783269961977186,0.9477090244303712,1.0,16/34,30.61%,DDX3X;IGF2;MAP2K2;CAB39L;IRGM;SPRY2;TAOK1;CCNT2;CCNK;ALS2;CDK5R1;DBF4;CALM3;INCENP;PARP16;CALM2
prerank,endopeptidase activator activity (GO:0061133),0.3467945675370193,0.6942213188515367,0.7809187279151943,1.0,1.0,1/10,2.96%,ADRM1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.3452903879083898,0.6896986421736268,0.7988721804511278,1.0,1.0,2/11,15.31%,CHRNA7;CHRNA4
prerank,3'-5' exonuclease activity (GO:0008408),0.2669367552635313,0.6883895703620266,0.8725099601593626,1.0,1.0,9/45,11.83%,PARN;ERI2;REXO4;RAD9A;DIS3L2;DIS3L;POLD1;CNOT7;POLG
prerank,GABA receptor binding (GO:0050811),0.33604643011615976,0.6877560850013734,0.8010752688172043,1.0,1.0,2/11,8.65%,GABARAP;TRAK1
prerank,ribonuclease P activity (GO:0004526),-0.2899705286804985,-0.6876836009300372,0.8685968819599109,0.9560491032645418,1.0,4/11,35.51%,POP1;POP4;RPP38;RPP21
prerank,phosphatidate phosphatase activity (GO:0008195),-0.27878173722033817,-0.6872261927368946,0.8689655172413793,0.9521341149949697,1.0,8/13,45.61%,LPIN2;PLPP5;LPIN3;LPIN1;PLPPR3;PLPP2;PLPP1;PLPPR4
prerank,mRNA 3'-UTR binding (GO:0003730),0.2468168474820499,0.6864569957406225,0.871638141809291,1.0,1.0,14/79,13.21%,RBM24;CRYZ;RBMS3;PARN;TP53;CPEB1;CIRBP;CELF1;SECISBP2L;RPL5;HNRNPU;HNRNPC;CPEB3;ZFP36L1
prerank,N-methyltransferase activity (GO:0008170),0.2963838284467559,0.6862525728677644,0.8146964856230032,1.0,1.0,5/20,14.57%,SETD3;TFB2M;ZCCHC4;N6AMT1;NNMT
prerank,endopeptidase regulator activity (GO:0061135),0.269415046581238,0.6858651069949394,0.8457223001402524,1.0,1.0,2/40,2.96%,ITIH4;ADRM1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.2207991052764845,-0.6851995186037285,0.9191919191919192,0.9497782184392929,1.0,5/30,14.60%,BIRC6;RPS6KA3;BIRC2;SNCA;BIRC3
prerank,protein phosphatase activator activity (GO:0072542),0.3224091221185963,0.6844759049049057,0.8126126126126126,1.0,1.0,2/13,7.03%,PPP2R5A;CALM1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.27672750354655684,0.6823704733016289,0.83,1.0,1.0,10/31,19.36%,TAF1;UBE2W;UBE2E1;UBE2D1;AKTIP;UBE2J1;UBE2K;UBE2L6;UBE2A;UBE2Q1
prerank,methylation-dependent protein binding (GO:0140034),-0.1872204793797179,-0.6799277488398842,0.9504504504504504,0.9507583512918206,1.0,12/57,19.91%,KDM7A;KMT2E;CBX5;ZMYND8;TRIM24;MORC4;CHD1;NCAPG2;MPHOSPH8;FMR1;RRP8;MSH6
prerank,tRNA methyltransferase activity (GO:0008175),0.3126001035717779,0.6775886382720636,0.8170731707317073,1.0,1.0,2/16,5.50%,TRDMT1;FTSJ1
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.3264553467302802,0.6753726033655957,0.8036697247706422,1.0,1.0,3/10,8.73%,PKIB;PKIA;PRKAR1B
prerank,phosphatase activity (GO:0016791),0.244331945715827,0.670597093014934,0.9028290282902829,1.0,1.0,12/73,13.94%,DUSP5;ACP3;PRUNE1;LHPP;DUSP3;SACM1L;PLPPR1;PPP1CB;PPP1CA;SBF1;DUSP16;NT5M
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.265970851756758,0.6685107801612776,0.8757225433526011,1.0,1.0,4/35,8.01%,TRDMT1;FTSJ1;GATB;FTO
prerank,sequence-specific DNA binding (GO:0043565),0.2164197126290639,0.6682949489400587,0.9939819458375125,1.0,1.0,59/590,11.77%,PRDM16;MEF2C;HEY2;TBX2;NR1H4;ZEB2;ALX4;RORA;NR4A1;GABPA;ETS2;IRX5;PRDM1;SIRT3;NR2F2;NR2C1;BCL2;UPF1;OSR2;ZCWPW1;CBFB;TBX18;MEF2A;KLF16;DBP;FOXJ3;KLF15;MYBBP1A;JUND;TAF1;MAPT;ARID5A;TERT;RXRG;GRHL1;ZBTB38;HOXC4;PPARGC1A;SOX9;SNAI2;HSF4;CUX2;PPARA;MBNL2;BBX;LONP1;NR4A2;NR1D1;ZBTB33;HIF1A;HNRNPU;NR2C2;TEAD1;SREBF2;ATF3;HOXC8;TERF2;ZBTB7A;ESRRA
prerank,phosphatase activator activity (GO:0019211),0.3088677960808188,0.6657780708058568,0.8201058201058201,1.0,1.0,2/14,7.03%,PPP2R5A;CALM1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.3394941820717256,0.665406300556908,0.8324125230202578,1.0,1.0,4/10,15.80%,HSD17B4;HADHB;ECI1;HADHA
prerank,translation initiation factor activity (GO:0003743),0.26884727450348284,0.6644620212975167,0.8586956521739131,1.0,1.0,11/36,20.45%,EIF1;EIF3M;EIF2D;EIF4A1;EIF3E;EIF3H;EIF4E;EIF4E3;EIF4G2;EIF2S1;EIF2A
prerank,phospholipase inhibitor activity (GO:0004859),0.3333739845945757,0.6606549465234646,0.7864583333333334,1.0,1.0,2/10,10.90%,ANXA1;ANXA9
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.24072248223000578,0.6596474039776183,0.9043062200956937,1.0,1.0,22/69,21.76%,ZDHHC2;LPCAT3;CERS1;HHAT;ZDHHC1;SCP2;ZDHHC14;ZDHHC17;DGAT1;PLA2G4A;PLA2G4C;ELP3;ZDHHC13;ZDHHC5;ZDHHC8;ESCO1;ZDHHC3;KAT8;MBOAT7;PLA2G15;KAT6A;NMT1
prerank,ribosome binding (GO:0043022),0.25358860996383803,0.658000887345685,0.8740157480314961,1.0,1.0,15/46,21.25%,SRP68;CPEB1;PYM1;SRP72;CPEB3;SRP19;SEC61B;ETF1;EEF2;SERBP1;ERI1;C1QBP;EIF2S1;EIF2A;OXA1L
prerank,O-methyltransferase activity (GO:0008171),-0.27582196157694977,-0.6564457723092036,0.9048672566371682,0.967778108535833,1.0,5/10,38.20%,FTSJ3;CMTR1;COQ3;BCDIN3D;CMTR2
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.2566957635247485,-0.655941219395196,0.9032258064516129,0.9638527484800579,1.0,4/14,16.65%,NOD1;CTSH;MAL;APAF1
prerank,disordered domain specific binding (GO:0097718),0.28643590163966715,0.6523821592196744,0.8433544303797469,1.0,1.0,5/23,11.20%,TP53;CALM1;BCL2L2;PPIL1;RB1
prerank,ubiquitin protein ligase binding (GO:0031625),0.21540333360356778,0.6507818890617795,0.9658031088082901,1.0,1.0,47/254,15.54%,VCL;FZD5;FZD4;ACTG1;MFHAS1;BCL2;USP2;PIAS4;CUL2;FZD8;GABARAP;TP53;FBXW7;UBE2W;PA2G4;PPARGC1A;TRAF3;DIO2;RELA;AUP1;PRKACB;WASHC1;SKI;RPL5;HIF1A;TRAF5;UBE2D1;DNM1L;ANKRA2;RB1;MFN2;CCDC50;ACVR1B;NDUFS2;USP13;TSG101;CLU;SNX9;UBE2J1;MUL1;TRIM28;CKB;HM13;PRKACA;UBE2K;UBE2L6;HSPBP1
prerank,lipid phosphatase activity (GO:0042577),0.30744508031558543,0.6506244085389529,0.8434163701067615,1.0,1.0,2/14,9.89%,PLPPR1;PLPP7
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.30516529199605374,0.648598395620446,0.8591800356506238,1.0,1.0,3/12,11.10%,RPS27L;ATP2A3;CASP8AP2
prerank,signaling receptor complex adaptor activity (GO:0030159),0.25368243164041215,0.6454770420812337,0.8914518317503393,1.0,1.0,10/38,15.89%,NUP62;IRS1;SORBS1;SAV1;DEDD2;SHANK2;LDLRAP1;NCK2;LRRK2;SPAG9
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.30051760987158493,0.6432973614222551,0.8370883882149047,1.0,1.0,4/13,19.10%,ARHGDIG;SH3BP4;GDI2;RANBP1
prerank,MHC class II protein complex binding (GO:0023026),0.31019642455104324,0.6377558057731015,0.8333333333333334,1.0,1.0,3/11,19.38%,ATP1B1;ANXA11;PKM
prerank,cytochrome-c oxidase activity (GO:0004129),0.29965681409879175,0.6369628255172127,0.8548123980424144,1.0,1.0,2/15,7.27%,COX7A2L;COX8A
prerank,flavin adenine dinucleotide binding (GO:0050660),0.2378800409858361,0.6354097113188911,0.9152542372881356,1.0,1.0,11/53,15.60%,MICAL2;LDHD;DLD;KMO;ETFA;FOXRED2;GFER;SDHA;MICAL3;CYB5R3;NOS1
prerank,channel activity (GO:0015267),0.2484563341200921,0.6354027572462713,0.8955823293172691,1.0,1.0,5/41,12.39%,BCL2;TRPV2;PANX1;KCNK3;CHRNA7
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.24040651900290055,-0.632378513957831,0.904639175257732,0.9770511779677528,1.0,1/15,4.69%,CCR9
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.31092032488887467,0.6306083261904478,0.8542805100182149,1.0,1.0,3/10,16.55%,POLD1;EXD2;MGME1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.2866754549082811,0.6265328394126866,0.8623548922056384,1.0,1.0,3/16,13.12%,ATP6V0A2;ATP6V1C1;ATP6V0D2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.2866754549082811,0.6265328394126866,0.8623548922056384,1.0,1.0,3/16,13.12%,ATP6V0A2;ATP6V1C1;ATP6V0D2
prerank,kinesin binding (GO:0019894),0.2638644256123969,0.6258465790173113,0.8882265275707899,1.0,1.0,6/27,16.82%,FAM83D;ACTB;ATCAY;KIFAP3;SPAG9;CLSTN1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.24835110790763154,0.6231952931845817,0.9113924050632911,1.0,1.0,10/33,22.33%,PCF11;AR;HNRNPU;URI1;ELOF1;DHX9;AGO1;WDR43;RPRD1A;CCAR2
prerank,histone methyltransferase activity (GO:0042054),0.24916622520272824,0.6144553873284753,0.9328571428571428,1.0,1.0,3/32,9.03%,SMYD1;PRMT7;NSD3
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.22669479853361701,-0.6142946935566274,0.9333333333333333,0.9847472378477305,1.0,10/16,46.39%,CD38;SMUG1;ADPRS;TDG;NEIL1;NEIL3;NTHL1;ADPRH;NEIL2;BST1
prerank,steroid hydroxylase activity (GO:0008395),0.28230643153980195,0.6067479961712294,0.899513776337115,1.0,1.0,1/16,3.15%,CYP7B1
prerank,ionotropic glutamate receptor activity (GO:0004970),0.27857599194909605,0.6066063310781508,0.8888888888888888,1.0,1.0,2/17,8.77%,GRIN2C;GRIK5
prerank,dipeptidyl-peptidase activity (GO:0008239),0.3043328655016066,0.6054535703649662,0.8818342151675485,1.0,1.0,2/10,12.99%,DPP10;DPP8
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.23609794105839543,0.6038145948444531,0.9418282548476454,1.0,1.0,11/35,21.19%,TAF1;SMARCB1;TP53;RELA;BAZ2A;STAT1;HDAC1;AGO1;RRN3;POU2F1;H3-3A
prerank,histone acetyltransferase activity (GO:0004402),0.24703093563486406,0.6034355745698924,0.9179856115107914,1.0,1.0,10/30,20.95%,TAF1;EPC2;KAT7;MCM3AP;HAT1;CLOCK;TADA3;KAT8;KAT14;KAT6A
prerank,NF-kappaB binding (GO:0051059),0.2601489565263252,0.603019619979177,0.9264475743348983,1.0,1.0,3/24,7.90%,SETD6;MTDH;RELA
prerank,methyl-CpG binding (GO:0008327),0.25442533997127403,0.602024242632387,0.90625,1.0,1.0,4/22,14.22%,ZCWPW1;ZBTB38;ZBTB33;ZBTB4
prerank,CoA hydrolase activity (GO:0016289),0.27701924929167676,0.5975650638611145,0.8944723618090452,1.0,1.0,1/16,3.02%,NUDT7
prerank,MHC protein binding (GO:0042287),0.2686788376161727,0.5971760534780821,0.8873456790123457,1.0,1.0,1/20,4.01%,LAG3
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.24270691809392736,-0.5936828255188497,0.9448275862068966,0.9872899706128097,1.0,3/11,13.51%,BAG4;BAG1;PFN1
prerank,adenyl nucleotide binding (GO:0030554),-0.24270691809392736,-0.5936828255188497,0.9448275862068966,0.9872899706128097,1.0,3/11,13.51%,BAG4;BAG1;PFN1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.27899767111243334,0.5842840028931402,0.9107142857142857,1.0,1.0,2/12,11.81%,PARN;CNOT7
prerank,myosin V binding (GO:0031489),0.2748045048157388,0.5829608661963966,0.9078014184397163,1.0,1.0,3/15,16.60%,RAB3A;RAB14;RAB8A
prerank,RNA polymerase core enzyme binding (GO:0043175),0.23249722140495657,0.5815628166217877,0.9424964936886395,1.0,1.0,11/33,22.33%,PCF11;HNRNPU;URI1;ELOF1;DHX9;AGO1;RRN3;WDR43;ERBB2;RPRD1A;CCAR2
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.2536399036065568,0.5783855580225421,0.9167950693374423,1.0,1.0,7/22,19.28%,ANKRA2;CLU;LDLRAP1;SNX17;HSPG2;LANCL1;CLTC
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.24562613777005063,-0.5758511652015671,0.9617834394904459,0.9910551334016576,1.0,2/10,12.14%,CXADR;SIRPA
prerank,MAP kinase kinase activity (GO:0004708),0.26456164445656827,0.5758098815686973,0.9177215189873418,1.0,1.0,4/15,15.50%,MAP2K1;MAP2K3;LRRK2;MAP2K4
prerank,NAD binding (GO:0051287),0.24634006734135108,0.5736675389263355,0.9183673469387755,1.0,1.0,6/26,16.52%,CRYZ;SIRT3;SIRT2;QDPR;HADH;SIRT6
prerank,mitogen-activated protein kinase binding (GO:0051019),0.23745615067844153,0.5730177842037071,0.9310344827586207,1.0,1.0,3/29,8.19%,DUSP5;MAPKAPK2;TNIP1
prerank,chemokine receptor binding (GO:0042379),-0.17207091163295088,-0.5709710532171,0.9858156028368794,0.9887490933360545,1.0,4/35,15.55%,ITCH;CXCL16;CX3CL1;CKLF
prerank,glutathione transferase activity (GO:0004364),0.247725005166885,0.5680976127781197,0.9261006289308176,1.0,1.0,3/23,12.12%,GSTT1;GSTP1;GSTA4
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.2613693685513786,0.5662329616173626,0.9110738255033557,1.0,1.0,2/15,8.09%,KMT2D;SETD3
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.21664400487675825,-0.5638484098188683,0.9763593380614657,0.9873270156438025,1.0,3/14,17.60%,ALDH4A1;BLVRB;ALDH1L1
prerank,mRNA methyltransferase activity (GO:0008174),-0.22627162169124243,-0.5613336301105712,0.9468822170900693,0.9840305949311443,1.0,5/12,28.17%,METTL3;METTL14;METTL16;CMTR1;METTL8
prerank,triglyceride lipase activity (GO:0004806),0.2474937834432825,0.5612547655920405,0.9225908372827805,1.0,1.0,1/20,3.34%,LPL
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.1704814962814362,-0.5590661068892336,0.9919354838709677,0.9805883320960832,1.0,10/40,23.15%,PCMTD1;HNMT;TARBP1;AS3MT;THUMPD3;ARMT1;RRP8;TPMT;SUV39H1;THUMPD2
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.22704078151764837,0.5525956990653618,0.9490806223479491,1.0,1.0,9/33,20.13%,PARN;ERI2;DIS3L2;DIS3L;CNOT7;EXD2;REXO2;EXOSC10;ERI1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.2627835151156571,0.5511454690240056,0.929701230228471,1.0,1.0,1/10,6.72%,HEXIM1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.2136815796566024,-0.5506551908605111,0.9651972157772621,0.9792902228869119,1.0,2/14,16.74%,CAPNS1;CAPN10
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.226070015252635,0.5503190931130159,0.9560906515580736,1.0,1.0,9/34,20.13%,PARN;ERI2;DIS3L2;DIS3L;CNOT7;EXD2;REXO2;EXOSC10;ERI1
prerank,exopeptidase activity (GO:0008238),0.21218792749381946,0.5394172491532347,0.9703989703989704,1.0,1.0,12/50,21.38%,LNPEP;RNPEP;BLMH;ENPEP;DPP10;DPP8;CTSA;METAP1;TRHDE;CNDP2;KDM8;XPNPEP3
prerank,C-C chemokine receptor activity (GO:0016493),0.23289130741538266,0.5345844153071759,0.9645061728395061,1.0,1.0,1/21,5.56%,CXCR6
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.23308059123531874,0.531749661245184,0.9533437013996889,1.0,1.0,3/21,11.83%,CHRAC1;POLD1;POLG
prerank,snoRNA binding (GO:0030515),0.2187060334445415,0.5257985424404833,0.9668587896253602,1.0,1.0,2/30,4.45%,NUDT7;NUDT4
prerank,phosphate ion binding (GO:0042301),0.2651683213122969,0.5216541495615187,0.9346289752650176,1.0,1.0,3/10,18.15%,RELA;ADSS1;RPH3A
prerank,aspartic-type endopeptidase activity (GO:0004190),0.2434227439271456,0.5199330805708091,0.9461400359066428,1.0,1.0,3/12,14.39%,DDI2;HM13;SPPL2B
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.24124425294848145,0.5172512932593332,0.9389830508474576,1.0,1.0,3/14,18.41%,AK7;CMPK1;CMPK2
prerank,nucleotide diphosphatase activity (GO:0004551),0.24074571100824785,0.5063101907964991,0.9532554257095158,1.0,1.0,2/14,10.23%,NUDT4;NUDT13
prerank,deoxyribonuclease activity (GO:0004536),0.2357219235177942,0.5038247634666677,0.9667250437828371,1.0,1.0,4/14,18.34%,MBD4;DNASE1L1;ZRANB3;MAP1S
prerank,adrenergic receptor binding (GO:0031690),0.22676030535793307,0.5005128899447812,0.9582637729549248,1.0,1.0,3/16,11.19%,NEDD4;SAV1;PDE4D
prerank,chemokine activity (GO:0008009),0.20620909899370837,0.4964585635909768,0.98005698005698,1.0,1.0,2/31,10.44%,CCL5;CCL14
prerank,methylated histone binding (GO:0035064),0.1835302779843248,0.49263144117956953,0.9949174078780177,1.0,1.0,7/62,9.38%,ZCWPW1;NCAPD3;TAF1;L3MBTL2;MSL3;TDRD3;CDYL
prerank,C-C chemokine binding (GO:0019957),0.20780965650817687,0.4788674649380363,0.9907407407407407,1.0,1.0,1/22,5.56%,CXCR6
prerank,proton transmembrane transporter activity (GO:0015078),0.19280550945928185,0.4767859031387468,0.9906914893617021,1.0,1.0,11/39,22.45%,COX7A2L;COX8A;UQCRFS1;UQCRH;COX5B;UQCRQ;SLC11A2;CLCN5;COX6A1;SLC9A1;ATP6V1F
prerank,ligand-gated channel activity (GO:0022834),0.1965023621019124,0.46491252256826304,0.9850523168908819,1.0,1.0,4/29,16.83%,GRIN2C;GRIK5;CHRNA4;GRIK4
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.1926503295911744,0.4640146233228076,0.9869186046511628,1.0,1.0,4/29,11.20%,NEU3;GLA;GANC;PARG
prerank,aspartic-type peptidase activity (GO:0070001),-0.20230718886199683,-0.46384300925698,0.9823788546255506,0.9942220570538685,1.0,5/10,45.88%,BACE2;CTSD;PSEN1;CTSE;BACE1
prerank,ligand-gated ion channel activity (GO:0015276),0.19443597797588857,0.4627325801682077,0.9852289512555391,0.9988829271733967,1.0,4/30,16.83%,GRIN2C;GRIK5;CHRNA4;GRIK4
prerank,purinergic nucleotide receptor activity (GO:0001614),0.2070199673489889,0.4396019020858863,0.9738134206219312,1.0,1.0,15/15,79.32%,P2RX4;P2RY14;GPR34;P2RX6;P2RX7;P2RX2;P2RY13;GPR87;P2RX1;GPR171;P2RX3;P2RX5;PTAFR;P2RY12;P2RY1
prerank,DNA replication origin binding (GO:0003688),0.18949234772166504,0.43660174061272705,0.9860248447204969,0.9997019416752366,1.0,4/23,16.81%,KAT7;MCMDC2;ORC2;DHX9
prerank,neuropeptide receptor binding (GO:0071855),0.19771457273811782,0.42665854935609737,0.9763513513513513,0.9990641377090484,1.0,14/14,80.25%,NTS;NPY;UCN3;APELA;QRFP;GHRH;NPPA;UCN2;GAL;AGRP;APLN;SHANK1;NMU;PPY
prerank,1-phosphatidylinositol binding (GO:0005545),0.1926071117644429,0.4142629775114316,0.9899665551839465,0.9985609206917152,1.0,4/15,21.47%,SNX9;SNAP91;ZFYVE16;ZFYVE9
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.18378622274583595,0.4042234259068889,0.9903381642512077,0.9974434695595934,1.0,1/17,4.87%,AK7
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.17472077459878935,0.392568416169901,0.9953198127925117,0.9964255604686774,1.0,3/21,18.03%,CHRNA7;CHRNA4;P2RX4
